View Filing Data

Print Document View Excel Document

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2014	Feb. 23, 2015	Jun. 30, 2014
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Trading Symbol	GSAT
Entity Registrant Name	Globalstar, Inc.
Entity Central Index Key	0001366868
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 1,471.5
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Voting Common Stock
Entity Common Stock, Shares Outstanding		869,414,107
Nonvoting Common Stock
Entity Common Stock, Shares Outstanding		134,008,656

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 7,121	$ 17,408
Accounts receivable, net of allowance of $4,788 and $7,419, respectively	15,015	15,723
Inventory	14,734	31,817
Advances for inventory	196	9,359
Prepaid expenses and other current assets	7,748	7,059
Total current assets	44,814	81,366
Property and equipment, net	1,113,560	1,169,785
Restricted cash	37,918	37,918
Deferred financing costs	63,862	76,436
Intangible and other assets, net	8,266	7,103
Total assets	1,268,420	1,372,608
Current liabilities:
Current portion of long-term debt	6,450	4,046
Accounts payable, including contractor payables of $1,180 and $7,665, respectively	6,922	14,627
Accrued contract termination charge	21,308	24,133
Accrued expenses	22,342	22,700
Payables to affiliates	481	202
Derivative liabilities	0	57,048
Deferred revenue	21,740	17,284
Total current liabilities	79,243	140,040
Long-term debt, less current portion	623,640	665,236
Employee benefit obligations	5,499	3,529
Derivative liabilities	441,550	405,478
Deferred revenue	6,572	7,079
Debt restructuring fees	20,795	20,795
Other non-current liabilities	12,205	13,696
Total non-current liabilities	1,110,261	1,115,813
Commitments and contingent liabilities (Notes 6 and 7)
Stockholders’ equity:
Preferred Stock	0	0
Additional paid-in capital	1,503,619	1,074,837
Accumulated other comprehensive income (loss)	(2,898)	871
Retained deficit	(1,421,904)	(959,038)
Total stockholders’ equity	78,916	116,755
Total liabilities and stockholders’ equity	1,268,420	1,372,608
Common Stock
Stockholders’ equity:
Common Stock	86	54
Nonvoting Common Stock
Stockholders’ equity:
Common Stock	$ 13	$ 31

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Accounts receivable, allowance	$ 4,788	$ 7,419
Contractor payables	$ 1,180	$ 7,665
Preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series A Preferred Stock
Preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1	1
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Voting Common Stock
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,200,000,000	1,200,000,000
Common stock, shares issued	864,378,563	535,883,461
Common stock, shares outstanding	864,378,563	535,883,461
Nonvoting Common Stock
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	134,008,656	309,008,656
Common stock, shares outstanding	134,008,656	309,008,656

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended												12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenue:
Service revenues													$ 69,823	$ 64,644	$ 57,468
Subscriber equipment sales													20,241	18,067	18,850
Total revenue	$ 22,093	$ 23,441	$ 23,994	$ 20,536	$ 20,994	$ 22,549	$ 19,835	$ 19,333	$ 19,062	$ 20,537	$ 19,981	$ 16,738	90,064	82,711	76,318
Operating expenses:
Cost of services (exclusive of depreciation, amortization and accretion shown separately below)													29,668	30,210	30,071
Cost of subscriber equipment sales													14,857	13,623	13,280
Cost of subscriber equipment sales - reduction in the value of inventory													21,684	5,794	1,397
Marketing, general and administrative													33,520	29,888	27,496
Reduction in the value of long-lived assets													84	0	7,218
Contract termination charge													0	0	22,048
Depreciation, amortization and accretion													86,146	90,592	69,801
Total operating expenses													185,959	170,107	171,311
Loss from operations													(95,895)	(87,396)	(94,993)
Other income (expense):
Loss on extinguishment of debt													(39,846)	(109,092)	0
Loss on equity issuance							(14,000)						0	(16,701)	0
Interest income and expense, net of amounts capitalized													(43,233)	(67,828)	(21,486)
Derivative gain (loss)													(286,049)	(305,999)	6,974
Other													3,038	(2,962)	(2,280)
Total other income (expense)													(366,090)	(502,582)	(16,792)
Loss before income taxes													(461,985)	(589,978)	(111,785)
Income tax expense													881	1,138	413
Net loss	$ 92,015	$ 129,390	$ (433,730)	$ (250,541)	$ (234,797)	$ (204,969)	$ (126,272)	$ (25,078)	$ (18,952)	$ (41,188)	$ (27,533)	$ (24,525)	$ (462,866)	$ (591,116)	$ (112,198)
Loss per common share:
Basic (USD per share)	$ 0.09	$ 0.13	$ (0.48)	$ (0.29)	$ (0.36)	$ (0.30)	$ (0.25)	$ (0.05)	$ (0.05)	$ (0.10)	$ (0.07)	$ (0.07)	$ (0.50)	$ (0.96)	$ (0.29)
Diluted (USD per share)	$ 0.08	$ 0.11	$ (0.48)	$ (0.29)	$ (0.36)	$ (0.30)	$ (0.25)	$ (0.05)	$ (0.05)	$ (0.10)	$ (0.07)	$ (0.07)	$ (0.50)	$ (0.96)	$ (0.29)
Weighted-average shares outstanding:
Basic (shares)	993,427	987,668	904,994	849,321	779,483	673,546	496,169	472,187	424,180	392,344	379,433	357,418	934,356	614,959	388,453
Diluted (shares)	1,192,263	1,189,190	904,994	849,321	779,483	673,546	496,169	472,187	424,180	392,344	379,433	357,418	934,356	614,959	388,453

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Net loss	$ (462,866)	$ (591,116)	$ (112,198)
Other comprehensive income (loss):
Defined benefit pension plan liability adjustment	(2,467)	3,485	78
Net foreign currency translation adjustment	(1,302)	(856)	1,264
Total comprehensive loss	$ (466,635)	$ (588,487)	$ (110,856)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Thermo Capital Partners LLC	Terrapin	Hughes Network Systems LLC	Warrants Associated with 8.00% Notes, Issued in 2009	Warrants Associated with 5.00% Notes	Warrants issued in conjunction with Contingent Equity Agreement	Warrants Associated With Thermo Loan Agreement	8.00% Convertible Senior Unsecured Notes Issued in 2009	Exchanging Note Holders	Conversions of 5.0% Notes	Conversions of 8.00% Notes, Issued in 2013	Common Stock	Common Stock Thermo Capital Partners LLC	Common Stock Terrapin	Common Stock Hughes Network Systems LLC	Common Stock Warrants Associated with 8.00% Notes, Issued in 2009	Common Stock Warrants Associated with 5.00% Notes	Common Stock Warrants issued in conjunction with Contingent Equity Agreement	Common Stock Warrants Associated With Thermo Loan Agreement	Common Stock 8.00% Convertible Senior Unsecured Notes Issued in 2009	Common Stock Exchanging Note Holders	Common Stock Conversions of 5.0% Notes	Common Stock Conversions of 8.00% Notes, Issued in 2013	Additional Paid-In Capital	Additional Paid-In Capital Thermo Capital Partners LLC	Additional Paid-In Capital Terrapin	Additional Paid-In Capital Hughes Network Systems LLC	Additional Paid-In Capital Warrants Associated with 8.00% Notes, Issued in 2009	Additional Paid-In Capital Warrants Associated with 5.00% Notes	Additional Paid-In Capital Warrants issued in conjunction with Contingent Equity Agreement	Additional Paid-In Capital Warrants Associated With Thermo Loan Agreement	Additional Paid-In Capital 8.00% Convertible Senior Unsecured Notes Issued in 2009	Additional Paid-In Capital Exchanging Note Holders	Additional Paid-In Capital Conversions of 5.0% Notes	Additional Paid-In Capital Conversions of 8.00% Notes, Issued in 2013	Accumulated Other Comprehensive Income (Loss)	Retained Deficit
Balance, shares at Dec. 31, 2011													353,058
Balance at Dec. 31, 2011	$ 533,795												$ 35												$ 792,584												$ (3,100)	$ (255,724)
Net issuance of restricted stock awards and recognition of stock-based compensation, shares													711
Net issuance of restricted stock awards and recognition of stock-based compensation	706																								706
Contribution of services	529																								529
Warrants issued associated with Contingent Equity Agreement	8,079																								8,079
Common stock issued in connection with conversions of 8.00% Notes, shares																					1,903
Issuance of common stock to converting note holders at fair value	0								$ 1,338																								$ 1,338
Warrants exercised associated with Notes, shares													191
Warrants exercised associated with Notes	420																								420
Issuance of stock in connection with interest payments for 8.00% Notes, shares													2,737
Issuance of stock in connection with interest payments for 8.00% Notes	912												$ 1												911
Issuance of stock in connection with contingent consideration, shares													5,232
Issuance of stock in connection with contingent consideration	2,209												$ 1												2,208
Issuance of stock to Thermo for contingent equity draws, shares													124,310
Issuance of stock to Thermo for contingent equity draws	57,250												$ 12												57,238
Issuance of stock through employee stock purchase plan, shares													944
Issuance of stock through employee stock purchase plan	138																								138
Issuance of stock for legal and consulting services	24																								24
Other comprehensive income (loss)	1,342																																				1,342
Net loss	(112,198)																																					(112,198)
Balance, shares at Dec. 31, 2012													489,086
Balance at Dec. 31, 2012	494,544												$ 49												864,175												(1,758)	(367,922)
Net issuance of restricted stock awards and recognition of stock-based compensation, shares													1,213
Net issuance of restricted stock awards and recognition of stock-based compensation	1,823																								1,823
Contribution of services	548																								548
Common stock issued in connection with conversions of 8.00% Notes, shares																								14,863
Issuance of common stock to converting note holders at fair value	10,227											$ 10,228												$ 2												$ 10,226
Warrants exercised associated with Notes, shares																	21,353	6,707
Warrants exercised associated with Notes					$ 22,218	$ 2,313											$ 2	$ 1											$ 22,216	$ 2,312
Issuance of stock in connection with interest payments for 8.00% Notes, shares													1,279
Issuance of stock in connection with interest payments for 8.00% Notes	644																								644
Issuance of stock in connection with contingent consideration, shares													3,939
Issuance of stock in connection with contingent consideration	1,844																								1,844
Issuance of stock for legal settlements, other issuances of stock and other transactions, shares													98
Issuance of stock for legal settlements, other issuances of stock and other transactions	101																								101
Issuance of stock through employee stock purchase plan, shares													952
Issuance of stock through employee stock purchase plan	$ 207																								207
Issuance of stock for legal and consulting services, shares
Issuance of stock, shares														174,009	6,131	9,501
Issuance of stock		$ 82,726	$ 6,000	$ 15,413										$ 17	$ 1	$ 1										$ 82,709	$ 5,999	$ 15,412
Purchase of stock in connection with the termination of Share Lending Arrangement	$ 4,429																								4,429
Return of stock in connection with the termination of Share Lending Arrangement, shares													(10,185)
Return of stock in connection with the termination of Share Lending Arrangement	(1)												$ (1)
Issuance of stock for employee stock option exercises, shares													2,621
Issuance of stock for employee stock option exercises	1,874																								1,874
Other comprehensive income (loss)	2,629																																				2,629
Net loss	(591,116)																																					(591,116)
Balance, shares at Dec. 31, 2013													844,892
Balance at Dec. 31, 2013	116,755												$ 85												1,074,837												871	(959,038)
Net issuance of restricted stock awards and recognition of stock-based compensation, shares													672
Net issuance of restricted stock awards and recognition of stock-based compensation	4,217																								4,217
Contribution of services	548																								548
Warrants exercised associated with Contingent Equity Agreement																			11,276
Warrants issued associated with Contingent Equity Agreement							$ 112																								$ 112
Common stock issued in connection with conversions of 8.00% Notes, shares																						30,319	93,006	46,353
Issuance of common stock to converting note holders at fair value	271,982									$ 12,127	$ 48,204	$ 161,848										$ 3	$ 10	$ 5										$ 12,124	$ 48,194	$ 161,843
Warrants exercised associated with Notes, shares																	38,200			4,206
Warrants exercised associated with Notes					$ 132,102			$ 42									$ 4												$ 132,098			$ 42
Issuance of stock in connection with contingent consideration, shares													750
Issuance of stock in connection with contingent consideration	2,040																								2,040
Issuance of stock through employee stock purchase plan, shares													306
Issuance of stock through employee stock purchase plan	538																								538
Issuance of stock, shares													47,067		6,100	2,765
Issuance of stock	114,211			$ 11,722									$ 5			$ 0									114,206			$ 11,722
Return of stock in connection with the termination of Share Lending Arrangement, shares													(10,200)
Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net	93																								93
Issuance of stock for employee stock option exercises, shares													1,900
Issuance of stock for employee stock option exercises	1,323																								1,323
Other comprehensive income (loss)	(3,769)																																				(3,769)
Net loss	(462,866)																																					(462,866)
Balance, shares at Dec. 31, 2014													998,387
Balance at Dec. 31, 2014	$ 78,916												$ 99												$ 1,503,619												$ (2,898)	$ (1,421,904)

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows provided by (used in) operating activities:
Net loss	$ (462,866)	$ (591,116)	$ (112,198)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation, amortization and accretion	86,146	90,592	69,801
Change in fair value of derivative assets and liabilities	286,049	305,155	(6,974)
Stock-based compensation expense	3,400	2,127	793
Amortization of deferred financing costs	10,043	8,792	7,907
Reduction in the value of long-lived assets and inventory	21,768	5,794	8,615
Provision for bad debts	2,281	2,321	1,097
Noncash interest and accretion expense	16,214	44,488	6,525
Contract termination charge	0	0	22,048
Loss on extinguishment of debt	39,846	109,092	0
Loss on equity issuance	0	16,701	0
Discount on shares issued to vendor	748	1,008	0
Unrealized foreign currency (gain) loss	(4,059)	1,013	1,456
Other, net	945	1,370	1,574
Changes in operating assets and liabilities:
Accounts receivable	(2,200)	(4,321)	(2,875)
Inventory	4,187	3,124	(1,018)
Prepaid expenses and other current assets	(1,339)	(727)	855
Other assets	202	(89)	5,427
Accounts payable and accrued expenses	(1,725)	(2,595)	3,431
Payables to affiliates	279	(29)	(148)
Other non-current liabilities	(619)	(1,079)	(224)
Deferred revenue	4,681	1,917	782
Net cash provided by (used in) operating activities	3,981	(6,462)	6,874
Cash flows used in investing activities:
Second-generation satellites, ground and related launch costs (including interest)	(14,604)	(43,693)	(56,679)
Property and equipment additions	(4,673)	(1,651)	(781)
Investment in businesses	0	(634)	(550)
Restricted cash	0	8,859	0
Net cash used in investing activities	(19,277)	(37,119)	(58,010)
Cash flows provided by financing activities:
Borrowings from Facility Agreement	0	672	7,375
Principal payments of the Facility Agreement	(4,046)	0	0
Proceeds from contingent equity account	0	1,071	45,800
Payments to reduce principal amount of exchanged 5.75% Notes	0	(13,544)	0
Payments for 5.75% Notes not exchanged	0	(6,250)	0
Payments to lenders and other fees associated with exchange	0	(2,482)	0
Proceeds from equity issuance to related party	0	65,000	0
Proceeds from issuance of stock to Terrapin	0	6,000	0
Payment of deferred financing costs	(164)	(16,909)	(1,033)
Proceeds from issuance of common stock and exercise of warrants	9,547	15,414	244
Net cash provided by financing activities	5,337	48,972	52,386
Effect of exchange rate changes on cash	(328)	225	591
Net (decrease) increase in cash and cash equivalents	(10,287)	5,616	1,841
Cash and cash equivalents, beginning of period	17,408	11,792	9,951
Cash and cash equivalents, end of period	7,121	17,408	11,792
Supplemental disclosure of cash flow information:
Cash paid for interest	20,216	21,413	27,383
Cash paid for: Income taxes	61	116	223
Supplemental disclosure of non-cash financing and investing activities:
Increase in non-cash capitalized accrued interest for second-generation satellites and ground costs	1,684	4,291	2,752
Capitalization of the accretion of debt discount and amortization of prepaid financing costs	2,708	5,600	15,680
Capitalized accrued interest and other payments made in convertible notes and common stock	3,974	12,056	7,948
Conversion of debt into common stock	76,532	49,757	2,000
Reduction in debt discount and deferred financing costs related to note conversions	28,249	27,458	0
Issuance of common stock to converting note holders at fair value	271,982	10,227	0
Reduction in derivative value due to conversion of debt	183,663	10,236	0
Extinguishment of principal amount of 5.75% Notes	0	(71,804)	0
Issuance of principal amount of 8.00% Notes Issued in 2013	0	54,611	0
Issuance of common stock to exchanging note holders at fair value	0	12,127	0
Reduction in carrying amount of Thermo Loan Agreement due to amendment	0	(35,026)	0
Issuance of common stock to vendor for payment of invoices	10,687	9,227	0
Conversion of contingent equity account derivative liability to equity	0	0	5,853
Value of warrants issued in connection with the contingent equity account loan fee	$ 0	$ 0	$ 2,226

CONSOLIDATED STATEMENTS OF CASH FLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)	Dec. 31, 2014
5.0% Convertible Senior Unsecured Notes
Loan interest rate	5.00%
8.00% Convertible Senior Notes Issued in 2013
Loan interest rate	8.00%
Interest rate, payable in cash	5.75%
5.75% Convertible Senior Unsecured Notes
Interest rate, payable in cash	5.75%

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business

Globalstar, Inc. (“Globalstar” or the “Company”) was formed as a Delaware limited liability company in November 2003 and was converted into a Delaware corporation on March 17, 2006.

Globalstar is a leading provider of Mobile Satellite Services (“MSS”) including voice and data communications services globally via satellite. Globalstar’s first-generation network, originally owned by Globalstar, L.P. (“Old Globalstar”), was designed, built and launched in the late 1990s by a technology partnership led by Loral Space and Communications (“Loral”) and Qualcomm Incorporated (“Qualcomm”). On February 15, 2002, Old Globalstar and three of its subsidiaries filed voluntary petitions under Chapter 11 of the United States Bankruptcy Code. In 2004, Thermo Capital Partners LLC (“Thermo”) became Globalstar’s principal owner, and Globalstar completed the acquisition of the business and assets of Old Globalstar. Thermo and its affiliates remain Globalstar’s largest stockholder. Globalstar’s Executive Chairman and CEO controls Thermo and its affiliates. Two other members of Globalstar’s Board of Directors are also directors, officers or minority equity owners of various Thermo entities.

The Company’s satellite communications business, by providing critical mobile communications to subscribers, serves principally the following markets: recreation and personal; government; public safety and disaster relief; oil and gas; maritime and fishing; natural resources, mining and forestry; construction; utilities; and transportation.

Globalstar currently provides the following communications services via satellite which are available only with equipment designed to work on the Globalstar network:


•	two-way voice communication and data transmissions (“Duplex”) using mobile or fixed devices; and


•	one-way data transmissions using a mobile or fixed device that transmits its location and other information to a central monitoring station, which includes certain SPOT and Simplex products.

Globalstar provides Duplex, SPOT and Simplex products and services to customers directly and through a variety of independent agents, dealers and resellers, and independent gateway operators (“IGOs”).

Use of Estimates in Preparation of Financial Statements

The preparation of Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from estimates. Certain reclassifications have been made to prior year Consolidated Financial Statements to conform to current year presentation. The Company evaluates estimates on an ongoing basis. Significant estimates include the value of derivative instruments, the allowance for doubtful accounts, the net realizable value of inventory, the useful life and value of property and equipment, the value of stock-based compensation, the reserve for product warranties, and income taxes.

Principles of Consolidation

The Consolidated Financial Statements include the accounts of Globalstar and all its subsidiaries. All significant inter-company transactions and balances have been eliminated in the consolidation.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less.

Restricted Cash

Restricted cash is comprised of funds held in escrow by the agent for the Company’s senior secured facility agreement (the “Facility Agreement”) to secure the Company’s principal and interest payment obligations under certain circumstances related to its Facility Agreement. The Company classifies restricted cash for certain debt instruments consistent with the classification of the related debt outstanding at the end of the reporting period.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents and restricted cash. Cash and cash equivalents and restricted cash consist primarily of highly liquid short-term investments deposited with financial institutions that are of high credit quality.

Accounts Receivable

Accounts receivable are uncollateralized, without interest and consist primarily of service revenue and equipment receivables. The Company performs ongoing credit evaluations of its customers and records specific allowances for bad debts based on factors such as current trends, the length of time the receivables are past due and historical collection experience. Accounts receivable are considered past due in accordance with the contractual terms of the arrangements. Accounts receivable balances that are determined likely to be uncollectible are included in the allowance for doubtful accounts. After all attempts to collect a receivable have failed, the receivable is written off against the allowance.

The following is a summary of the activity in the allowance for doubtful accounts (in thousands):



	Year Ended December 31,
	2014			2013			2012
Balance at beginning of period	$	7,419		$	6,667		$	7,296
Provision, net of recoveries	2,281			2,321			1,097
Write-offs and other adjustments	(4,912		)	(1,569		)	(1,726		)
Balance at end of period	$	4,788		$	7,419		$	6,667

During 2014, the Company deactivated approximately 26,000 subscribers in its Duplex subscriber base who were either suspended or non-paying. The increase in write-offs and other adjustments in 2014 reflects the balances related to these accounts.

Inventory

Inventory consists primarily of purchased products. Inventory is stated at the lower of cost or market value. Cost is computed using the first-in, first-out (FIFO) method. Inventory write downs are measured as the difference between the cost of inventory and the market value, and are recorded as a cost of subscriber equipment sales - reduction in the value of inventory in the Company’s Consolidated Financial Statements. At the point of any inventory write downs to market, a new, lower cost basis for that inventory is established, and any subsequent changes in facts and circumstances do not result in the restoration of the former cost basis or increase in that newly established cost basis. Product sales and returns from the previous 12 months and future demand forecasts are reviewed and excess and obsolete inventory is written off. A liability is recorded for firm, noncancelable, and unconditional purchase commitments with contract manufacturers and suppliers for quantities in excess of future demand forecasts consistent with the valuation of excess and obsolete inventory. In the year ended December 31, 2014, the Company wrote down the value of inventory by $21.7 million after evaluating its Duplex inventory and estimating the timing of new product launches. The assessment indicated that there was an excess of Duplex equipment included in inventory on hand based on the current sales run-rate. Additionally, the Company's future business plan contemplates using Hughes-based technology in future product development. As a result, much of the raw material held by Qualcomm is not likely to be used in the future production of additional inventory and was impaired. The Company wrote down the value of inventory by $5.8 million and $1.4 million in the years ended December 31, 2013 and 2012, respectively.

Property and Equipment

The Globalstar System includes costs for the design, manufacture, test, and launch of a constellation of low earth orbit satellites (the “Space Component”), and primary and backup control centers and gateways (the “Ground Component”). Property and equipment is stated at cost, net of accumulated depreciation.

Costs associated with the design, manufacture, test and launch of the Company’s Space and Ground Components are capitalized. Capitalized costs associated with the Company’s Space Component, Ground Component, and other assets are tracked by fixed asset category and are allocated to each asset as it comes into service. When a second-generation satellite was incorporated into the second-generation constellation, the Company began depreciation on the date the satellite was placed into service, which was the point that the satellite reached its orbital altitude, over its estimated depreciable life.

The Company capitalizes interest costs associated with the costs of assets in progress, including primarily the construction of its Space and Ground Components. Capitalized interest is added to the cost of the underlying asset and is amortized over the depreciable life of the asset after it is placed into service. As the Company’s construction in progress decreases, specifically due to the Company placing second-generation satellites or gateways into service, the Company capitalizes less interest, resulting in greater amounts of interest expense recognized under GAAP.

Depreciation is provided using the straight-line method over the estimated useful lives of the respective assets as follows:

Second Generation Space Component - 15 years from the commencement of service

Ground Component - Up to 15 years from commencement of service

Software, Facilities & Equipment - 3 to 10 years

Buildings - 18 years

Leasehold Improvements - Shorter of lease term or the estimated useful lives of the improvements

The Company evaluates and revises the estimated depreciable lives assigned to property and equipment based on changes in facts and circumstances. When changes are made to estimated useful lives, the remaining carrying amounts are depreciated prospectively over the remaining useful lives.

For assets that are sold or retired, including satellites that are de-orbited and no longer providing services, the estimated cost and accumulated depreciation is removed from property and equipment.

The Company assesses the impairment of long-lived assets when indicators of impairment are present. Recoverability of assets is measured by comparing the carrying amounts of the assets to the estimated future undiscounted cash flows, excluding financing costs. If an impairment is determined to exist, any related impairment loss is estimated based on fair values. The Company records losses from the in-orbit failure of a satellite in the period it is determined that the satellite is not recoverable.

Derivative Instruments

The Company enters into financing arrangements that are hybrid instruments that contain embedded derivative features. Derivative instruments are recognized as either assets or liabilities in the consolidated balance sheets and are measured at fair value with gains or losses recognized in earnings. The Company determines the fair value of derivative instruments based on available market data using appropriate valuation models.

Deferred Financing Costs

Deferred financing costs are those incurred in obtaining long-term debt. These costs are amortized as additional interest expense over the term of the corresponding debt, or the first put option date for the Company’s 8.00% Convertible Senior Notes Issued in 2013 (“8.00% Notes Issued in 2013”). As of December 31, 2014 and 2013, the Company had net deferred financing costs of $63.9 million and $76.4 million, respectively. The Company classifies deferred financing costs consistent with the classification of the related debt outstanding at the end of the reporting period.

Fair Value of Financial Instruments

The carrying amount of accounts receivable and accounts payable is equal to or approximates fair value.

The Company believes it is not practicable to determine the fair value of the Facility Agreement. Unlike typical long-term debt, interest rates and other terms for long-term debt are not readily available and generally involve a variety of factors, including due diligence by the debt holders. As such, it is not practicable to determine the fair value of long-term debt without incurring significant additional costs.

The Company was required to record at fair value, at inception, the Company’s Amended and Restated Loan Agreement with Thermo (the “Loan Agreement”) and the 8.00% Notes Issued in 2013. The Loan Agreement was amended and restated in 2013 and qualified for extinguishment accounting under applicable accounting rules. In May 2013, the Company issued 8.00% Notes Issued in 2013 and other consideration in exchange for a portion of the Company’s 5.75% Convertible Senior Notes (the “5.75% Notes”). This transaction qualified for extinguishment accounting. See Note 3: Long-Term Debt and Other Financing Arrangements for further discussion.

Gain/Loss on Extinguishment of Debt

Gain or loss on extinguishment of debt is generally recorded upon an extinguishment of a debt instrument or the conversion of certain of the Company’s convertible notes. Gain or loss on extinguishment of debt is calculated as the difference between the reacquisition price and net carrying amount of the debt. Differences are recorded as an extinguishment gain or loss in the Company’s consolidated statement of operations.

Revenue Recognition and Deferred Revenue

Duplex Service Revenue. For Duplex customers and resellers, the Company recognizes revenue for monthly access fees in the period services are rendered. Access fees represent the minimum monthly charge for each line of service based on its associated rate plan. The Company also recognizes revenue for airtime minutes in excess of the monthly access fees in the period such minutes are used. Under certain annual plans where customers prepay for minutes, revenue is deferred until the minutes are used or the prepaid time period expires. Unused minutes are accumulated until they expire, usually one year after activation. In addition, the Company offers other annual plans whereby the customer is charged an annual fee to access the Company’s system. These fees are recognized on a straight-line basis over the term of the plan. In some cases, the Company charges a per minute rate whereby it recognizes the revenue when each minute is used.

Credits granted to customers are expensed or charged against revenue or deferred revenue upon issuance.

Certain subscriber acquisition costs, including such items as dealer commissions and internal sales commissions, are expensed at the time of the related sale, except when related to a multi-element contract as discussed below.

SPOT and Simplex Service Revenue. The Company sells SPOT and Simplex services as annual plans or multi-year plans and defers and recognizes revenue ratably over the service term or as service is used, beginning when the service is activated by the customer. Royalty payments are deferred and recognized as expense over the contract term.

IGO Service Revenue. The Company owns and operates its satellite constellation and earns a portion of its revenues through the sale of airtime minutes or data on a wholesale basis to IGOs. Revenue from services provided to IGOs is recognized based upon airtime minutes used by customers of the IGOs and contractual fee arrangements. Where collection is uncertain, revenue is recognized when cash payment is received.

Equipment Revenue. Subscriber equipment revenue represents the sale of fixed and mobile user terminals, accessories and SPOT and Simplex products. The Company recognizes revenue upon shipment provided title and risk of loss have passed to the customer, persuasive evidence of an arrangement exists, the fee is fixed and determinable and collection is probable.

Other Service Revenue. At times, the Company will sell subscriber equipment through multi-element contracts with services. When the Company sells subscriber equipment and services in bundled arrangements and determines that it has separate units of accounting, the Company will allocate the bundled contract price among the various contract deliverables based on each deliverable’s relative fair value. The Company will determine vendor specific objective evidence of fair value by assessing sales prices of subscriber equipment and services when they are sold to customers on a stand-alone basis. Initial direct costs incurred related to these contracts will be deferred to the extent they exceed the profit margin recognized at the time of sale.

The Company does not record sales taxes collected from customers in revenue.

The Company provides certain engineering services to assist customers in developing new applications related to its system. The revenues associated with these services are recorded when the services are rendered, and the expenses are recorded when incurred.

Stock-Based Compensation

The Company recognizes compensation expense in the financial statements for both employee and non-employee share-based awards based on the grant date fair value of those awards. The Company uses the Black-Scholes option pricing model to estimate fair values of share-based awards. Option pricing models, including the Black-Scholes model, require the use of input estimates and assumptions, including expected volatility, term, and risk-free interest rate. The assumptions for expected volatility and expected term most significantly affect the estimated grant-date fair value. The Company's estimate of the forfeiture rate of its share-based awards also impacts the timing of expense recorded over the vesting period of the award. The Company's estimate for pre-vesting forfeitures is recognized over the requisite service periods of the awards on a straight-line basis, which is generally commensurate with the vesting term. See Note 13: Stock Compensation for a description of methods used to determine the Company's assumptions. If the Company determined that another method used to estimate expected volatility or expected life was more reasonable than its current methods, or if another method for calculating these input assumptions was prescribed by authoritative guidance, the estimated fair value calculated for share-based awards could change significantly. Higher volatility and longer expected lives result in increases to share-based compensation determined at the date of grant.

Foreign Currency

The functional currency of the Company’s foreign consolidated subsidiaries is their local currency. Assets and liabilities of its foreign subsidiaries are translated into United States dollars based on exchange rates at the end of the reporting period. Income and expense items are translated at the average exchange rates prevailing during the reporting period. For 2014 and 2013, the foreign currency translation adjustments were losses of $1.3 million and $0.9 million, respectively. For 2012, the foreign currency translation adjustment recorded was income of $1.3 million. These amounts are reflected in the consolidated statements of comprehensive loss.

Foreign currency transaction gains/losses were a $4.1 million gain, a $1.0 million loss and a $2.0 million loss for 2014, 2013, and 2012, respectively. These were classified as other income (expense) on the consolidated statement of operations.

In February 2013, the Venezuelan government devalued its currency. This devaluation did not have a material impact on the Company’s operations or financial performance.

Asset Retirement Obligation

Liabilities arising from legal obligations associated with the retirement of long-lived assets are measured at fair value and recorded as a liability. Upon initial recognition of a liability for retirement obligations, the Company records an asset, which is depreciated over the life of the asset to be retired. Accretion of the asset retirement obligation liability and depreciation of the related assets are included in depreciation, amortization and accretion in the accompanying consolidated statements of operations.

The Company capitalizes, as part of the carrying amount, the estimated costs associated with the eventual retirement of gateways owned by the Company. As of December 31, 2014 and 2013, the Company had accrued approximately $1.2 million and $1.1 million, respectively, for asset retirement obligations. The Company believes this estimate will be sufficient to satisfy the Company’s obligation under leases to remove the gateway equipment and restore the sites to their original condition.

Warranty Expense

Warranty terms extend from 90 days on equipment accessories to one year for fixed and mobile user terminals. An accrual is made when it is estimable and probable that a loss has been incurred based on historical experience. Warranty costs are based on historical trends in warranty charges as a percentage of gross product shipments. A provision for estimated future warranty costs is recorded as cost of sales when products are shipped. The resulting accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates.

Research and Development Expenses

Research and development costs were $0.5 million, $0.6 million and $0.3 million for 2014, 2013 and 2012, respectively. These costs are expensed as incurred as cost of services and primarily include the cost of new product development, chip set design, software development and engineering.

Advertising Expenses

Advertising costs were $2.6 million, $2.9 million and $1.9 million for 2014, 2013, and 2012, respectively. These costs are expensed as incurred as marketing, general and administrative expenses.

Income Taxes

Until January 1, 2006, the Company and its U.S. operating subsidiaries were treated as partnerships for U.S. tax purposes. Generally, taxable income or loss, deductions and credits of the partnerships were passed through to the partners. Effective January 1, 2006, the Company elected to be taxed as a C corporation for U.S. tax purposes, and the Company and its U.S. operating subsidiaries began accounting for income taxes as a corporation.

The Company recognizes deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, operating losses and tax credit carry-forwards. The Company measures deferred tax assets and liabilities using tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates in income in the period that includes the enactment date.

The Company also recognizes valuation allowances to reduce deferred tax assets to the amount that is more likely than not to be realized. In assessing the likelihood of realization, management considers: (i) future reversals of existing taxable temporary differences; (ii) future taxable income exclusive of reversing temporary differences and carry-forwards; (iii) taxable income in prior carry-back year(s) if carry-back is permitted under applicable tax law; and (iv) tax planning strategies.

Comprehensive Income (Loss)

All components of comprehensive income (loss), including the minimum pension liability adjustment and foreign currency translation adjustment, are reported in the financial statements in the period in which they are recognized. Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources.

Loss Per Share

The Company is required to present basic and diluted earnings per share. Basic loss per share is computed by dividing loss available to common stockholders by the weighted average number of common shares outstanding during the period. For 2014, 2013, and 2012, diluted net loss per share of common stock was the same as basic net loss per share of common stock because the effects of potentially dilutive securities are anti-dilutive. Potentially dilutive securities include outstanding stock-based awards, convertible notes, warrants and shares issuable pursuant to the Company's Employee Stock Purchase Plan. See Note 3: Long-Term Debt and Other Financing Arrangements and Note 13: Stock Compensation for further discussion of these instruments.

As of December 31, 2012, 17.3 million Borrowed Shares, as defined, related to the Company’s Share Lending Agreement were outstanding. The Company did not consider the Borrowed Shares to be outstanding for the purposes of computing and reporting its earnings per share. Effective in July 2013, the Company and the Borrower, as defined, terminated the Share Lending Agreement resulting in the Borrower returning 10.2 million Borrowed Shares to Globalstar and agreeing to pay a cash settlement for the remaining 7.1 million Borrowed Shares at an average of the volume weighted stock prices over a 20-day trading period ending in August 2013.

PROPERTY AND EQUIPMENT

12 Months Ended

Dec. 31, 2014

Property, Plant and Equipment [Abstract]

PROPERTY AND EQUIPMENT

Property and equipment consists of the following (in thousands):



	December 31, 2014			December 31, 2013
Globalstar System:
Space component
Second-generation satellites in service	$	1,211,904		$	1,212,099
Prepaid long-lead items	17,040			17,040
Second-generation satellite, on-ground spare	32,481			32,365
Ground component	47,595			48,378
Construction in progress:
Space component	30			—
Ground component	141,789			116,377
Other	2,458			1,115
Total Globalstar System	1,453,297			1,427,374
Internally developed and purchased software	15,392			14,931
Equipment	12,647			12,385
Land and buildings	3,590			3,768
Leasehold improvements	1,620			1,644
Total property and equipment	1,486,546			1,460,102
Accumulated depreciation	(372,986		)	(290,317		)
Total property and equipment, net	$	1,113,560		$	1,169,785

Amounts in the above table consist primarily of costs incurred related to the construction of the Company’s second-generation constellation and ground upgrades. Amounts included in the Company’s second-generation satellite, on-ground spare balance as of December 31, 2014 consist primarily of costs related to a spare second-generation satellite that is capable of being included in a future launch of satellites.

Capitalized Interest and Depreciation Expense

The following table summarizes capitalized interest for the periods indicated below (in thousands):



	Year Ended December 31,
	2014			2013			2012
Interest cost eligible to be capitalized	$	44,854		$	45,308		$	57,249
Interest cost recorded in interest income (expense), net	(36,909		)	(28,211		)	(17,133		)

Net interest capitalized	$	7,945		$	17,097		$	40,116

The following table summarizes depreciation expense for the periods indicated below (in thousands):



	Year Ended December 31,
	2014		2013		2012
Depreciation Expense	$	84,802	$	89,828	$	67,289

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS

12 Months Ended

Dec. 31, 2014

Debt Disclosure [Abstract]

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS

The principal amount and carrying value of long-term debt consists of the following (in thousands):



	December 31, 2014				December 31, 2013
	Principal Amount		Carrying Value		Principal Amount		Carrying Value
Facility Agreement	$	582,296	$	582,296	$	586,342	$	586,342
Thermo Loan Agreement	68,154		32,971		60,383		22,854
8.00% Convertible Senior Notes Issued in 2013	22,799		14,823		46,971		26,291
8.00% Convertible Senior Unsecured Notes Issued in 2009	—		—		51,652		33,795
Total Debt	673,249		630,090		745,348		669,282
Less: Current Portion	6,450		6,450		4,046		4,046
Long-Term Debt	$	666,799	$	623,640	$	741,302	$	665,236

The principal amounts shown above include payment of in-kind interest, if any. The carrying value is net of any discounts to the loan amounts at issuance, including accretion, as further described below. The current portion of long-term debt represents the scheduled semi-annual principal repayments under the Facility Agreement due within one year of the balance sheet date.

Amended and Restated Facility Agreement

On July 31, 2013, the Company entered into the Global Deed of Amendment and Restatement (the “GARA”) with Thermo, the Company's domestic subsidiaries (the “Subsidiary Guarantors”), a syndicate of bank lenders, including BNP Paribas, Société Générale, Natixis, Credit Agricole Corporate and Investment Bank and Credit Industrial et Commercial as arrangers and BNP Paribas as the security agent and COFACE Agent, providing for the amendment and restatement of the Former Facility Agreement (described below) and certain related credit documents (the amended and restated facility agreement is herein referred to as the "Facility Agreement"). The GARA became effective on August 22, 2013 and, among other things, waived all of the Company's defaults under the Former Facility Agreement and restructured the financial covenants.

The Facility Agreement is scheduled to mature in December 2022. Semi-annual principal repayments began in December 2014. The Facility Agreement bears interest at a floating LIBOR rate plus a margin of 2.75% through June 2017, increasing by an additional 0.5% each year to a maximum rate of LIBOR plus 5.75%. Ninety-five percent of the Company's obligations under the Facility Agreement are guaranteed by COFACE, the French export credit agency. The Company's obligations under the Facility Agreement are guaranteed on a senior secured basis by all of the Company's domestic subsidiaries and are secured by a first priority lien on substantially all of the assets of the Company's domestic subsidiaries (other than their FCC licenses), including patents and trademarks, 100% of the equity of the Company's domestic subsidiaries and 65% of the equity of certain of the Company's foreign subsidiaries.

The Facility Agreement contains customary events of default and requires that the Company satisfy various financial and non-financial covenants. If the Company violates any of these covenants and is unable to obtain waivers, it would be in default under the agreement and payment of the indebtedness could be accelerated. The acceleration of the Company's indebtedness under one agreement may permit acceleration of indebtedness under other agreements that contain cross-acceleration provisions. The covenants under the Facility Agreement limit the Company's ability to, among other things, incur or guarantee additional indebtedness; make investments, acquisitions or capital expenditures; repurchase or redeem capital stock or subordinated indebtedness; grant liens on its assets; incur restrictions on the ability of its subsidiaries to pay dividends or to make other payments to the Company; enter into transactions with its affiliates; merge or consolidate with other entities or transfer all or substantially all of its assets; and transfer or sell assets.

The compliance calculations of the financial covenants defined in the Facility Agreement include certain cash funds contributed to the Company from the issuance of the Company's common stock and/or Subordinated Indebtedness. These funds are referred to as "Equity Cure Contributions" and may be funded subsequent to the covenant measurement dates in order to achieve compliance with the covenants described above subject to the conditions set forth in the Facility Agreement. Each Equity Cure Contribution must be made in a minimum amount of $10 million with no maximum amount for each measurement period or in the aggregate for all periods until the date that such funding is no longer allowed by the Facility Agreement (which will be the case for any period after the measurement period ending June 30, 2017). Equity Cure Contributions that are in excess of the amounts required to achieve the required covenant calculation, as a result of the $10 million minimum per funding, may be applied to determining compliance with future covenant calculations. In February 2015, the Company drew $10 million under its agreement with Terrapin (described below). These funds were deemed an Equity Cure Contribution under the Facility Agreement and were used in the Company's calculation of compliance with certain financial covenants under the Facility Agreement. As a result, the Company was in compliance with its financial and non-financial covenants as of December 31, 2014.

The Facility Agreement requires that:


•	the Company maintain funds in a debt service reserve account. The use of the funds in this account is restricted to making principal and interest payments under the Facility Agreement. As of December 31, 2014, the balance in the debt service reserve account was $37.9 million and is classified as restricted cash.

•

the Company's capital expenditures do not exceed $18.8 million for the full year 2015, $13.2 million for the full year 2016 and $15.0 million for each year thereafter. Pursuant to the terms of the Facility Agreement, if, in any relevant period, the capital expenditures are less than the permitted amount for that relevant period, a permitted excess amount may be added to the maximum amount of capital expenditures in the next period;


•	the Company maintain at all times a minimum liquidity balance of $4.0 million;


•	the Company achieve for each period the following minimum adjusted consolidated EBITDA (as defined in the Facility Agreement)(amounts in thousands):



Period	Minimum Amount
7/1/14-12/31/14	$	14,062
1/1/15-6/30/15	$	16,958
7/1/15-12/31/15	$	23,469
1/1/16-6/30/16	$	24,502
7/1/16-12/31/16	$	32,426

The minimum adjusted consolidated EBITDA Minimum Amount changes semi-annually through December 31, 2022, for which measurement period the Minimum Amount is $65.7 million.


•	the Company maintain a minimum debt service coverage ratio of 1.00:1; and


•	the Company maintain a maximum net debt to adjusted consolidated EBITDA ratio of 27.00:1 for the December 31, 2014 measurement period, decreasing gradually each semi-annual period until the requirement equals 2.50:1 for the five semi-annual measurement periods leading up to December 31, 2022.

Pursuant to the GARA,

•

In August 2013, the Company paid the lenders a restructuring fee plus an additional underwriting fee to COFACE in the aggregate amount of approximately $13.9 million, representing 40% of the total restructuring and underwriting fee; the balance of $20.8 million is due no later than December 31, 2017. This remaining amount is included in noncurrent liabilities on the December 31, 2014 consolidated balance sheet. The Company also paid all outstanding incurred transaction expenses for the Lenders.


•	In August 2013, the Company drew the remaining approximately $0.7 million not previously borrowed under the Former Facility Agreement for certain milestone payments due to Thales for the construction of the second-generation satellites.


•	In August 2013, all amounts remaining under the Thermo Contingent Equity Account (approximately $1.1 million) and approximately $0.2 million in the Debt Service Reserve Account were paid to the Company's launch services provider for certain costs for the launch of its second-generation satellites.

•

Thermo confirmed its obligations under the Equity Commitment, Restructuring and Consent Agreement dated as of May 20, 2013 to make, or arrange for third parties to make, cash contributions to the Company in exchange for equity, subordinated convertible debt or other equity-linked securities of $20.0 million on or prior to December 26, 2013, and an additional amount of up to $20.0 million on or prior to December 31, 2014. See further discussion below on the details of the Consent Agreement and subsequent cash contributions to the Company.

The GARA made the following changes to the terms of the Facility Agreement:


•	The initial principal payment date, formerly June 30, 2013, was postponed to December 31, 2014, and the final maturity date was extended from June 30, 2020 to December 31, 2022.


•	The remaining principal payments, with the final payment due December 31, 2022, were also restructured, resulting in an aggregate postponement of $235.3 million in principal payments through 2019.


•	The annual interest rate increased by 0.5% to LIBOR plus 2.75% through July 1, 2017, and increases by an additional 0.5% each year thereafter to a maximum rate of LIBOR plus 5.75%.

•

Mandatory prepayments were expanded in specified circumstances and amounts, including if the Company generates excess cash flow, monetizes its spectrum rights, receives the proceeds of certain asset dispositions or receives more than $145.0 million from the sale of additional debt or equity securities (excluding the Thermo commitments described above and up to $19.5 million under its equity line with Terrapin).

•

The financial covenants were modified, including changing the amount of permitted capital expenditures, reducing the required minimum liquidity amount from $5.0 million to $4.0 million, restructuring the other existing financial covenants to correspond to the Company's revised business plan reflecting the delays in delivery of its second-generation satellites, and adding a new covenant with respect to its interest coverage ratio (as defined in the Facility Agreement). This new ratio requires that the Company must maintain an adjusted consolidated EBITDA to consolidated interest expense ratio (as defined in the Facility Agreement) of 0.95:1 for the December 31, 2014 measurement period, increasing gradually each semi-annual period until the requirement equals 5.00:1 for the five semi-annual measurement periods leading up to December 31, 2022.


•	The definition of Change of Control was amended to require a mandatory prepayment of the entire facility if Thermo and certain of its affiliates own less than 51% of the Company's voting common stock.


•	The required balance of the Debt Service Reserve Account was fixed at the current amount of approximately $37.9 million for the length of the Facility Agreement.


•	Any new subordinated indebtedness may not mature or pay cash interest prior to the final maturity date of the Facility Agreement.


•	The Company, while the Facility Agreement is outstanding, is prohibited from paying any cash dividends or repaying any principal or interest with respect to its indebtedness to Thermo under the Thermo Loan Agreement.

•The Company is prohibited from amending its material agreements without the lenders’ prior consent.


•	An event of default was added if any litigation against the Company results in a final judgment that imposes a material liability that was not anticipated by its business plan.

The Company evaluated the GARA under applicable accounting guidance and determined that the amendment and restatement of its Facility Agreement was a modification of the former indebtedness.

The Former Facility Agreement

In 2009, the Company entered into a facility agreement with a syndicate of bank lenders, including BNP Paribas, Natixis, Société Générale, Caylon, Crédit Industriel et Commercial as arrangers and BNP Paribas as the security agent and agent for its facility agreement (the "Former Facility Agreement"). The Former Facility Agreement was amended and restated in 2013 (see discussion above). The Former Facility Agreement had a maturity of 84 months after the first principal repayment date, as amended. Semi-annual principal repayments were scheduled to begin on June 30, 2013, as amended. The Former Facility Agreement bore interest at a floating LIBOR rate, plus a margin of 2.25% through December 2017, increasing to 2.40% thereafter.

The Former Facility Agreement required the Company to maintain a total of $46.8 million in a debt service reserve account. The use of the funds in this account was restricted to making principal and interest payments under the Former Facility Agreement. The minimum required balance, not to exceed $46.8 million, fluctuated over time based on the timing of principal and interest payment dates. In December 2012, the amount required to be funded into the debt service reserve account was reduced by approximately $8.9 million due to the timing of the first principal repayment date scheduled for June 2013. In January 2013, the agent for the Former Facility Agreement permitted the Company to withdraw from the debt service reserve account $8.9 million that was in excess of the required balance to enable the Company to pay costs relating to the fourth launch of its second-generation satellites.

The Former Facility Agreement contained customary events of default and required the Company to satisfy various financial and non-financial covenants. As a result of the Thales arbitration ruling and the subsequent settlement agreements reached with Thales related to the arbitration ruling in 2012, the lenders concluded that events of default had occurred under the Former Facility Agreement. The Company was also in default of certain other financial and non-financial covenants, including, but not limited to, failing to make a payment of principal in June 2013 in accordance with the terms of the Former Facility Agreement, failure to maintain minimum required funding for its debt service account, and failure to achieve in-orbit acceptance of all of its second-generation satellites by April 2013. Prior to the Former Facility Agreement’s amendment and restatement in August 2013, the borrowings were shown as current on the Company's consolidated balance sheet in accordance with applicable accounting rules. The Company also projected that it would not be in compliance with certain future financial and non-financial covenants specified under the Former Facility Agreement. These events of default were waived or cured by the August 2013 amendment and restatement of the Former Facility Agreement.

Contingent Equity Agreement

In June 2009, the Company entered into a Contingent Equity Agreement with Thermo whereby Thermo agreed to deposit $60.0 million into a contingent equity account to fulfill a condition precedent for borrowing under the Facility Agreement. Under the terms of the Facility Agreement, the Company had the right to make draws from this account if and to the extent it had an actual or projected deficiency in its ability to meet obligations due within a forward-looking 90-day period.

The Contingent Equity Agreement provided that the Company would pay Thermo an availability fee of 10% per year for maintaining funds in the contingent equity account. This annual fee was payable solely in warrants to purchase common stock at $0.01 per share with a five-year exercise period from issuance. The number of shares issuable under the warrants was calculated by taking the outstanding funds available in the contingent equity account multiplied by 10% divided by the lower of the Company's common stock price on the issuance date or $1.37, but not to be lower than $0.20. Prior to June 19, 2012, the common stock price was subject to a reset provision on certain valuation dates whereby the warrant price used in the calculation would be the lower of the warrant price on the issuance date or the Company's common stock price on the valuation date. The warrants issued to Thermo are no longer subject to any reset provisions. The Company determined that the warrants issued in conjunction with the availability fee were derivatives and recorded the value of the derivatives as a component of other non-current liabilities, at issuance. The offset was recorded in other assets and was amortized over the one-year availability period. The warrants issued on June 19, 2012 were not subject to a reset provision subsequent to issuance and are therefore not considered a derivative instrument. The offset was recorded in other assets and was amortized over the one-year availability period. On June 19, 2012, the warrants issued on June 19, 2011 were no longer variable, and the related $5.9 million liability was reclassified to equity.

When the Company made draws on the contingent equity account, it issued Thermo shares of common stock calculated using a price per share equal to 80% of the average closing price of the common stock for the 15 trading days immediately preceding the draw. The 20% discount on the value of the shares issued to Thermo is treated as a deferred financing cost and is amortized over the remaining term of the Facility Agreement. The Company has drawn the entire $60.0 million from this account as well as interest earned from the funds previously held in this account of approximately $1.1 million.

Since the origination of the Contingent Equity Agreement, the Company has issued to Thermo warrants to purchase 41.5 million shares of common stock for the annual availability fee and subsequent resets due to provisions in the Contingent Equity Agreement and 160.9 million shares of common stock resulting from the Company's draws on the contingent equity account pursuant to the terms of the Contingent Equity Agreement. The Company also issued to Thermo 2.1 million shares of common stock resulting from the interest earned from the funds previously held in this account.

As of December 31, 2014, Thermo had exercised warrants to purchase approximately 11.3 million of these shares prior to the expiration of the associated warrants. See Note 4: Derivatives and Note 9: Related Party Transactions for additional information related to the warrants exercised in connection with the Contingent Equity Agreement.

No voting common stock is issuable if it would cause Thermo and its affiliates to own more than 70% of the Company's outstanding voting stock. The Company may issue nonvoting common stock in lieu of common stock to the extent issuing common stock would cause Thermo and its affiliates to exceed this 70% ownership level.

Thermo Loan Agreement

The Company has an Amended and Restated Loan Agreement (the “Loan Agreement”) with Thermo whereby Thermo agreed to lend the Company $25.0 million for the purpose of funding the debt service reserve account required under the Facility Agreement. In 2011, this loan was increased to $37.5 million. This loan is subordinated to, and the debt service reserve account is pledged to secure, all of the Company's obligations under the Facility Agreement. Amounts deposited in the debt service reserve account are restricted to payments due under the Facility Agreement, unless otherwise authorized by the lenders.

The loan accrues interest at 12% per annum, which is capitalized and added to the outstanding principal in lieu of cash payments. The Company will make payments to Thermo only when permitted under the Facility Agreement. The loan becomes due and payable six months after the obligations under the Facility Agreement have been paid in full, the Company has a change in control or any acceleration of the maturity of the loans under the Facility Agreement occurs. As of December 31, 2014, $30.7 million of interest was outstanding and is included in the principal amount of the Thermo Loan Agreement. The amount by which the if-converted value of the the Thermo Loan Agreement exceeds the principal amount at December 31, 2014, assuming conversion at the closing price of the Company's common stock on that date of $2.75 per share, is approximately $244 million.

As additional consideration for the loan, the Company issued Thermo a warrant to purchase 4.2 million shares of common stock at $0.01 per share with a five-year exercise period. No voting common stock is issuable upon such exercise if such issuance would cause Thermo and its affiliates to own more than 70% of the Company's outstanding voting stock. The Company may issue nonvoting common stock in lieu of common stock to the extent issuing common stock would cause Thermo and its affiliates to exceed this 70% ownership level. The Company determined that the warrant was an equity instrument and recorded it as a part of stockholders’ equity with a corresponding debt discount of $5.2 million, which is netted against the principal amount of the loan. The Company accreted this debt discount associated with the warrant using an effective interest method to interest expense over the term of the loan agreement prior to the amendment and restatement as further discussed below.

As previously disclosed, in connection with the amendment and restatement of the Facility Agreement, the Company also amended and restated the Loan Agreement in July 2013. The Amended and Restated Loan Agreement made the following changes:


•	Provided that the indebtedness would be represented by a promissory note.


•	Provided that if a Fundamental Change (as defined in the Fourth Supplemental Indenture with respect to the 8.00% Notes issued in 2013) occurs prior to the repayment of the indebtedness, the Company would pay Thermo an amount equal to the Fundamental Make-Whole Amount (as defined in the New Indenture - see 8.00% Convertible Senior Notes Issued in 2013 below).


•	Provided that the indebtedness is convertible into common stock of the Company on substantially the same terms as the 8.00% Notes Issued in 2013, excluding the conversion features on special conversion dates as provided in the New Indenture.

The terms of the amendment and restatement were approved by a special committee of the Company's board of directors consisting solely of its unaffiliated directors. The committee was represented by independent legal counsel.

Based on the Company's evaluation of the Amended and Restated Loan Agreement, this transaction was determined to be an extinguishment of the debt under the prior Loan Agreement. The Company recorded a loss on the extinguishment of this debt of $66.1 million in its consolidated statement of operations during the third quarter of 2013. This loss represents the difference between the fair value of the Loan Agreement, as amended and restated, and its carrying value just prior to amendment and restatement. See Note 5: Fair Value Measurements for further discussion on the fair value of this instrument.

The Company evaluated the various embedded derivatives within the Loan Agreement and determined that the conversion option and the contingent put feature upon a fundamental change required bifurcation from the Loan Agreement. The conversion option and the contingent put feature were not deemed clearly and closely related to the Loan Agreement and were separately accounted for as a standalone derivative. The Company recorded this compound embedded derivative liability as a non-current liability in its consolidated balance sheet with a corresponding debt discount which is netted against the face value of the Loan Agreement.

The Company is accreting the debt discount associated with the compound embedded derivative liability to interest expense through the maturity of the Loan Agreement using an effective interest rate method. The fair value of the compound embedded derivative liability will be marked-to-market at the end of each reporting period, with any changes in value reported in the consolidated statements of operations. The Company determined the fair value of the compound embedded derivative using a blend of a Monte Carlo simulation model and market prices.

The Company netted the debt discount associated with the compound embedded derivative against the fair value of the Loan Agreement to determine the carrying amount of the Loan Agreement. The accretion of the debt discount will increase the carrying amount of the debt through the maturity of the Loan Agreement. The Company allocated the fair value at issuance as follows (in thousands):



Loan Agreement	$	18,958
Compound embedded derivative liability	101,114
Fair value of Loan Agreement	$	120,072

5.75% Convertible Senior Unsecured Notes

In 2008, the Company issued $150.0 million aggregate principal amount of 5.75% Notes. The 5.75% Notes were senior unsecured debt obligations. The 5.75% Notes were to mature on April 1, 2028 and bore interest at a rate of 5.75% per annum. Interest on the 5.75% Notes was payable semi-annually in arrears on April 1 and October 1 of each year.

The 5.75% Notes were subject to repurchase by the Company for cash at the option of the holders in whole or part on April 1, 2013 at a purchase price equal to 100% of the principal amount ($71.8 million aggregate principal was outstanding at April 1, 2013) of the 5.75% Notes, plus accrued and unpaid interest, if any.

On March 29, 2013, U.S. Bank National Association, the Trustee under the Indenture and the First Supplemental Indenture governing the 5.75% Notes, each dated as of April 15, 2008, between the Company and the Trustee (collectively, as amended and supplemented or otherwise modified, the "Indenture"), notified the Company in writing that holders of approximately $70.7 million principal amount of 5.75% Notes had exercised their purchase rights pursuant to the Indenture. Under the Indenture, the Company was required to deposit with the Trustee on April 1, 2013, the purchase price of approximately $70.7 million in cash to effect the repurchase of the 5.75% Notes from the exercising holders. The Company did not have sufficient funds to pay the purchase price when due, which constituted an event of default under the Indenture.

In addition, the Indenture also required that, on April 1, 2013, the Company pay interest on the 5.75% Notes in the aggregate amount of approximately $2.1 million for the six months ended March 31, 2013. The Company did not make this payment. Under the Indenture, failure to pay this interest by April 30, 2013 also constituted an event of default.

As discussed below, these events of default were cured pursuant to the Exchange Agreement transactions consummated on May 20, 2013.

Exchange Agreement

On May 20, 2013, the Company entered into an Exchange Agreement with the beneficial owners and investment managers for beneficial owners (the “Exchanging Note Holders”) of approximately 91.5% of its outstanding 5.75% Notes and completed the transactions contemplated by the Exchange Agreement.

Pursuant to the Exchange Agreement, the Exchanging Note Holders surrendered their 5.75% Notes (the “Exchanged Notes”) to the Company for cancellation in exchange for:


•	Approximately $13.5 million in cash, with respect to a portion of the principal amount of the Exchanged Notes, plus approximately $0.5 million in cash, equal to all accrued and unpaid interest on the Exchanged Notes from April 1, 2013 to the closing;


•	Approximately 30.3 million shares of the Company's voting common stock; and


•	Approximately $54.6 million principal amount of the Company's new 8.00% Convertible Senior Notes due April 1, 2028 (the “8.00% Notes Issued in 2013”), with an initial conversion price of $0.80 per share, subject to adjustment as described below.

In the Exchange Agreement, the Company also agreed that, if it granted certain liens to Thermo or its affiliates in connection with future financing transactions, the Exchanging Note Holders may participate in such transactions in an amount up to 50% of the participation of Thermo and its affiliates.

Pursuant to the Exchange Agreement, the Company also cured outstanding defaults under the 5.75% Notes by:


•	Cancelling the Exchanged Notes as described above;


•	Depositing with the Trustee approximately $2.1 million, an amount equal to the interest due on all of the 5.75% Notes on April 1, 2013 and accumulated interest thereon, for distribution to the holders of record of the 5.75% Notes as of March 15, 2013;


•	Depositing with the Trustee approximately $6.3 million, an amount equal to the principal amount of the 5.75% Notes (other than the Exchanged Notes) and interest thereon from April 1, 2013 to June 26, 2013 and directing the Trustee to pay such amounts to the holders of the 5.75% Notes (other than the Exchanged Notes); and


•	Redeeming the remaining 5.75% Notes.

On May 20, 2013, the Company called for redemption the remaining 5.75% Notes for cash equal to their principal amount.

Based on the Company's evaluation of the exchange transaction, the Exchange Agreement was determined to be an extinguishment of the 5.75% Notes. As a result of this exchange, the Company recorded a loss on the extinguishment of debt of $47.2 million in its consolidated statement of operations during the second quarter of 2013. This loss represented the difference between the carrying value of the 5.75% Notes and the fair value of the consideration given in the exchange (including the new 8.00% Notes Issued in 2013, cash payments to both exchanging and non-exchanging holders, equity issued to the holders and other fees incurred in the exchange). See Note 5: Fair Value Measurements for further discussion of the fair value of this instrument.

The Consent Agreement

To obtain the lenders’ consent to the transactions contemplated by the Exchange Agreement, pursuant to the Consent Agreement, Thermo agreed that it would make, or arrange for third parties to make, cash contributions to the Company in exchange for equity, subordinated convertible debt or other equity-linked securities as follows:


•	At the closing of the exchange transaction and thereafter each week until no later than July 31, 2013, an amount sufficient to enable the Company to maintain a consolidated unrestricted cash balance of at least $4.0 million;


•	At the closing of the exchange transaction, $25.0 million to satisfy all cash requirements associated with the exchange transaction, including agreed principal and interest payments to the holders of the 5.75% Notes as contemplated by the Exchange Agreement, with any remaining portion being retained by the Company for working capital and general corporate purposes;


•	Contemporaneously with, and as a condition to the closing of, any restructuring of the Facility Agreement, $20.0 million (less any amount contributed pursuant to the commitment described above with respect to the Company's minimum cash balance);


•	Subject to the prior closing of the Facility Agreement restructuring, on or prior to December 26, 2013, $20.0 million; and


•	Subject to the prior closing of the Facility Agreement restructuring, on or prior to December 31, 2014, $20.0 million, less the amount by which the aggregate amount of cash received by the Company under the first, third and fourth commitments described above exceeds $40 million.

In accordance with the terms of the Common Stock Purchase Agreement and Common Stock Purchase and Option Agreement discussed below, Thermo contributed a total of $65.0 million to the Company in exchange for 171.9 million shares of its nonvoting common stock.

The Common Stock Purchase Agreement

On May 20, 2013, the Company and Thermo entered into a Common Stock Purchase Agreement pursuant to which Thermo purchased 78.1 million shares of common stock for $25.0 million ($0.32 per share). Thermo also agreed to purchase additional shares of common stock at $0.32 per share as and when required to fulfill its equity commitment described above to maintain the Company's consolidated unrestricted cash balance at not less than $4.0 million until the earlier of July 31, 2013 and the closing of a restructuring of the Facility Agreement. In furtherance thereof, at the closing of the transactions contemplated by the Exchange Agreement, Thermo purchased an additional 15.6 million shares of common stock for an aggregate purchase price of $5.0 million. In June 2013, Thermo purchased an additional 28.1 million shares of common stock for an aggregate purchase price of $9.0 million pursuant to the Common Stock Purchase Agreement. Pursuant to its commitment, Thermo invested a further $6.0 million on July 29, 2013 and $6.5 million on August 19, 2013, on terms later determined by a special committee of the Company's board of directors consisting solely of its unaffiliated directors as described below.

During the second quarter of 2013, Thermo purchased in total approximately 121.9 million shares of the Company's common stock pursuant to the Common Stock Purchase Agreement for an aggregate $39.0 million. During the second quarter of 2013, the Company recognized a loss on the sale of these shares of approximately $14.0 million (included in other income/expense on the consolidated statement of operations), representing the difference between the purchase price and the fair value of the Company's common stock (measured as the closing stock price on the date of each sale). Pursuant to the Common Stock Purchase Agreement, the shares of common stock are intended to be shares of nonvoting common stock.

The terms of the Common Stock Purchase Agreement were approved by a special committee of the Company's board of directors consisting solely of its unaffiliated directors. The committee, which was represented by independent legal counsel, determined that the terms of the Common Stock Purchase Agreement were fair and in the best interests of the Company and its shareholders.

The Common Stock Purchase and Option Agreement

On October 14, 2013, the Company and Thermo entered into a Common Stock Purchase and Option Agreement pursuant to which Thermo agreed to purchase 11.5 million shares of the Company's non-voting common stock at a purchase price of $0.52 per share in exchange for the $6.0 million invested in July and an additional $20 million, or 38.5 million shares, of which $6.5 million was invested in August 2013 and the remaining $13.5 million was invested under the First Option, described below, in December 2013. The Common Stock Purchase and Option Agreement also granted the Company a First Option and a Second Option, as defined in the agreement, to sell to Thermo up to $13.5 million and $11.5 million, respectively, of nonvoting common stock, as and when exercised at the direction of the special committee through November 28, 2013 and December 31, 2013, respectively. The First Option to sell up to $13.5 million in shares to Thermo was at a purchase price of $0.52 per share. The Second Option to sell up to $11.5 million in shares to Thermo was at a price equal to 85% of the average closing price of the voting common stock during the ten trading days immediately preceding the date of the special committee’s request. In November 2013, with the approval of the special committee, the Company and Thermo amended the Common Stock Purchase and Option Agreement to defer the expiration date of the Second Option to March 31, 2014. The Second Option under the Common Stock Purchase and Option Agreement was not exercised and therefore has expired.

During the third quarter of 2013, Thermo purchased approximately 24.0 million shares of the Company's common stock pursuant to the terms of the Common Stock Purchase and Option Agreement for an aggregate purchase price of $12.5 million. During the third quarter of 2013, the Company recognized a loss on the sale of these shares of approximately $2.4 million (included in other income/expense in the consolidated statement of operations), representing the difference between the purchase price and the fair value of the common stock (measured as the closing stock price on the date of each sale).

In November 2013, the Company exercised the First Option, and on December 27, 2013 Thermo purchased 26.0 million shares of common stock at a purchase price of $0.52 per share for a total additional investment of $13.5 million.

The terms of the Common Stock Purchase and Option Agreement were approved by a special committee of the board of directors consisting solely of the unaffiliated directors. The committee, which was represented by independent legal counsel, determined that the terms of the Common Stock Purchase and Option Agreement were fair and in the best interests of the Company and its shareholders.

Share Lending Agreement

Concurrently with the 2008 offering of the 5.75% Notes, the Company entered into a share lending agreement (the “Share Lending Agreement”) with Merrill Lynch International (the “Borrower”), pursuant to which the Company agreed to lend up to 36.1 million shares of common stock (the “Borrowed Shares”) to the Borrower, subject to certain adjustments, for a period ending on the earliest of (i) at the Company's option, at any time after the entire principal amount of the 5.75% Notes ceases to be outstanding, (ii) the written agreement of the Company and the Borrower to terminate, (iii) the occurrence of a Borrower default, at the option of Lender, and (iv) the occurrence of a Lender default, at the option of the Borrower. Pursuant to the Share Lending Agreement, upon the termination of the share loan, the Borrower was required to return the Borrowed Shares to the Company. Upon the conversion of 5.75% Notes (in whole or in part), a number of Borrowed Shares proportional to the conversion rate for such notes was required to be returned to the Company. At the Company's election, the Borrower was permitted to deliver cash equal to the market value of the corresponding Borrowed Shares instead of returning to the Company the Borrowed Shares otherwise required by conversions of 5.75% Notes.

Pursuant to and upon the terms of the Share Lending Agreement, the Company issued and loaned the Borrowed Shares to the Borrower as a share loan. The Borrowing Agent also acted as an underwriter with respect to the Borrowed Shares, which were offered to the public. The Borrowed Shares included approximately 32.0 million shares of common stock initially loaned by the Company to the Borrower on separate occasions, delivered pursuant to the Share Lending Agreement and the Underwriting Agreement, and an additional 4.1 million shares of common stock that, from time to time, could be borrowed from the Company by the Borrower pursuant to the Share Lending Agreement and the Underwriting Agreement and subsequently offered and sold at prevailing market prices at the time of sale or negotiated prices. The Borrowed Shares are free trading shares.

During July 2013, in connection with the exchange or redemption of all of the 5.75% Notes, the Company and the Borrower terminated the Share Lending Agreement. In connection with this termination, the Borrower returned 10.2 million Borrowed Shares to the Company and paid approximately $4.4 million in cash for the remaining 7.1 million Borrowed Shares. As of December 31, 2012, approximately 17.3 million Borrowed Shares were outstanding. During 2013, the Share Lending Arrangement was terminated and all Borrowed Shares had been either returned to the Company or purchased by the Borrower.

8.00% Convertible Senior Notes Issued in 2013

On May 20, 2013, pursuant to the Exchange Agreement, the Company issued $54.6 million aggregate principal amount of 8.00% Convertible Senior Notes (the “8.00% Notes Issued in 2013”) to the Exchanging Note Holders. The 8.00% Notes Issued in 2013 are convertible into shares of common stock at an initial conversion price of $0.80 per share of common stock, or 1,250 shares of common stock per $1,000 principal amount of the 8.00% Notes Issued in 2013, subject to adjustment as provided in the Fourth Supplemental Indenture between the Company and U.S. Bank National Association, as Trustee (the “New Indenture”). The conversion price of the 8.00% Notes Issued in 2013 will be adjusted in the event of certain stock splits or extraordinary share distributions, or as a reset of the base conversion and exercise price as described below.

The 8.00% Notes Issued in 2013 are senior unsecured debt obligations. There is no sinking fund for the 8.00% Notes Issued in 2013. The 8.00% Notes Issued in 2013 will mature on April 1, 2028, subject to various call and put features as described below, and bear interest at a rate of 8.00% per annum. Interest on the 8.00% Notes Issued in 2013 is payable semi-annually in arrears on April 1 and October 1 of each year. Interest is paid in cash at a rate of 5.75% per annum and additional 8.00% Notes Issued in 2013 at a rate of 2.25% per annum.

Subject to certain conditions set forth in the New Indenture, including prior approval of the Majority Lenders (as defined in the Facility Agreement), the Company may redeem the 8.00% Notes Issued in 2013, in whole or in part, at any time on or after April 1, 2018, at a price equal to the principal amount of the 8.00% Notes Issued in 2013 to be redeemed plus all accrued and unpaid interest thereon.

A holder of 8.00% Notes Issued in 2013 has the right, at the Holder’s option, to require the Company to purchase some or all of the 8.00% Notes Issued in 2013 held by it on each of April 1, 2018 and April 1, 2023 at a price equal to the principal amount of the 8.00% Notes Issued in 2013 to be purchased plus accrued and unpaid interest.

A holder of the 8.00% Notes Issued in 2013 has the right, at the holder’s option, to require the Company to purchase some or all of the 8.00% Notes Issued in 2013 held by it at any time if there is a Fundamental Change. A Fundamental Change occurs if the Company's common stock ceases to be traded on a stock exchange or an established over-the-counter market or if there is a change of control. If there is a Fundamental Change, the purchase price of any 8.00% Notes Issued in 2013 purchased by the Company will be equal to its principal amount plus accrued and unpaid interest and a Fundamental Change Make-Whole Amount calculated as provided in the New Indenture.

Subject to the procedures for conversion and other terms and conditions of the New Indenture, a holder may convert its 8.00% Notes Issued in 2013 at its option at any time prior to the close of business on the business day immediately preceding April 1, 2028, into shares of common stock (or, at the Company's option, cash in lieu of all or a portion thereof, provided that, under the Facility Agreement, the Company may pay cash only with the consent of the Majority Lenders). Upon conversion, the holder will be entitled to receive shares of common stock, cash or a combination thereof (provided that, under the Facility Agreement, the Company may pay cash only with the consent of the Majority Lenders), in such amounts and subject to terms and conditions set forth in the New Indenture. The Company will pay cash in lieu of fractional shares otherwise issuable upon conversion of the 8.00% Notes Issued in 2013 as specified in the Indenture.

A holder was also entitled to elect to convert up to 15% of its 8.00% Notes Issued in 2013 on each of July 19, 2013 and March 20, 2014. If a holder elected to convert on either of those dates, it would receive, at the Company's option, either cash equal to the par value of the 8.00% Notes Issued in 2013 plus accrued interest (provided that, under the Facility Agreement, the Company may pay cash only with the consent of the Majority Lenders) or shares of common stock equal to the principal amount of the 8.00% Notes Issued in 2013 to be converted plus accrued interest divided by the lower of the average price of the common stock in a specified period and $0.50. On July 19, 2013, $7.0 million principal amount (approximately 12.9% of the outstanding principal amount) of 8.00% Notes Issued in 2013 were converted, resulting in the issuance of 14.3 million shares. On March 20, 2014, $7.0 million principal amount (approximately 15.0% of the outstanding principal amount) of 8.00% Notes Issued in 2013 were converted, resulting in the issuance of an additional 14.6 million shares.

Through December 31, 2014, a total of $32.9 million principal amount of 8.00% Notes Issued in 2013 had been converted, resulting in the issuance of approximately 60.3 million shares of voting common stock relating to the special conversions discussed above as well as normal conversions pursuant to the terms of the New Indenture. The Company recorded a gain on extinguishment of debt related to these conversions of approximately $4.2 million as of December 31, 2013 and a loss on extinguishment of debt of $44.1 million as of December 31, 2014. Pursuant to the terms in the New Indenture for the 8.00% Notes Issued in 2013 for normal conversions, holders receive conversion shares over a 40-consecutive trading day settlement period. As a result of this feature, the portion of converted debt is extinguished on an incremental basis over the 40-day settlement period, reducing the Company's debt balance outstanding. During November 2014, the Company received notice of conversion of approximately $0.7 million principal amount of 8.00% Notes Issued in 2013. As of December 31, 2014, $0.2 million of this conversion had not been settled.

The base conversion rate may be adjusted on each of April 1, 2014 and April 1, 2015 based on the average price of the Company's common stock in the 30-day period ending on that date. If the base conversion rate is adjusted on April 1, 2014 or April 1, 2015, the Company also will provide additional consideration to the holders of the 8.00% Notes Issued in 2013 in an amount equal to 25% of the principal amount of the outstanding 8.00% Notes Issued in 2013, payable in equity or cash at the Company's election (provided, under the Facility Agreement, that the Company may pay cash only with the consent of the Majority Lenders). That consideration will not reduce the principal amount of the 8.00% Notes Issued in 2013 or any interest otherwise payable on the 8.00% Notes Issued in 2013. The base conversion rate was not adjusted on April 1, 2014.

The New Indenture also provides for other customary adjustments of the base conversion rate, including upon the Company's sale of additional equity securities at a price below the then applicable conversion price. Due to common stock issuances since May 20, 2013, the base conversion rate was reduced to $0.73 per share of common stock as of December 31, 2014. The amount by which the if-converted value of the 8.00% Notes Issued in 2013 exceeds the principal amount at December 31, 2014, assuming conversion at the closing price of the Company's common stock on that date of $2.75 per share, is approximately $84 million.

The New Indenture provides that the Company and its subsidiaries may not, with specified exceptions, including the liens securing the Facility and liens approved in writing by the Agent, create, incur, assume or suffer to exist any lien on any of its assets, provided that if the Company or any of its subsidiaries creates, incurs or assumes any lien which is junior to the most senior lien securing the Facility Agreement (other than a lien pursuant to a restructuring of the Facility Agreement in which and its affiliates do not participate as a secured lender), the Company must promptly issue to the holders of the 8.00% Notes Issued in 2013 $3.6 million (representing 5.0% of the principal amount of the 5.75% Notes outstanding on the date of the Exchange Agreement, which was $71.8 million) of shares of the Company's common stock. At December 31, 2014, the Company did not expect that a lien will be created that does not meet at least one of the specified exceptions in the New Indenture, and therefore accrued no amount for this feature at December 31, 2014.

The New Indenture provides for customary events of default, including without limitation, failure to pay principal or premium on the 8.00% Notes Issued in 2013 when due or to distribute cash or shares of common stock when due as described above; failure by the Company to comply with its obligations and covenants in the New Indenture; default by the Company in the payment of principal or interest on any other indebtedness for borrowed money with a principal amount in excess of $10.0 million, if such indebtedness is accelerated and not rescinded with 30 days; rendering of certain final judgments; failure by Thermo to fulfill the contribution obligations described above; and certain events of insolvency or bankruptcy. If there is an event of default, the Trustee may, at the direction of the holders of 25% or more in aggregate principal amount of the 8.00% Notes Issued in 2013, accelerate the maturity of the 8.00% Notes Issued in 2013. The Company was not in default under the 8.00% Notes Issued in 2013 as of December 31, 2014.

The Company evaluated the various embedded derivatives within the New Indenture and determined that the conversion option and the contingent put feature within the New Indenture required bifurcation from the 8.00% Notes Issued in 2013. The conversion option and the contingent put feature were not deemed clearly and closely related to the 8.00% Notes Issued in 2013 and were separately accounted for as a standalone derivative. The Company recorded this compound embedded derivative liability as a non-current liability in the consolidated balance sheet with a corresponding debt discount which is netted against the face value of the 8.00% Notes Issued in 2013.

The Company is accreting the debt discount associated with the compound embedded derivative liability to interest expense through the first put date of the 8.00% Notes Issued in 2013 (April 1, 2018) using an effective interest rate method. The fair value of the compound embedded derivative liability is being marked-to-market at the end of each reporting period, with any changes in value reported in the consolidated statements of operations. The Company determined the fair value of the compound embedded derivative using a blend of a Monte Carlo simulation model and market prices.

The Company netted the debt discount associated with compound embedded derivative against the fair value of the 8.00% Notes Issued in 2013 to determine the carrying amount of the 8.00% Notes Issued in 2013. The accretion of the debt discount will increase the carrying amount of the debt through April 1, 2018 (the first put date of the 8.00% Notes Issued in 2013). The Company allocated the fair value at issuance as follows (in thousands):



Senior notes	$	27,890
Compound embedded derivative liability	56,752
Fair value of 8.00% Notes Issued in 2013	$	84,642

5.0% Convertible Senior Notes

In June 2011, the Company issued $38.0 million in aggregate principal amount of the 5.0% Convertible Senior Unsecured Notes (the “5.0% Notes”) and warrants (the “5.0% Warrants”) to purchase 15.2 million shares of voting common stock. The 5.0% Notes were convertible into shares of common stock at an initial conversion price of $1.25 per share of common stock, or 800 shares of common stock per $1,000 principal amount of the 5.0% Notes, subject to adjustment in the manner set forth in the Indenture. The 5.0% Notes were guaranteed on a subordinated basis by substantially all of the Company's domestic subsidiaries, on an unconditional joint and several basis, pursuant to a Guaranty Agreement. The 5.0% Warrants are exercisable until five years after their issuance. The 5.0% Notes and 5.0% Warrants have anti-dilution protection in the event of certain stock splits or extraordinary share distributions, and a reset of the conversion and exercise price on April 15, 2013 if the common stock were below the initial conversion and exercise price at that time. On April 15, 2013, the base conversion rate for the 5.0% Notes and the exercise price of the 5.0% Warrants were reset to $0.50 and $0.32, respectively.

The 5.0% Notes were senior unsecured debt obligations and ranked pari passu with the Company's 8.00% Notes Issued in 2009 and existing 8.00% Notes Issued in 2013 and were subordinated to the Company's obligations pursuant to its Facility Agreement. There was no sinking fund for the 5.0% Notes. The 5.0% Notes were scheduled to mature at the earlier to occur of December 14, 2021, or six months following the maturity date of the Facility Agreement and bore interest at a rate of 5.0% per annum. Interest on the notes was payable in-kind semi-annually in arrears on June 15 and December 15 of each year. Under certain circumstances, interest on the 5.0% Notes may have been payable in cash at the election of the holder if such payments are permitted under the Facility Agreement.

Subject to certain exceptions set forth in the Indenture, the 5.0% Notes were subject to repurchase for cash at the option of the holders of all or any portion of the 5.0% Notes upon a fundamental change at a purchase price equal to 100% of the principal amount of the 5.0% Notes, plus a make-whole payment and accrued and unpaid interest, if any. A fundamental change would have occurred upon certain changes in the ownership of the Company or certain events relating to the trading of the common stock.

Holders could convert their 5.0% Notes into voting common stock at their option at any time. Upon conversion of the 5.0% Notes, the Company paid the holders of the 5.0% Notes a make-whole premium by increasing the number of shares of common stock delivered upon such conversion. The number of additional shares constituting the make-whole premium per $1,000 principal amount of 5.0% Notes was equal to the quotient of (i) the aggregate principal amount of the 5.0% Notes so converted multiplied by 25.00%, less the aggregate interest paid on such Securities prior to the applicable Conversion Date divided by (ii) 95% of the volume-weighted average Closing Price of the Common Stock for the 10 trading days immediately preceding the conversion date.

Pursuant to the terms of the 5.0% Notes Indenture, if, at any time on or after June 14, 2013 and on or prior to Stated Maturity, the closing price of the common stock exceeded 200% of the conversion price then in effect for at least 30 consecutive trading days, then, at the Company's option, all Securities then outstanding were to convert automatically into shares of common stock. The conditions for the automatic conversion were met, and the Company elected to convert all outstanding 5.0% Notes into shares of common stock on November 7, 2013.

Prior to November 7, 2013, approximately $17.5 million principal amount of 5.0% Notes had been converted resulting in the issuance of 41.1 million shares of the Company's common stock and 5.0% Warrants had been exercised to purchase 7.2 million shares of common stock, which resulted in the Company issuing 6.7 million shares of common stock and receiving $2.0 million. On November 7, 2013, approximately $24.2 million, representing the remaining principal amount of 5.0% Notes plus paid in kind interest added to the principal amount of the 5.0% Notes, of 5.0% Notes were converted, resulting in the issuance of 51.9 million shares of the Company's common stock. 5.0% Warrants to purchase eight million shares of common stock were outstanding as of December 31, 2014.

Subject to certain exceptions set forth in the supplemental indenture, if certain changes of control or events relating to the listing of the common stock occur (a “fundamental change”), the 5.0% Notes were subject to repurchase for cash at the option of the holders of all or any portion of the 8.00% Notes Issued in 2009 at a purchase price equal to 100% of the principal amount of the 8.00% Notes Issued in 2009, plus a make-whole payment and accrued and unpaid interest, if any. Holders that require the Company to repurchase 8.00% Notes Issued in 2009 upon a fundamental change may elect to receive shares of common stock in lieu of cash. Such holders would receive a number of shares equal to (i) the number of shares they would have been entitled to receive upon conversion of the 8.00% Notes Issued in 2009, plus (ii) a make-whole premium of 12% or 15%, depending on the date of the fundamental change and the amount of the consideration, if any, received by the Company's stockholders in connection with the fundamental change.

The Company evaluated the various embedded derivatives resulting from the conversion rights and features within the Indenture for bifurcation from the 5.0% Notes. Due to the provisions and reset features in the 5.0% Warrants, the Company recorded the 5.0% Warrants as equity with a corresponding debt discount which is netted against the face value of the 5.0% Notes. The Company accreted the debt discount associated with the 5.0% Warrants to interest expense over the term of the 5.0% Warrants using the effective interest rate method. The Company determined the relative fair value of the 5.0% Warrants using a blend of a Monte Carlo simulation model and market prices based upon a risk-neutral stock price model.

The Company evaluated the embedded derivative resulting from the contingent put feature within the Indenture for bifurcation from the 5.0% Notes. The contingent put feature was not deemed clearly and closely related to the 5.0% Notes and had to be bifurcated as a standalone derivative. The Company recorded this embedded derivative liability as a non-current liability in its consolidated balance sheet with a corresponding debt discount which was netted against the principal amount of the 5.0% Notes.

The Company evaluated the conversion option within the convertible notes to determine whether the conversion price was beneficial to the note holders. The Company recorded a beneficial conversion feature (“BCF”) related to the issuance of the 5.0% Notes. The BCF for the 5.0% Notes was recognized and measured by allocating a portion of the proceeds to beneficial conversion feature, based on relative fair value, and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion feature. The Company accreted the discount recorded in connection with the BCF valuation as interest expense over the term of the 5.0% Notes, using the effective interest rate method.

As the remaining amount of 5.0% Notes converted prior to full accretion of the discounts created by the BCF, the Company recorded approximately $12.9 million of the unamortized discount for the BCF and other separable instruments to interest expense during the fourth quarter of 2013. The Company also recorded approximately $0.8 million to derivative gain for the derivative embedded in the 5.0% Notes that is no long outstanding as a result of this conversion.

The Company netted the debt discount associated with the 5.0% Warrants, the beneficial conversion feature, and the contingent put feature against the face value of the 5.0% Notes to determine the carrying amount of the 5.0% Notes. The accretion of debt discount will increase the carrying amount of the debt over the term of the 5.0% Notes. The Company allocated the proceeds at issuance as follows (in thousands):



Debt	$	11,316
Fair value of 5.0% Warrants	8,081
Beneficial Conversion Feature	17,100
Contingent Put Feature	1,503
Face Value of 5.0% Notes	$	38,000

8.00% Convertible Senior Unsecured Notes Issued in 2009

Pursuant to the terms of the indenture governing the 8.00% Notes Issued in 2009, if at any time the closing price of the common stock exceeds 200% of the conversion price of the 8.00% Notes Issued in 2009 then in effect for 30 consecutive trading days, all of the outstanding 8.00% Notes Issued in 2009 would have been automatically converted into common stock. The condition for the automatic conversion was met on April 15, 2014, and all outstanding 8.00% Notes Issued in 2009 (approximately $37.8 million principal amount at that time) converted on that date into approximately 34.5 million shares of voting common stock. Prior to expiration of the 8.00% Warrants and the automatic conversion of the 8.00% Notes Issued in 2009, the exercise price of the 8.00% Warrants was $0.32 and the base conversion price of the 8.00% Notes Issued in 2009 was $1.14.

In June 2009, the Company sold $55.0 million in aggregate principal amount of 8.00% Convertible Senior Unsecured Notes (the “8.00% Notes Issued in 2009”) and Warrants (the “8.00% Warrants”) to purchase 15.3 million shares of common stock. The 8.00% Notes Issued in 2009 were subordinated to all of the Company's obligations under the Facility Agreement. The 8.00% Notes Issued in 2009 were senior unsecured debt obligations and, except as described in the preceding sentence, ranked pari passu with the Company's existing unsecured, unsubordinated obligations, including the 8.00% Notes Issued in 2013. The 8.00% Notes Issued in 2009 were to mature at the later of the tenth anniversary of closing (June 19, 2019) or six months following the maturity date of the Facility Agreement and bore interest at a rate of 8.00% per annum. Interest on the 8.00% Notes Issued in 2009 was payable in the form of additional 8.00% Notes Issued in 2009 or, subject to certain restrictions, in common stock at the option of the holder. Interest was payable semi-annually in arrears on June 15 and December 15 of each year.

The 8.00% Warrants had full ratchet anti-dilution protection and the exercise price of the Warrants was subject to adjustment under certain other circumstances. In the event of certain transactions that involve a change of control, the holders of the 8.00% Warrants have the right to make the Company purchase the warrants for cash, subject to certain conditions. The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 19, 2014. As a result of the expiration of this period on June 19, 2014, all outstanding 8.00% Warrants were exercised during the second quarter of 2014, resulting in the issuance of 38.2 million shares of the Company's common stock. Holders of the 8.00% Warrants had the right to exercise on either a cash or cashless basis. The Company received approximately $7.5 million in cash as a result of these exercises.

Subject to certain exceptions set forth in the supplemental indenture, if certain changes of control or events relating to the listing of the common stock occur (a “fundamental change”), the 8.00% Notes Issued in 2009 were subject to repurchase for cash at the option of the holders of all or any portion of the 8.00% Notes Issued in 2009 at a purchase price equal to 100% of the principal amount of the 8.00% Notes Issued in 2009, plus a make-whole payment and accrued and unpaid interest, if any. Holders that require the Company to repurchase 8.00% Notes Issued in 2009 upon a fundamental change could elect to receive shares of common stock in lieu of cash. Such holders would have received a number of shares equal to the number of shares they would have been entitled to receive upon conversion of the 8.00% Notes Issued in 2009, plus a make-whole premium of 12% or 15%, depending on the date of the fundamental change and the amount of the consideration, if any, received by the Company's stockholders in connection with the fundamental change.

The Company recorded the conversion rights and features and the contingent put feature embedded within the 8.00% Notes Issued in 2009 as a compound embedded derivative liability on the consolidated balance sheets with a corresponding debt discount, which is netted against the principal amount of the 8.00% Notes Issued in 2009. Due to the cash settlement provisions and reset features in the 8.00% Warrants issued with the 8.00% Notes Issued in 2009, the Company recorded the 8.00% Warrants as an embedded derivative liability in the consolidated balance sheets with a corresponding debt discount, which is netted against the principal amount of the 8.00% Notes Issued in 2009.

Prior to the automatic conversion of these notes, the Company was accreting the debt discount associated with the compound embedded derivative liability to interest expense over the term of the 8.00% Notes Issued in 2009 using an effective interest rate method. The fair value of the compound embedded derivative liability was being marked-to-market at the end of each reporting period, with any changes in value reported in the consolidated statements of operations. The Company determined the fair value of the compound embedded derivative using a blend of a Monte Carlo simulation model and market prices. Upon the automatic conversion of the 8.00% Notes Issued in 2009, the remaining debt discount and derivative liability were written off through extinguishment gain (loss). The Company recorded a gain on extinguishment of debt of approximately $4.3 million related to these conversions.

Due to the cash settlement provisions and reset features in the 8.00% Warrants, the Company initially recorded the 8.00% Warrants as a component of other non-current liabilities on the consolidated balance sheet with a corresponding debt discount which is netted with the face value of the 8.00% Notes Issued in 2009. Prior to exercise, the Company was accreting the debt discount associated with the 8.00% Warrants liability to interest expense over the term of the 8.00% Notes Issued in 2009 using an effective interest rate method. The fair value of the 8.00% Warrants liability was marked-to-market at the end of each reporting period, with any changes in value reported in the consolidated statements of operations. The Company determined the fair value of the 8.00% Warrants derivative using a blend of a Monte Carlo simulation model and market prices. As the exercise period for the 8.00% Warrants expired in June 2014, the Company had classified this derivative liability as current in the consolidated balance sheet at December 31, 2013.

The Company allocated the proceeds received from the 8.00% Notes Issued in 2009 among the compound embedded derivative liability, the detachable 8.00% Warrants and the remainder to the underlying debt. The Company netted the debt discount associated with the compound embedded derivative and 8.00% Warrants against the face value of the 8.00% Notes Issued in 2009 to determine the carrying amount of the 8.00% Notes Issued in 2009. The accretion of debt discount will increase the carrying amount of the debt over the term of the 8.00% Notes Issued in 2009. The Company allocated the proceeds at issuance as follows (in thousands):



Fair value of compound embedded derivative	$	23,542
Fair value of Warrants	12,791
Debt	18,667
Face Value of 8.00% Notes Issued in 2009	$	55,000

Warrants Outstanding

As a result of the borrowings described above there were warrants outstanding to purchase shares of common stock as shown in the table below:



	Outstanding Warrants		Strike Price
	December 31,		December 31,
	2014	2013	2014		2013
Contingent Equity Agreement (1)	30,191,866	41,467,980	$	0.01	$	0.01
Thermo Loan Agreement (2)	—	4,205,608	—		0.01
5.0% Notes (3)	8,000,000	8,000,000	0.32		0.32
8.00% Notes Issued in 2009 (4)	—	39,842,813	—		0.32
	38,191,866	93,516,401


(1)	Warrants issued in connection with the Contingent Equity Agreement have a five-year exercise period from issuance. These warrants were originally issued between June 2009 and June 2012 and the exercise periods related to the remaining unexercised warrants will expire from June 2015 to June 2017.


(2)	The exercise period of the warrants issued in connection with the Thermo Loan Agreement was five years from issuance, which ended June 2014.


(3)	On April 15, 2013, the exercise price of the 5.0% Warrants was reset to $0.32 due to the reset provision in the indenture. The 5.0% Warrants are exercisable until five years after their issuance, which is June 2016.


(4)	According to the terms of the indenture, additional 8.00% Warrants would have been issued to holders if shares of common stock were issued below the then current warrant strike price. The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 14, 2014.

Debt maturities

Annual debt maturities for each of the five years following December 31, 2014 and thereafter are as follows (in thousands):



2015	$	6,450
2016	32,835
2017	75,755
2018	100,665
2019	94,870
Thereafter	362,674
Total	$	673,249

Amounts in the above table are calculated based on amounts outstanding at December 31, 2014, and therefore exclude paid-in-kind interest payments that will be made in future periods.

The 8.00% Notes Issued in 2013 are subject to repurchase by the Company at the option of the holders on April 1, 2018. As such, the amounts are included in the 2018 maturities in the table above.

Terrapin Opportunity, L.P. Common Stock Purchase Agreement

On December 28, 2012, the Company entered into a Common Stock Purchase Agreement with Terrapin pursuant to which the Company may, subject to certain conditions, require Terrapin to purchase up to $30.0 million of shares of voting common stock over the 24-month term following the effectiveness of a resale registration statement, which became effective on August 2, 2013. This type of arrangement is sometimes referred to as a committed equity line financing facility. From time to time over the 24-month term, and in the Company's sole discretion, it may present Terrapin with up to 36 draw down notices requiring Terrapin to purchase a specified dollar amount of shares of voting common stock, based on the price per share per day over 10 consecutive trading days (a "Draw Down Period"). The per share purchase price for these shares equals the daily volume weighted average price of common stock on each date during the Draw Down Period on which shares are purchased, less a discount ranging from 3.5% to 8% based on a minimum price that the Company solely specifies. In addition, in the Company's sole discretion, but subject to certain limitations, it may require Terrapin to purchase a percentage of the daily trading volume of the Company's common stock for each trading day during the Draw Down Period. The Company has agreed not to sell to Terrapin a number of shares of voting common stock which, when aggregated with all other shares of voting common stock then beneficially owned by Terrapin and its affiliates, would result in the beneficial ownership by Terrapin or any of its affiliates of more than 9.9% of the then issued and outstanding shares of voting common stock.

When the Company makes a draw under the Terrapin equity line agreement, it will issue Terrapin shares of common stock calculated using a price per share as specified in the agreement. As of December 31, 2014, Terrapin had purchased a total of 6.1 million shares of voting common stock at a purchase price of $6.0 million pursuant to the terms of the agreement. In February 2015, the Company drew $10.0 million under the agreement with Terrapin, which amount was an Equity Cure Contribution under the terms of the Facility Agreement, and issued 4.5 million shares of voting common stock to Terrapin at an average price of $2.22 per share. As a result, the Company was in compliance with its financial and non-financial covenants as of December 31, 2014. The Company anticipates that it will make additional draws under the Terrapin Agreement during 2015 to achieve compliance with its financial covenants under the Facility Agreement.

DERIVATIVES

12 Months Ended

Dec. 31, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES

In connection with certain borrowings disclosed in Note 3: Long-Term Debt and Other Financing Arrangements, the Company was required to record derivative instruments on its consolidated balance sheets. None of these derivative instruments are designated as a hedge. The following tables disclose the fair values and classification of the derivative instruments on the Company’s consolidated balance sheets (in thousands):



	December 31, 2014			December 31, 2013
Intangible and other assets:
Interest rate cap	$	46		$	185
Total intangible and other assets	$	46		$	185

Derivative liabilities, current:
Warrants issued with 8.00% Notes Issued in 2009	—			(57,048		)

Derivative liabilities, non-current:
Compound embedded derivative with 8.00% Notes Issued in 2009	$	—		$	(66,022	)
Compound embedded derivative with 8.00% Notes Issued in 2013	(79,040		)	(109,794		)
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	(362,510		)	(229,662		)
Total derivative liabilities, non-current:	(441,550		)	(405,478		)

Total derivative liabilities, current and non-current	$	(441,550	)	$	(462,526	)

The following tables disclose the changes in value recorded as derivative gain (loss) on the Company’s consolidated statement of operations (in thousands):



	Year ended December 31,
	2014			2013			2012
Interest rate cap	$	(139	)	$	101		$	(171	)
Warrants issued with 8.00% Notes Issued in 2009	(67,523		)	(54,518		)	4,218
Compound embedded derivative with 8.00% Notes Issued in 2009	(16,406		)	(61,859		)	2,546
Warrants issued in conjunction with Contingent Equity Agreement	—			—			302
Contingent put feature embedded in the 5.0% Notes	—			2,978			79
Compound embedded derivative with 8.00% Notes Issued in 2013	(69,133		)	(64,153		)	—
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	(132,848		)	(128,548		)	—
Total derivative gain (loss)	$	(286,049	)	$	(305,999	)	$	6,974

Intangible and Other Assets

Interest Rate Cap

In June 2009, in connection with entering into the Facility Agreement, which provides for interest at a variable rate, the Company entered into five 10-year interest rate cap agreements. The interest rate cap agreements reflect a variable notional amount at interest rates that provide coverage to the Company for a portion of the exposure resulting from escalating interest rates over the term of the Facility Agreement. The interest rate cap provides limits on the six-month Libor rate (“Base Rate”) used to calculate the coupon interest on outstanding amounts on the Facility Agreement and is capped at 5.50% should the Base Rate not exceed 6.5%. Should the Base Rate exceed 6.5%, the Company’s Base Rate will be 1% less than the then six-month Libor rate. The Company paid an approximately $12.4 million upfront fee for the interest rate cap agreements. The interest rate cap did not qualify for hedge accounting treatment, and changes in the fair value of the agreements are included in the consolidated statements of operations.

Derivative Liabilities

The Company has identified various embedded derivatives resulting from certain features in the Company’s debt instruments. These embedded derivatives required bifurcation from the debt host agreement. All embedded derivatives that required bifurcation, excluding the warrants issued in connection with the Company’s contingent equity agreement (see below for further discussion), are recorded as a derivative liability on the Company’s consolidated balance sheet with a corresponding debt discount netted against the principal amount of the related debt instrument. The Company accretes the debt discount associated with each derivative liability to interest expense over the term of the related debt instrument using an effective interest rate method. The fair value of each embedded derivative liability is marked-to-market at the end of each reporting period with any changes in value reported in its consolidated statements of operations. See below for further discussion for each liability and the features embedded in the debt instrument which required the Company to account for the instrument as a derivative.

Compound Embedded Derivative with 8.00% Notes Issued in 2009

As a result of the conversion rights and features and the contingent put feature embedded within the 8.00% Notes Issued in 2009, the Company recorded a compound embedded derivative liability on its consolidated balance sheet with a corresponding debt discount which is netted against the principal amount of the 8.00% Notes Issued in 2009. The Company determined the fair value of the compound embedded derivative using a blend of a Monte Carlo simulation model and market prices. On April 15, 2014, the remaining principal amount of 8.00% Notes Issued in 2009 was converted into common stock; accordingly, the derivative liability embedded in the 8.00% Notes Issued in 2009 is no longer outstanding.

Warrants Issued with 8.00% Notes Issued in 2009

Due to the cash settlement provisions and reset features in the 8.00% Warrants issued with the 8.00% Notes Issued in 2009, the Company recorded the 8.00% Warrants as an embedded derivative liability on its consolidated balance sheet with a corresponding debt discount which is netted against the principal amount of the 8.00% Notes Issued in 2009. The Company determined the fair value of the warrant derivative using a Monte Carlo simulation model. The exercise period for the 8.00% Warrants expired in June 2014; accordingly, the derivative liability for the 8.00% Warrants is no longer outstanding.

Warrants Issued in Conjunction with Contingent Equity Agreement

Prior to June 19, 2012, the Company determined that the warrants issued in conjunction with the availability fee for the Contingent Equity Agreement were a liability at issuance. The offset was recorded in other non-current assets and was amortized over the one-year availability period. The Company determined the principal amount of the warrant derivative using a Monte Carlo simulation model.

On June 19, 2012, the Company issued additional warrants in conjunction with the availability fee for the Contingent Equity Agreement. This tranche of warrants was not subject to a reset provision in the agreement and therefore is not marked-to-market at the end of each reporting period. The Company determined that the warrant was an equity instrument and recorded it as equity on its consolidated balance sheet.

Contingent Put Feature Embedded in the 5.0% Notes

As a result of the contingent put feature within the 5.0% Notes, the Company recorded a derivative liability on its consolidated balance sheet with a corresponding debt discount which is netted against the principal amount of the 5.0% Notes. The Company determined the fair value of the contingent put feature derivative using a blend of a Monte Carlo simulation model and market prices. On November 7, 2013, the remaining principal amount of the 5.0% Notes was converted into common stock; therefore the derivative liability embedded in the 5.0% Notes is no longer outstanding (see further discussion in Note 3: Long-Term Debt and Other Financing Arrangements).

Compound Embedded Derivative with 8.00% Notes Issued in 2013

As a result of the conversion option and the contingent put feature within the 8.00% Notes Issued in 2013, the Company recorded a compound embedded derivative liability on its consolidated balance sheet with a corresponding debt discount which is netted against the face value of the 8.00% Notes Issued in 2013. The Company determined the fair value of the compound embedded derivative liability using a blend of a Monte Carlo simulation model and market prices.

Compound Embedded Derivative with the Amended and Restated Thermo Loan Agreement

As a result of the conversion option and the contingent put feature within the Loan Agreement with Thermo entered into in July 2013, the Company recorded a compound embedded derivative liability on its consolidated balance sheet with a corresponding debt discount which is netted against the face value of the Amended and Restated Loan Agreement. The Company determined the fair value of the compound embedded derivative liability using a blend of a Monte Carlo simulation model and market prices.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

FAIR VALUE MEASUREMENTS

12 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

The Company follows the authoritative guidance for fair value measurements relating to financial and non-financial assets and liabilities, including presentation of required disclosures herein. This guidance establishes a fair value framework requiring the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

Recurring Fair Value Measurements

The following table provides a summary of the financial assets and liabilities measured at fair value on a recurring basis (in thousands):



	Fair Value Measurements at December 31, 2014:
	(Level 1)		(Level 2)		(Level 3)			Total Balance
Assets:
Interest rate cap	$	—	$	46	$	—		$	46
Total assets measured at fair value	$	—	$	46	$	—		$	46

Liabilities:
Warrants issued with 8.00% Notes Issued in 2009	$	—	$	—	$	—		$	—
Compound embedded derivative with 8.00% Notes Issued in 2009	—		—		—			—
Compound embedded derivative with 8.00% Notes Issued in 2013	—		—		(79,040		)	(79,040		)
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	—		—		(362,510		)	(362,510		)
Total liabilities measured at fair value	$	—	$	—	$	(441,550	)	$	(441,550	)



	Fair Value Measurements at December 31, 2013:
	(Level 1)		(Level 2)		(Level 3)			Total Balance
Assets:
Interest rate cap	$	—	$	185	$	—		$	185
Total assets measured at fair value	$	—	$	185	$	—		$	185

Liabilities:
Derivative Liabilities:
Warrants issued with 8.00% Notes Issued in 2009	$	—	$	—	$	(57,048	)	$	(57,048	)
Compound embedded derivative with 8.00% Notes Issued in 2009	—		—		(66,022		)	(66,022		)
Compound embedded derivative with 8.00% Notes Issued in 2013	—		—		(109,794		)	(109,794		)
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	—		—		(229,662		)	(229,662		)
Total Derivative Liabilities	—		—		(462,526		)	(462,526		)

Other Liabilities:
Liability for contingent consideration	—		—		(1,923		)	(1,923		)

Total liabilities measured at fair value	$	—	$	—	$	(464,449	)	$	(464,449	)

Assets

Interest Rate Cap

The fair value of the interest rate cap is determined using observable pricing inputs including benchmark yields, reported trades, and broker/dealer quotes at the reporting date. See Note 4: Derivatives for further discussion.

Liabilities

The derivative liabilities in Level 3 include the 8.00% Warrants issued with the 8.00% Notes Issued in 2009 (prior to June 2014), the compound embedded derivative in the 8.00% Notes Issued in 2009 (prior to April 2014), the contingent put feature embedded in the 5.0% Notes (prior to November 2013), the compound embedded derivative in the 8.00% Notes Issued in 2013 and the compound embedded derivative in the Amended and Restated Loan Agreement with Thermo. The Company marks-to-market these liabilities at each reporting date with the changes in fair value recognized in the Company’s consolidated statements of operations. See Note 4: Derivatives for further discussion.

The significant quantitative Level 3 inputs utilized in the valuation models as of December 31, 2014 and December 31, 2013 are shown in the tables below:



	Level 3 Inputs at December 31, 2014:
	Stock Price Volatility	Risk-Free Interest Rate		Note Conversion Price		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2013	70 - 100 %	1.2	%	$	0.73	$	2.75
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	50 - 100 %	2.1	%	$	0.73	$	2.75



	Level 3 Inputs at December 31, 2013:
	Stock Price Volatility	Risk-Free Interest Rate		Note Conversion Price		Warrant Exercise Price		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2009	65 - 100 %	1.5	%	$	1.14	N/A		$	1.75
Warrants issued with 8.00% Notes Issued in 2009	100%	0.1	%	N/A		$	0.32	$	1.75
Compound embedded derivative with 8.00% Notes Issued in 2013	65 - 100 %	1.5	%	$	0.73	N/A		$	1.75
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	65 - 100 %	3.0	%	0.73		N/A		$	1.75

Fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. The Company’s stock price increased 58% from December 31, 2013 to December 31, 2014. As the stock price increases above the current conversion prices or exercise prices for each of the related derivative instruments, the value to the holder of the instrument generally increases, therefore increasing the liability on the Company’s consolidated balance sheet. The Company uses a blend of a Monte Carlo simulation model and market prices to determine the fair value of the derivative valuations. These valuations are sensitive to the weighting applied to each of the simulated values. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the Company’s expected volatility. Decreases in expected volatility would generally result in a lower fair value measurement.

Probability of a change of control is another significant unobservable input used in the fair value measurement of the Company’s derivative instruments, excluding the 8.00% Warrants issued with the 8.00% Notes Issued in 2009. Subject to certain restrictions in each indenture, the Company’s debt instruments contain certain provisions whereby holders may require the Company to purchase all or any portion of the convertible debt instrument upon a change of control. A change of control will occur upon certain changes in the ownership of the Company or certain events relating to the trading of the Company’s common stock. The simulated fair value of the derivative liabilities above is sensitive to changes in the assumed probabilities of a change of control. Decreases in the assumed probability of a change of control would generally result in a lower fair value measurement.

In addition to the Level 3 inputs described above, the indentures governing the related debt instrument for each of the derivative liabilities included in the Company’s Level 3 fair value measurements have specific features that impact the valuation of each liability at reporting periods. These features are further described below for each of the Company’s derivative liabilities.

Compound Embedded Derivative with 8.00% Notes Issued in 2009

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivative with the 8.00% Notes Issued in 2009 included payment in kind interest payments, make whole premiums and automatic conversions. Pursuant to the terms of the 8.00% Notes Issued in 2009, the base conversion rate cannot reset to lower than $1.00; therefore if the Company had made future equity issuances at prices below the then current conversion price, this conversion price would have been adjusted downward to as low as $1.00.

As discussed in Note 3: Long-Term Debt and Other Financing Arrangements, pursuant to the terms of the indenture governing the 8.00% Notes Issued in 2009, if at any time the closing price of the common stock had exceeded 200% of the conversion price of the 8.00% Notes Issued in 2009 then in effect for 30 consecutive trading days, all of the outstanding 8.00% Notes Issued in 2009 automatically would have been converted into common stock. This condition for the automatic conversion was met on April 15, 2014, and all outstanding 8.00% Notes Issued in 2009 converted into shares of the Company’s common stock; accordingly, this derivative liability is no longer outstanding.

Warrants Issued with 8.00% Notes Issued in 2009

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the 8.00% Warrants issued with the 8.00% Notes Issued in 2009 included certain reset features. Pursuant to the terms of the 8.00% Warrants, there was no floor within the reset feature for the exercise price of the 8.00% Warrants; therefore if the Company had made future equity issuances at prices below the current exercise price, this exercise price would have be adjusted downward. If the stock price on the issuance date had been less than the then current exercise price of the outstanding 8.00% Warrants, additional warrants would have been issued, which would have increased the fair value of the warrant liability.

The exercise period for the 8.00% Warrants expired in June 2014; accordingly, this derivative liability is no longer outstanding.

Compound Embedded Derivative with 8.00% Notes Issued in 2013

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivative within the Company’s 8.00% Notes Issued in 2013 includes payment in kind interest payments, make whole premiums, and automatic conversions. Pursuant to the terms of the 8.00% Notes Issued in 2013 Indenture, there are also special distributions and certain put and call features within the notes which impact the valuation model. The trading activity in the market provides the Company with additional valuation support. In 2014, the Company applied a scaling factor to the fair value of the embedded derivative to align the fair value produced from the valuation model to the fair value of the notes traded in the market.

Compound Embedded Derivative with Amended and Restated Thermo Loan Agreement

In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivative within the Amended and Restated Loan Agreement with Thermo includes payment in kind interest payments, make whole premiums, and automatic conversions. The compound embedded derivative in the Amended and Restated Loan Agreement with Thermo contains similar features to the 8.00% Notes Issued in 2013. As stated in the previous section, in 2014, the Company applied a scaling factor to the fair value of the embedded derivative in the 8.00% Notes Issued in 2013 to align the fair value produced from the valuation model to the fair value of the notes traded in the market. Due to the similarities in the debt instruments, a similar weight factor was applied to the embedded derivative in the Amended and Restated Loan Agreement with Thermo.

Other Liabilities

Liability for Contingent Consideration

In connection with the acquisition of Axonn LLC (“Axonn”) in December 2009, the Company is obligated to pay up to an additional $10.8 million in contingent consideration for earnouts based on sales of existing and new products over a five-year earnout period beginning January 1, 2010. The Company will make earnout payments in stock not to exceed 26.7 million shares of common stock (10% of the Company’s pre-transaction outstanding shares of common stock), but at its option may make payments in cash after 13.0 million shares have been issued. The Company’s initial estimate of the total earnout expected to be paid was $10.8 million. Since the earnout period started, the Company has made revisions to this estimate, which was $9.6 million at December 31, 2014. Through December 31, 2014, the Company had made $9.1 million in earnout payments by issuing 18.8 million shares of voting common stock. The liability of $0.5 million recorded at December 31, 2014 represents the last remaining earnout payment to be made under the agreement based on actual sales during the fourth quarter of 2014. This amount is no longer an estimate of fair value as of December 31, 2014.

At previous balance sheet dates, the fair value of the accrued contingent consideration was determined using a probability-weighted discounted cash flow approach at the acquisition date and reporting date. The approach is based on significant inputs that are not observable in the market, which are referred to as Level 3 inputs. The fair value is based on the Company's achievement of specific performance metrics through the remaining earnout period. The change in fair value of the contingent consideration is recorded through accretion expense in the Company’s consolidated statements of operations.

The significant unobservable inputs used in the fair value measurement of the Company’s liability for contingent consideration are projected future sales of existing and new products as well as earnout payments made each quarter determined by actual product sales. Decreases in forecasted sales would have resulted in a lower fair value measurement.

The following table presents a rollforward for all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for 2014 as follows (in thousands):



Balance at December 31, 2013	$	(464,449	)
Removal of liability for contingent consideration as no longer recorded at fair value	1,923
Derivative adjustment related to conversions and exercises	306,886
Unrealized loss, included in derivative gain (loss)	(285,910		)
Balance at December 31, 2014	$	(441,550	)

Nonrecurring Fair Value Measurements

The Company follows the authoritative guidance regarding non-financial assets and non-financial liabilities that are remeasured at fair value on a nonrecurring basis. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. During 2014, there were no material items remeasured at fair value on a nonrecurring basis. During 2013, items measured on a nonrecurring basis included the 8.00% Notes Issued in 2013, the Amended and Restated Thermo Loan Agreement with Thermo and equity issued in connection with the Exchange Agreement and the Consent Agreement. As a result of certain transactions that have occurred with the Company’s debt instruments, the Company was required to record these items at fair value as of the date of the respective agreements. See below for a further discussion of the fair value measurement for each item measured on a nonrecurring basis.

8.00% Notes Issued in 2013

The Company was required to record the 8.00% Notes Issued in 2013 initially at fair value as the issuance was considered to be an extinguishment of debt. Level 3 inputs were required to be used as there was not an active market for a substantial period of time between the issuance date and the balance sheet date. As of the issuance date, the fair value of the notes was $27.9 million and the fair value of the compound embedded derivative liability was $56.7 million, for a total fair value of the 8.00% Notes Issued in 2013 of $84.6 million. As stated above, the value of the compound embedded derivative was bifurcated from the 8.00% Notes Issued in 2013 and is marked to market on a recurring basis. The Company recorded a loss on extinguishment of debt of $47.2 million in its consolidated statement of operations during the second quarter of 2013. This loss was computed as the difference between the net carrying amount of the old 5.75% Notes of $71.8 million and the fair value of consideration given in the exchange of $119.0 million (including the new 8.00% Notes Issued in 2013, cash payments to both exchanging and non-exchanging holders, equity issued to the exchanging holders and other fees incurred for the exchange). See Note 3: Long-Term Debt and Other Financing Arrangements and Note 4: Derivatives for further discussion.

The significant quantitative Level 3 inputs utilized in the valuation models as of the issuance date of the 8.00% Notes Issued in 2013 are shown in the table below:



	Level 3 Inputs at May 20, 2013:
	Stock Price Volatility	Risk-Free Interest Rate		Note Conversion Price		Discount Rate		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2013	65 - 100 %	0.9	%	$	0.80	27	%	$	0.40

Other inputs used in the valuation model of the 8.00% Notes Issued in 2013 include the underlying features of the compound embedded derivative, including payment in kind interest payments, make whole premiums, automatic conversions, future equity issuances and probability of change of control of the Company. See further discussion above in “Derivative Liabilities” for the impact these inputs have on the fair value measurement.

Amended and Restated Loan Agreement with Thermo

The Company was required to record this Loan Agreement initially at fair value as the amendment and restatement of the Loan Agreement was considered to be an extinguishment of debt. Level 3 inputs were required to be used as there is not an active market for this debt instrument. As of the amendment and restatement date, the fair value of the Loan Agreement was $19.0 million and the fair value of the compound embedded derivative liability was $101.1 million, for a total fair value of the Loan Agreement of $120.1 million. As stated above, the value of the compound embedded derivative was bifurcated from the Loan Agreement and is marked to market on a recurring basis. The Company recorded a loss on extinguishment of debt of $66.1 million in its consolidated statement of operations for the third quarter of 2013. This loss was computed as the difference between the fair value of the debt, as amended and restated, and its carrying value just prior to amendment and restatement. See Note 3: Long-Term Debt and Other Financing Arrangements and Note 4: Derivatives for further discussion.

The significant quantitative Level 3 inputs utilized in the valuation models as of the amendment and restatement date of the Loan Agreement are shown in the table below:



	Level 3 Inputs at July 31, 2013:
	Stock Price Volatility	Risk-Free Interest Rate		Note Conversion Price		Discount Rate		Market Price of Common Stock
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	65 - 100 %	2.6	%	$	0.75	26	%	$	0.60

Other inputs used in the valuation model of the Amended and Restated Loan Agreement include the underlying features of the compound embedded derivative, including payment in kind interest payments, make whole premiums, automatic conversions, future equity issuances and probability of change of control of the Company. See further discussion above in “Derivative Liabilities” for the impact these inputs have on the fair value measurement.

Equity issued in connection with the Exchange Agreement

The stockholders’ equity balances measured on a nonrecurring basis in Level 1 include the approximately 30.3 million shares of voting common stock of the Company issued to Exchanging Note Holders in partial payment for exchanged 5.75% Notes in connection with the Exchange Agreement executed on May 20, 2013. The Company was required to record this equity issuance at fair value initially as the Exchange Agreement was considered to be an extinguishment of debt. See Note 3: Long-Term Debt and Other Financing Arrangements for further discussion. The Company calculated the aggregate fair value of the shares issued as approximately $12.1 million using the closing stock price on the issuance date (May 20, 2013) and included that amount in stockholders’ equity in its consolidated balance sheet.

Equity issued in connection with the Consent Agreement

On May 20, 2013, the Company and Thermo entered into the Consent Agreement. The commitments between the Company and Thermo pursuant to the Consent Agreement represent a written forward contract under the applicable accounting rules the equity issuances under the Consent Agreement are therefore required to be recorded at fair value. On May 20, 2013, the Company and Thermo also entered into the Common Stock Purchase Agreement, and subsequently on October 14, 2013, the Common Stock Purchase and Option Agreement. Those agreements defined the pricing terms for certain equity purchases under the Consent Agreement. The following table summarizes the amount invested in the Company pursuant to the Consent Agreement with Thermo (dollars in thousands, except amounts per share):



	Amount Invested		Issuance Price per Share		Closing Price per Share		Discount Value (4)		Total Fair Value		Shares Issued (5)
May 20, 2013 (1)	$	25,000	$	0.32	$	0.40	$	6,250	$	31,250	78,125,000
May 20, 2013 (1)	5,000		0.32		0.40		1,250		6,250		15,625,000
June 28, 2013 (1)	9,000		0.32		0.55		6,469		15,469		28,125,000
July 29, 2013 (2)	6,000		0.52		0.62		1,154		7,154		11,538,462
August 19, 2013 (2)	6,500		0.52		0.62		1,250		7,750		12,500,000
December 27, 2013 (2)	13,500		0.52		1.82		33,750		47,250		25,961,538
Total (3)	$	65,000					$	50,123	$	115,123	171,875,000


(1)	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.


(2)	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.

(3)

Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduced the amounts committed by Thermo. Since the execution of the Consent Agreement, the Company had received approximately $20.0 million through warrant exercises and other equity issuances in addition to amounts received through the Company’s exercise of the First Option under the Common Stock Purchase and Option Agreement (see Note 3: Long-Term Debt and Other Financing Arrangements for further discussion).


(4)	The discount on shares issued is recorded on the Company’s consolidated statement of operations in loss on equity issuance. This expense item represents the discount on shares issued to Thermo as well as certain other losses recorded on equity issued during 2013 related to cashless exercises of warrants issued with the 5.0% Notes.


(5)	All shares issued to Thermo in connection with these agreements were shares of the Company’s nonvoting common stock.

Long-Lived Assets

The following tables reflect the fair value measurements used in testing the impairment of long-lived assets at December 31, 2014 and 2012. For the year ended December 31, 2013, there were no events or changes in circumstances indicating that the carrying amount of long-lived assets may not be recoverable. Therefore, no impairment loss was recorded. Amounts shown below are in thousands.



	Fair Value Measurements at December 31, 2014:
	(Level 1)		(Level 2)		(Level 3)		Total Losses
Other assets:
Property and equipment, net	$	—	$	—	$	1,113,560	$	84
Total	$	—	$	—	$	1,113,560	$	84



	Fair Value Measurements at December 31, 2012:
	(Level 1)		(Level 2)		(Level 3)		Total Losses
Other assets:
Property and equipment, net	$	—	$	—	$	1,215,156	$	7,218
Total	$	—	$	—	$	1,215,156	$	7,218

During 2014, the Company recorded a loss of $0.1 million related to an adjustment made to the carrying value of certain items included in construction in progress. During 2012, the Company reduced the carrying value of its first-generation constellation by approximately $7.1 million. These losses are recorded in operating expenses in the consolidated statement of operations during the respective years. For assets that are no longer providing service, the Company removes the estimated cost and accumulated depreciation from property and equipment.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

COMMITMENTS

12 Months Ended

Dec. 31, 2014

COMMITMENTS [Abstract]

COMMITMENTS

Contractual Obligations

As of December 31, 2014, the Company had purchase commitments with Thales, Ericsson, and Hughes Network Systems, LLC (“Hughes”) related to the procurement, deployment and maintenance of the second-generation network. The Company is obligated to make payments under these purchase commitments, excluding accrued interest, as shown below (in thousands):



Years Ending December 31,
2015	$	28,964
2016	8,033
2017	—
2018	—
2019	—
Thereafter	—
Total purchase commitments	$	36,997

Second-Generation Satellites

As of December 31, 2014, the Company had a contract with Thales for the construction of the Company’s second-generation low-earth orbit satellites and related services. The Company has successfully launched all of these second-generation satellites, excluding one on-ground spare. Discussions between the Company and Thales are ongoing regarding certain deliverables under this contract. No costs associated with this contract are included in the table above.

Effective October 24, 2014, the Company entered into a contract with Thales for in-orbit support services for the second-generation satellites delivered under the 2009 contract described above. These services will be performed over a three-year period for a total cost of approximately €1.9 million. A credit of €0.6 million will be applied to the total cost, reducing the first annual payment to €0. This credit results from a settlement of amounts previously paid in conjunction with the 2009 contract.

Next-Generation Gateways and Other Ground Facilities

As of December 31, 2014, the Company had a contract with Hughes under which Hughes will design, supply and implement the Radio Access Network (RAN) ground network equipment and software upgrades for installation at a number of the Company’s satellite gateway ground stations and satellite interface chips to be used in various next-generation Globalstar devices.

In August 2013, the Company entered into an agreement with Hughes under which Hughes had the option to receive all or any portion of the deferred payments and accrued interest in our common stock. If Hughes chose to receive any payment in stock, shares would be provided at a 7% discount based upon a trailing volume weighted average price calculation. Hughes elected to receive payment in the form of shares of common stock for approximately $14.4 million of certain milestone payments and accrued interest. In valuing the Company's obligation to issue discounted shares to Hughes, a loss of approximately $1.0 million was recorded in the consolidated statement of operations for the year ended December 31, 2013.

In December 2013, the Company amended our contract with Hughes to extend the schedule of the program and to revise the remaining payment milestones and program milestones to reflect the revised program timeline. This amendment extended certain payments previously due in 2013 to 2014 and beyond.

In May 2014, the Company entered into an agreement with Hughes to incorporate changes to the scope of work for the RAN and UTS being supplied to the Company. The additional work increased the total contract value by $3.8 million. The Company also entered into a letter agreement with Hughes whereby Hughes was granted the option to accept the pre-payment of certain payment milestones in the form of our common stock at a 7% discount in lieu of cash. The Company issued the stock to Hughes on July 1, 2014. The payment milestones totaled $9.9 million. In valuing the shares, the Company recorded a loss of approximately $0.7 million in its consolidated statement of operations during the second quarter of 2014.

In October 2014, the Company and Hughes formally amended the contract to include the revised scope of work agreed to in the May letter agreement. The amendment also adjusted the schedule of the program and the remaining payment milestones and program milestones to incorporate the agreed upon changes. The additional $3.8 million in work agreed to in May is now reflected in the contract through this amendment.

As of December 31, 2014, the Company had an agreement with Ericsson. Ericsson will work with the Company to develop, implement and maintain a ground interface, or core network system that will be installed at a number of the Company’s satellite gateway ground stations.

In September 2013, the Company entered into an agreement with Ericsson which deferred certain milestone payments previously due under the contract to 2014 and beyond. The deferred payments continue to incur interest at a rate of 6.5% per annum. As of December 31, 2014, the Company had recorded $3.0 million in accounts payable and accrued expenses, excluding interest, related to these required payments and had incurred and capitalized $11.2 million of costs related to this contract. The costs are recorded as an asset in property and equipment. The Company and Ericsson are currently negotiating a revised milestone schedule which will include the remaining $1.0 million outstanding as of December 31, 2013.

In July 2014, the Company entered into an amended and restated agreement with Ericsson for the Company's core network system specifying the remaining contract value of $25.4 million for the work and a new milestone schedule to reflect the new program timeline.

Since 2004, the Company has issued separate purchase orders for additional phone equipment and accessories under the terms of an executed commercial agreement with Qualcomm. This contract was canceled in March 2013; the parties thereafter sought to resolve the issues related to the contract termination. The Company and Qualcomm signed an agreement in July 2014 specifying terms for the sale of the remaining inventory to the Company. The Company previously recorded total advances to Qualcomm for inventory of $9.2 million on its consolidated balance sheet. The Company agreed to pay to Qualcomm $0.1 million to take ownership of the finished goods and raw materials held by Qualcomm, as well as certain limited support services to be provided to the Company. This final payment was made in July 2014 and eliminated Globalstar's obligations to purchase additional equipment from Qualcomm. As a result of the July 2014 agreement, the Company recorded a reduction in the value of inventory of $7.3 million related to raw materials that are not likely to be used in the future production of inventory. With the final payment of $0.1 million made in July, the Company assumed title to the inventory; therefore, the remaining balance of approximately $2.0 million, representing primarily finished goods, is included in inventory on the Company's consolidated balance sheet as of December 31, 2014.

Future Minimum Lease Obligations

The Company has noncancelable operating leases for facilities and equipment throughout the United States and around the world, including Louisiana, California, Florida, Canada, Ireland, France, Brazil, Panama, and Singapore. The leases expire on various dates through 2021. The Company is currently in the process of negotiating a lease for its Botswana gateway. The following table presents the future minimum lease payments for leases having an initial or remaining noncancelable lease term in excess of one year (in thousands) as of December 31, 2014, excluding possible lease payment reimbursement from the State of Louisiana pursuant to the Cooperative Endeavor Agreement the Company entered into with the Louisiana Department of Economic Development (See Note 8: Accrued Expenses and Non-Current Liabilities):



2015	$	1,237
2016	1,152
2017	1,148
2018	1,083
2019	269
Thereafter	375
Total minimum lease payments	$	5,264

Rent expense for 2014, 2013 and 2012 was approximately $1.4 million. $2.0 million and $2.0 million, respectively.

CONTINGENCIES	12 Months Ended
CONTINGENCIES	Dec. 31, 2014
CONTINGENCIES [Abstract]
CONTINGENCIES	CONTINGENCIES Arbitration On June 3, 2011, Globalstar filed a demand for arbitration against Thales before the American Arbitration Association to enforce certain rights to order additional satellites under the Amended and Restated Contract for the construction of the Globalstar Satellite for the Second Generation Constellation dated and executed in June 2009 (“2009 Contract”). Globalstar did not include within its demand any claims that it had against Thales for work previously performed under the contract to design, manufacture and timely deliver the first 25 second-generation satellites. On May 10, 2012, the arbitration tribunal issued its award in which it determined that Globalstar materially breached the contract by failing to pay to Thales termination charges in the amount of €51.3 million by October 9, 2011, and that absent further agreement between the parties, Thales has no further obligation to manufacture or deliver satellites under Phase 3 of the 2009 Contract. The award also required Globalstar to pay Thales approximately €53 million in termination charges and interest by June 9, 2012. On May 23, 2012, Thales commenced an action in the United States District Court for the Southern District of New York by filing a petition to confirm the arbitration award (the “New York Proceeding”). Thales and the Company entered into a Tolling Agreement as of June 13, 2013 under which Thales dismissed the New York Proceeding without prejudice. Thales may refile the petition at a later date and pursue the confirmation of the arbitration award, which Globalstar will oppose. Should Thales be successful in confirming the arbitration award, this would have a material adverse effect on the Company’s financial condition and liquidity. On June 24, 2012, the Company and Thales agreed to settle their prior commercial disputes, including those disputes that were the subject of the arbitration award. In order to effectuate this settlement, the Company and Thales entered into a Release Agreement, a Settlement Agreement and a Submission Agreement. Under the terms of the Release Agreement, Thales agreed unconditionally and irrevocably to release and forever discharge the Company from any obligation to pay €35.6 million of the termination charges awarded in the arbitration together with all interest on the award amount effective upon the earlier of December 31, 2012 and the effective date of the financing for the purchase of any additional second-generation satellites. Under the terms of the Release Agreement, Globalstar agreed unconditionally and irrevocably to release and forever discharge Thales from any and all claims related to Thales’ work under the 2009 satellite construction contract, including any obligation to pay liquidated damages, effective upon the earlier of December 31, 2012 and the effective date of the financing for the purchase of any additional second-generation satellites. In connection with the Release Agreement, the Company recorded a contract termination charge of approximately €17.5 million which is recorded in the Company’s consolidated balance sheet as of December 31, 2014. The releases became effective on December 31, 2012. Under the terms of the Settlement Agreement, Globalstar agreed to pay €17.5 million to Thales, representing one-third of the termination charges awarded to Thales in the arbitration, subject to certain conditions, on the later of the effective date of the new contract for the purchase of any additional second-generation satellites and the effective date of the financing for the purchase of these satellites. Because the effective date of the new contract for the purchase of additional second-generation satellites did not occur on or prior to February 28, 2013, any party may terminate the Settlement Agreement. If any party terminates the Settlement Agreement, all parties’ rights and obligations under the Settlement Agreement shall terminate. However, the Release Agreement provides that it will survive a termination of the Settlement Agreement. As of December 31, 2014, no party had terminated the Settlement Agreement. Litigation Due to the nature of the Company's business, the Company is involved, from time to time, in various litigation matters or subject to disputes or routine claims regarding its business activities. Legal costs related to these matters are expensed as incurred. In management's opinion, there is no pending litigation, dispute or claim, other than the arbitration award discussed above, that may have a material adverse effect on the Company's financial condition, results of operations or liquidity.

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES

12 Months Ended

Dec. 31, 2014

Payables and Accruals [Abstract]

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES

Accrued expenses consist of the following (in thousands):



	December 31,
	2014		2013
Accrued interest	$	827	$	1,200
Accrued compensation and benefits	2,597		3,927
Accrued property and other taxes	6,727		5,744
Accrued customer liabilities and deposits	2,751		2,663
Accrued professional and other service provider fees	1,925		705
Accrued liability for contingent consideration	481		1,922
Accrued commissions	686		1,316
Accrued telecommunications expenses	1,135		649
Accrued satellite and ground costs	1,531		—
Other accrued expenses	3,682		4,574
Total accrued expenses	$	22,342	$	22,700

Other accrued expenses primarily include outsourced logistics services, storage, inventory purchases, inventory in transit, warranty reserve and maintenance.

The following is a summary of the activity in the warranty reserve account, which is included in other accrued expenses above (in thousands):



	Year Ended December 31,
	2014			2013			2012
Balance at beginning of period	$	142		$	235		$	179
Provision	246			189			293
Utilization	(259		)	(282		)	(237		)
Balance at end of period	$	129		$	142		$	235

Non-current liabilities consist of the following (in thousands):



	December 31,
	2014		2013
Long-term accrued interest	$	131	$	451
Asset retirement obligation	1,184		1,083
Deferred rent	404		456
Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana	1,391		1,575
Uncertain income tax positions	6,061		5,918
Foreign tax contingencies	3,034		4,213
Total noncurrent liabilities	$	12,205	$	13,696

The Company relocated to Louisiana in 2011. In connection with its relocation, the Company entered into a Cooperative Endeavor Agreement with the Louisiana Department of Economic Development (“LED”) whereby the Company would be reimbursed for certain qualified relocation costs and lease expenses. In accordance with the terms of the agreement, these reimbursement costs, not to exceed $8.1 million, will be reimbursed to the Company as incurred provided the Company maintains required annual payroll levels in Louisiana through 2019. Under the terms of the agreement, the Company was reimbursed a total of $4.5 million for qualifying relocation and lease expenses and $1.3 million for facility improvements and replacement equipment in connection with the relocation through December 31, 2014.

LED will continue to reimburse the Company approximately $352,000 per year through 2019 for certain qualifying lease expenses, provided the Company meets the required payroll levels set forth in the agreement. If the Company fails to meet the required payroll in any project year, the Company will reimburse LED for a portion of the shortfall not to exceed the total reimbursement received from LED. The Company has projected that it will not meet the required payroll levels set forth in the agreement. As of December 31, 2014, the estimated impact of the payroll shortfall in future years is approximately $1.4 million and is included in non-current liabilities.

RELATED PARTY TRANSACTIONS

12 Months Ended

Dec. 31, 2014

RELATED PARTY TRANSACTIONS

Payables to Thermo and other affiliates relate to normal purchase transactions and were $0.5 million and $0.2 million at each of December 31, 2014 and 2013, respectively.

Transactions with Thermo

Thermo incurs certain expenses on behalf of the Company. The table below summarizes the total expense for the periods indicated below (in thousands):



	Year Ended December 31,
	2014		2013		2012
General and administrative expenses	$	274	$	268	$	180
Non-cash expenses	548		548		529
Loss on sale of equity issuance	—		16,373		—
Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement	—		66,088		—
Total	$	822	$	83,277	$	709

General and administrative expenses are related to expenses incurred by Thermo on the Company’s behalf which are charged to the Company. Non-cash expenses are related to services provided by two executive officers of Thermo (who are also directors of the Company) who receive no cash compensation from the Company which are accounted for as a contribution to capital. The Thermo expense charges are based on actual amounts (with no mark-up) incurred or upon allocated employee time.

Since June 2009, Thermo and its affiliates have also deposited $60.0 million into a contingent equity account to fulfill a condition precedent for borrowing under the Facility Agreement, purchased $20.0 million of the Company’s 5.0% Notes, purchased $11.4 million of the Company's 8.00% Notes Issued in 2009, provided a $2.3 million short-term loan to the Company (which was subsequently converted into nonvoting common stock), and loaned $37.5 million to the Company to fund the debt service reserve account.

On May 20, 2013, the Company issued 8.00% Notes Issued in 2013 in exchange for 5.75% Notes. In connection with this exchange, the Company entered into the Consent Agreement, the Common Stock Purchase Agreement and the Common Stock Purchase and Option Agreement (see Note 3: Long-Term Debt and Other Financing Arrangements for further discussion). During the second quarter of 2013, Thermo and its affiliates funded $39.0 million in accordance with the Consent Agreement and the Common Stock Purchase Agreement. During the third quarter of 2013, Thermo and its affiliates funded an additional $12.5 million in accordance with the Consent Agreement and the Common Stock Purchase and Option Agreement. During the fourth quarter of 2013, Thermo and its affiliates funded an additional $13.5 million in accordance with the Common Stock Purchase and Option Agreement.

In July 2013, the Company and Thermo entered into an Amended and Restated Loan Agreement. As a result of this transaction, the Company was required to record this Loan Agreement initially at fair value as the amendment and restatement of the Loan Agreement was considered to be an extinguishment of debt. As of the amendment and restatement date the fair value of the Loan Agreement was $120.1 million. The Company recorded a loss on extinguishment of debt of $66.1 million in its consolidated statement of operations during the third quarter of 2013. The Company computed this loss as the difference between the fair value of the debt, as amended and restated, and its carrying value just prior to amendment and restatement.

The terms of the Amended and Restated Loan Agreement with Thermo, the Common Stock Purchase Agreement and the Common Stock Purchase and Option Agreement were approved by a special committee of the Company’s board of directors consisting solely of the Company’s unaffiliated directors. The committee, which was represented by independent legal counsel, determined that the terms of these agreements were fair and in the best interests of the Company and its shareholders.

In August 2013, the Company drew the remaining $1.1 million from the interest earned on the contingent equity account and issued 2,133,656 shares of nonvoting common stock to Thermo in October 2013. The value of the 20% discount on the shares issued to Thermo was recorded as a deferred financing cost on the Company’s consolidated balance sheet.

For the year ended December 31, 2013, the Company recognized a loss on the sale of shares of approximately $16.4 million (included in other income/expense on the consolidated statement of operations), representing the difference between the purchase price and the fair value of the Company’s common stock (measured as the closing stock price on the date of each sale).

During 2014, Thermo exercised warrants that were scheduled to expire between June 2014 and June 2015. The warrants that were exercised included warrants for 4.2 million shares issued as partial consideration for the Thermo Loan Agreement, resulting in the issuance of 4.2 million shares of Globalstar common stock; warrants for 11.3 million shares issued in connection with the annual availability fee for the Contingent Equity Agreement in 2009, resulting in the issuance of 11.3 million shares of Globalstar common stock; and 8.00% Warrants issued in 2009 to purchase 16.3 million shares of common stock, resulting in the issuance of 14.7 million shares of Globalstar common stock. As of December 31, 2014, warrants to purchase approximately 30.2 million shares issued under the Contingent Equity Agreement and 8.0 million 5.0% Warrants remain outstanding, all of which are held by Thermo and are scheduled to expire between June 2016 and June 2017.

Thermo is required to maintain minimum and maximum ownership levels in the Company's common stock as defined in the Facility Agreement. As needed, Thermo may convert shares of nonvoting common stock into shares of voting common stock to ensure compliance with the ownership limitations. During 2014, Thermo converted 175.0 million shares of nonvoting common stock to voting common stock to ensure compliance with these covenants.

See Note 3: Long-Term Debt and Other Financing Arrangements for further discussion of the Company's debt and financing transactions with Thermo.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References + Details

PENSIONS AND OTHER EMPLOYEE BENEFITS

12 Months Ended

Dec. 31, 2014

Compensation and Retirement Disclosure [Abstract]

PENSIONS AND OTHER EMPLOYEE BENEFITS

Defined Benefit Plan

Until June 1, 2004, substantially all Old and New Globalstar employees and retirees who participated and/or met the vesting criteria for the plan were participants in the Retirement Plan of Space Systems/Loral (the "Loral Plan"), a defined benefit pension plan. The accrual of benefits in the Old Globalstar segment of the Loral Plan was curtailed, or frozen, by the administrator of the Loral Plan as of October 23, 2003. Prior to October 23, 2003, benefits for the Loral Plan were generally based upon contributions, length of service with the Company and age of the participant. On June 1, 2004, the assets and frozen pension obligations of the Globalstar Segment of the Loral Plan were transferred into a new Globalstar Retirement Plan (the "Globalstar Plan"). The Globalstar Plan remains frozen and participants are not currently accruing benefits beyond those accrued as of October 23, 2003. Globalstar's funding policy is to fund the Globalstar Plan in accordance with the Internal Revenue Code and regulations.

Defined Benefit Pension Obligation and Funded Status

Below is a reconciliation of projected benefit obligation, plan assets, and the funded status of the Company’s defined benefit plan (in thousands):



	Year Ended December 31,
	2014			2013
Change in projected benefit obligation:
Projected benefit obligation, beginning of year	$	16,685		$	18,804
Service cost	103			85
Interest cost	781			671
Actuarial (gain) loss	2,489			(1,796		)
Benefits paid	(1,126		)	(1,079		)
Projected benefit obligation, end of year	$	18,932		$	16,685
Change in fair value of plan assets:
Fair value of plan assets, beginning of year	$	13,156		$	11,583
Return on plan assets	673			1,985
Employer contributions	730			667
Benefits paid	(1,126		)	(1,079		)
Fair value of plan assets, end of year	$	13,433		$	13,156
Funded status, end of year- net liability	$	(5,499	)	$	(3,529	)

Net Benefit Cost and Amounts Recognized

Components of the net periodic benefit cost of the Company’s contributory defined benefit pension plan were as follows (in thousands):



	Year Ended December 31,
	2014			2013			2012
Net periodic benefit cost:
Service cost	$	103		$	85		$	66
Interest cost	781			671			712
Expected return on plan assets	(932		)	(813		)	(739		)
Amortization of unrecognized net actuarial loss	281			518			583
Total net periodic benefit cost	$	233		$	461		$	622

Amounts recognized in balance sheet were as follows (in thousands):



	December 31,
	2014			2013
Amounts recognized:
Funded status recognized in other non-current liabilities	$	(5,499	)	$	(3,529	)
Net actuarial loss recognized in accumulated other comprehensive loss	6,950			4,484
Net amount recognized in retained deficit	$	1,451		$	955

Assumptions

The weighted-average assumptions used to determine the benefit obligation and net periodic benefit cost were as follows:



	For the Year Ended December 31,
	2014		2013		2012
Benefit obligation assumptions:
Discount rate	4.03	%	4.80	%	3.75	%
Rate of compensation increase	N/A		N/A		N/A
Net periodic benefit cost assumptions:
Discount rate	4.80	%	3.75	%	4.00	%
Expected rate of return on plan assets	7.12	%	7.12	%	7.12	%
Rate of compensation increase	N/A		N/A		N/A

The assumptions, investment policies and strategies for the Globalstar Plan are determined by the Globalstar Plan Committee. The Globalstar Plan Committee is responsible for ensuring the investments of the plans are managed in a prudent and effective manner. Amounts related to the pension plan are derived from actuarial and other assumptions, including discount rates, mortality, expected rate of return, compensation increases, participant data and termination. The Company reviews assumptions on an annual basis and make adjustments as considered necessary.

The expected long-term rate of return on pension plan assets is selected by taking into account the expected duration of the projected benefit obligation for the plans, the asset mix of the plan and the fact that the plan assets are actively managed to mitigate risk.

Plan Assets and Investment Policies and Strategies

The plan assets are invested in various mutual funds which have quoted prices. The plan has a target allocation. On a weighted-average basis, target allocations for equity securities range from 50% to 60% for debt securities 25% to 50% and for other investments 0% to 15%. The defined benefit pension plan asset allocation as of the measurement date presented as a percentage of total plan assets were as follows:



	December 31,
	2014		2013
Equity securities	56	%	57	%
Debt securities	30		29
Other investments	14		14
Total	100	%	100	%

The fair values of the Company’s pension plan assets by asset category were as follows (in thousands):



	December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
United States equity securities	$	6,103	$	—	$	6,103	$	—
International equity securities	1,356		—		1,356		—
Fixed income securities	4,034		—		4,034		—
Other	1,940		—		1,940		—
Total	$	13,433	$	—	$	13,433	$	—



	December 31, 2013
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
United States equity securities	$	6,119	$	—	$	6,119	$	—
International equity securities	1,435		—		1,435		—
Fixed income securities	3,749		—		3,749		—
Other	1,853		—		1,853		—
Total	$	13,156	$	—	$	13,156	$	—

Accumulated Benefit Obligation

The accumulated benefit obligation of the defined benefit pension plan recognized in accumulated other comprehensive loss was $7.0 million and $4.5 million at December 31, 2014 and 2013, respectively.

Benefits Payments and Contributions

The benefit payments to retirees over the next ten years are expected to be paid as follows (in thousands):



2015	$	970
2016	965
2017	956
2018	970
2019	993
2020 - 2024	5,163

For each of 2014 and 2013, the Company contributed $0.7 million to the Globalstar Plan.

401(k) Plan

The Company has a defined contribution employee savings plan, or “401(k),” which provides that the Company may match the contributions of participating employees up to a designated level. Under this plan, the matching contributions were approximately $0.3 million, $0.2 million and $0.1 million for 2014, 2013, and 2012, respectively. Due to an effort to reduce operating costs, the Company temporarily suspended its match of contributions for substantially all of its U.S. employees beginning in the fourth quarter of 2011. This plan was reinstated for all participating U.S. employees during the third quarter of 2013.

TAXES

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

TAXES

The components of income tax expense (benefit) were as follows (in thousands):



	Year Ended December 31,
	2014			2013		2012
Current:
Federal tax (benefit)	$	—		$	—	$	—
State tax	20			240		274
Foreign tax	2,430			898		139
Total	2,450			1,138		413
Deferred:
Federal and state tax (benefit)	—			—		—
Foreign tax (benefit)	(1,569		)	—		—
Total	(1,569		)	—		—
Income tax expense (benefit)	$	881		$	1,138	$	413

U.S. and foreign components of income (loss) before income taxes are presented below (in thousands):



	Year Ended December 31,
	2014			2013			2012
U.S. income (loss)	$	(461,250	)	$	(585,801	)	$	(105,722	)
Foreign income (loss)	(735		)	(4,177		)	(6,063		)
Total income (loss) before income taxes	$	(461,985	)	$	(589,978	)	$	(111,785	)

As of December 31, 2014, the Company had cumulative U.S. and foreign net operating loss carry-forwards for income tax reporting purposes of approximately $1.3 billion and $159.2 million, respectively. As of December 31, 2013, the Company had cumulative U.S. and foreign net operating loss carry-forwards for income tax reporting purposes of approximately $1.1 billion and $179.1 million, respectively. The net operating loss carry-forwards expire when the Company files its returns from 2014 through 2034.

The Company has not provided United States income taxes and foreign withholding taxes on approximately $9.7 million of undistributed earnings from certain foreign subsidiaries indefinitely invested outside the United States. Should the Company decide to repatriate these foreign earnings, the Company would have to adjust the income tax provision in the period in which management determines that it intends to repatriate the earnings.

The components of net deferred income tax assets were as follows (in thousands):



	December 31,
	2014			2013
Federal and foreign net operating loss and credit carry-forwards	$	554,122		$	492,839
Property and equipment and other long-term assets	111,891			53,196
Accruals and reserves	29,315			4,240
Deferred tax assets before valuation allowance	695,328			550,275
Valuation allowance	(693,759		)	(550,275		)
Net deferred income tax assets	$	1,569		$	—

The change in property and equipment and other long-term deferred tax assets during 2014 and 2013 was due primarily to the difference in depreciation between tax and book depreciable lives as the Company placed the remaining second-generation satellites into service during 2013 and, for the 2014 change, the difference between the tax and book treatment of the Company’s debt refinancing activity that occurred during 2013. The change in the valuation allowance during 2014 and 2013 was $143.5 million and $206.0 million, respectively, which was due to the Company's providing valuation allowances against substantially all of the tax benefit generated from the consolidated net losses in both periods. The Company's net deferred tax asset of December 31, 2014, results from its Canadian subsidiary. The Company's Canadian subsidiary has recorded net income for financial reporting purposes for more than three years and anticipates that it will use all of its net operating loss carryforwards before expiration.

The actual provision for income taxes differs from the statutory U.S. federal income tax rate as follows (in thousands):



	Year Ended December 31,
	2014			2013			2012
Provision at U.S. statutory rate of 35%	$	(161,702	)	$	(206,576	)	$	(39,125	)
State income taxes, net of federal benefit	(27,656		)	(34,923		)	(6,070		)
Change in valuation allowance	143,484			206,022			40,641
Effect of foreign income tax at various rates	243			508			759
Permanent differences	33,138			38,911			(220		)
Change in unrecognized tax benefit	(3,839		)	388			381
Recognition of pre-acquisition losses in Brazil	—			—			—
Net Change in permanent items due to provision to tax return	21,008			—			—
Other (including amounts related to prior year tax matters)	(3,795		)	(3,192		)	4,047
Total	$	881		$	1,138		$	413

Tax Audits

The Company operates in various U.S. and foreign tax jurisdictions. The process of determining its anticipated tax liabilities involves many calculations and estimates which are inherently complex. The Company believes that it has complied in all material respects with its obligations to pay taxes in these jurisdictions. However, its position is subject to review and possible challenge by the taxing authorities of these jurisdictions. If the applicable taxing authorities were to challenge successfully its current tax positions, or if there were changes in the manner in which the Company conducts its activities, the Company could become subject to material unanticipated tax liabilities. It may also become subject to additional tax liabilities as a result of changes in tax laws, which could in certain circumstances have a retroactive effect.

In January 2012, the Company’s Canadian subsidiary was notified that its income tax returns for the years ended October 31, 2008 and 2009 had been selected for audit. The Canada Revenue Agency is in the process of reviewing the information provided by the Canadian subsidiary. The Canada Revenue Agency has reviewed the information provided by the Canadian subsidiary and has issued an assessment for those years under audit. The Canadian subsidiary has filed an objection for the cash settlement and for the net operating loss carry forward to be adjusted for the assessed amount.

In December 2013, the Company’s Singapore subsidiary was notified that its income tax returns for the years ended 2009 to 2012 had been selected for audit. The Inland Revenue Authority reviewed the submitted information and had minimal adjustments to the Singapore subsidiary’s total net operating loss carried forward schedule.

Except for the audits noted above, neither the Company nor any of its subsidiaries are currently under audit by the IRS or by any state jurisdiction in the United States. The Company's corporate U.S. tax returns for 2010 and subsequent years remain subject to examination by tax authorities. State income tax returns are generally subject to examination for a period of three to five years after filing of the respective return. The state impact of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states.

Through a prior foreign acquisition the Company acquired a tax liability for which the Company has been indemnified by the previous owners. As of December 31, 2014 and 2013, the Company had recorded a tax liability of $1.1 million and $2.2 million, respectively, to the foreign tax authorities with an offsetting tax receivable from the previous owners, which is included in Intangible and Other Assets in the accompanying balance sheets. An agreement was reached in November of 2014 to settle the outstanding tax liability by utilization of the Brazilian Tax Amnesty program and the accumulated fiscal losses related to tax periods preceding the date of the agreement. The Company may be exposed to liabilities in the future if its subsidiary in Brazil, after making use of all available tax benefits and fiscal losses, incurs additional tax liabilities for which it may not be fully indemnified by the seller, or the seller may fail to perform its indemnification obligations.

In the Company's international tax jurisdictions, numerous tax years remain subject to examination by tax authorities, including tax returns for 2004 and subsequent years in most of the Company's international tax jurisdictions.

A rollforward of the Company's unrecognized tax benefits is as follows (in thousands):



Gross unrecognized tax benefits at January 1, 2014	$	8,073
Gross decreases based on tax positions related to current year	(3,839		)
Gross increases based on tax positions related to prior years	—
Gross unrecognized tax benefits at December 31, 2014	$	4,234



Gross unrecognized tax benefits at January 1, 2013	$	7,750
Gross increases based on tax positions related to current year	388
Gross decreases based on tax positions related to prior years	(65		)
Gross unrecognized tax benefits at December 31, 2013	$	8,073

The unrecognized tax benefit at December 31, 2014 does not include any derecognized amounts which could potentially reduce the effective income tax rate in future periods. The decrease in the Company's unrecognized tax benefits is attributable to accrued interest on intercompany balances between the Company's U.S. and foreign subsidiaries because the Company’s position has changed to include the accrued interest adjustment in the U.S. tax return.

As of December 31, 2014 and 2013, the Company had recorded cumulative interest and penalties of $1.8 million and $1.6 million, respectively, in connection with the adjustments related to Accounting Standards Codification Topic 740 Accounting for Uncertainty in Income Taxes. The Company classifies interest and penalties as a component of income tax expense.

It is anticipated that the amount of unrecognized tax benefit reflected at December 31, 2014, will not materially change in the next 12 months; any changes are not anticipated to have a significant impact on the results of operations, financial position or cash flows of the Company.

On September 13, 2013, the United States Treasury Department and the Internal Revenue Service issued final regulations regarding the deduction and capitalization of expenditures related to tangible property. The final regulations under Internal Revenue Code Sections 162, 167 and 263(a) apply to amounts paid to acquire, produce, or improve tangible property as well as dispositions of such property and are generally effective for tax years beginning on or after January 1, 2014. The Company has evaluated these regulations and determined they will not have a material impact on its consolidated results of operations, cash flows or financial position.

GEOGRAPHIC INFORMATION

12 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

GEOGRAPHIC INFORMATION

The Company attributes equipment revenue to various countries based on the location where equipment is sold. Service revenue is attributed to the various countries based on the Globalstar entity that holds the customer contract. Long-lived assets consist primarily of property and equipment and are attributed to various countries based on the physical location of the asset at a given fiscal year-end, except for the Company’s satellites which are included in the long-lived assets of the United States. The Company’s information by geographic area is as follows (in thousands):



	Year Ended December 31,
	2014		2013		2012
Revenues:
Service:
United States	$	46,519	$	44,909	$	41,139
Canada	14,584		12,436		10,505
Europe	5,536		4,085		3,132
Central and South America	2,623		2,678		2,287
Others	561		536		405
Total service revenue	69,823		64,644		57,468
Subscriber equipment:
United States	10,931		11,284		12,899
Canada	5,668		3,913		3,654
Europe	2,123		1,708		1,297
Central and South America	1,279		1,094		798
Others	240		68		202
Total subscriber equipment revenue	20,241		18,067		18,850
Total revenue	$	90,064	$	82,711	$	76,318



	December 31,
	2014		2013
Long-lived assets:
United States	$	1,108,675	$	1,164,358
Canada	357		247
Europe	413		408
Central and South America	3,309		3,595
Others	806		1,177
Total long-lived assets	$	1,113,560	$	1,169,785

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

+ Details

STOCK COMPENSATION

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK COMPENSATION

The Company’s 2006 Equity Incentive Plan (“Equity Plan”) provides long-term incentives to the Company’s key employees, including officers, directors, consultants and advisers (“Eligible Participants”) and to align stockholder and employee interests. Under the Equity Plan, the Company may grant incentive stock options, restricted stock awards, restricted stock units, and other stock based awards or any combination thereof to Eligible Participants. The Compensation Committee of the Company’s Board of Directors establishes the terms and conditions of any awards granted under the plans. As of December 31, 2014 and 2013, the number of shares of common stock that was authorized and remained available for issuance under the Equity Plan was 23.5 million and 15.9 million, respectively.

Stock Options

The Company has granted incentive stock options under the Equity Plan. The options generally vest in equal installments over three or four years and expire in ten years. Non-vested options are generally forfeited upon termination of employment.

The Company recognizes compensation expense for stock option grants based on the fair value at the date of grant using the Black-Scholes option pricing model. The Company uses historical data, among other factors, to estimate the expected price volatility, the expected option life and the expected forfeiture rate. The market price of common stock has been volatile in recent years. As the Company does not expect this volatility to reoccur during the entire expected term of the options, it considered historical volatility of the share prices of its peer group over the relevant time periods in addition to its historical volatility for purposes of determining expected volatility. Because the Company has limited historical stock option exercise experience upon which to base an estimate of expected term, it estimated the expected term in 2014, 2013 and 2012 from historical exercise patterns, while also considering other factors such as the recipients of the options granted in determining the expected term. The risk-free rate is based on the United States Treasury Department yield curve in effect at the time of grant for the expected life of the option. The table below summarizes the assumptions for the indicated periods:



	Year Ended December 31,
	2014		2013		2012
Risk-free interest rate	Less than 1 - 2%		Less than 1 - 2%		Less than 1 - 1%
Expected term of options (years)	5		2 - 6		1 - 5
Volatility	72%		72 - 115%		80 - 103%
Weighted average grant-date fair value per share	$	1.67	$	0.70	$	0.39

The Company assumes an expected dividend yield of zero for all periods.

The following table represents the Company’s stock option activity for the year ended December 31, 2014:



	Shares		Weighted Average Exercise Price
Outstanding at January 1, 2014	8,236,855		$	0.98
Granted	1,670,100		2.80
Exercised	(1,899,725	)	0.72
Forfeited or expired	(268,325	)	1.27
Outstanding at December 31, 2014	7,738,905		1.33

Exercisable at December 31, 2014	4,827,320		$	0.94

The following table summarizes the aggregate intrinsic value of stock options exercised during the years indicated below (in thousands):



	Year Ended December 31,
	2014		2013		2012
Intrinsic value of stock options exercised	$	5,083	$	2,263	$	78

The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. Net cash proceeds during the year ended December 31, 2014 from the exercise of stock options were $1.3 million. The aggregate intrinsic value of all outstanding stock options at December 31, 2014 was $11.1 million with a remaining contractual life of 7 years. The aggregate intrinsic value of all vested stock options at December 31, 2014 was $8.6 million with a remaining contractual life of 6.4 years.

The following table represents the Company’s nonvested stock option activity for the year ended December 31, 2014:



	Shares		Weighted Average Grant Date Fair Value
Nonvested stock options at January 1, 2014	3,156,759		$	0.72
Granted	1,670,100		1.67
Vested	(1,695,479	)	0.75
Forfeited or expired	(219,795	)	0.80
Nonvested stock options at December 31, 2014	2,911,585		1.20

The following table presents compensation expense related to stock options for the years indicated below (in millions):



	Year Ended December 31,
	2014		2013		2012
Total compensation expense	$	1.5	$	0.5	$	0.7

As of December 31, 2014, there was approximately $2.9 million of unrecognized compensation expense related to nonvested stock options outstanding to be recognized over a weighted-average period of 1.6 years.

The Company adjusts its estimates of expected equity awards forfeitures based upon its review of recent forfeiture activity and expected future employee turnover. The Company considers the impact of both pre-vesting forfeitures and post-vesting cancellations for purposes of evaluating forfeiture estimates. The effect of adjusting the forfeiture rate is recognized in the period in which the forfeiture estimate is changed.

Nonstatutory Stock Options

In October 2011, the Company granted to certain Eligible Participants nonstatutory stock options for 2,710,000 shares of common stock and 273,000 restricted shares that vest and become exercisable on the earlier of (i) the first trading day after the Company's common stock shall have traded on the then-applicable national or regional securities exchange or market system constituting the primary market for the stock for more than ten consecutive trading days at or above a per-share closing price of $2.50 or (ii) the day that a binding written agreement is signed for the sale of the Company, as determined by the Company's board of directors in its discretion reasonably exercised. In July 2013, the Compensation Committee of the Company's Board of Directors modified this award to revise the vesting terms from $2.50 to $0.80. As a result of this modification, the Company's incremental compensation cost was approximately $0.6 million. In September 2013, the Company's stock price traded for more than ten consecutive trading days above a price per-share closing price of $0.80, which resulted in immediate vesting of these options. The Company recognized the remaining unamortized compensation cost related to immediate vesting of these options of approximately $0.8 million in the third quarter of 2013.

Restricted Stock

Shares of restricted stock generally vest in equal annual installments over three years. Non-vested shares are generally forfeited upon the termination of employment. Holders of restricted stock are entitled to all rights of a stockholder of the Company with respect to the restricted stock, including the right to vote the shares and receive any dividends or other distributions. Compensation expense associated with restricted stock is measured based on the grant date fair value of the common stock and is recognized on a straight line basis over the vesting period. The table below summarizes the weighted average grant-date fair value of restricted stock for the indicated periods:



	Year Ended December 31,
	2014		2013		2012
Weighted average grant-date fair value	$	3.32	$	1.06	$	0.71

The following is a rollforward of the activity in restricted stock for the year ended December 31, 2014:



	Shares		Weighted Average Grant Date Fair Value
Nonvested at January 1, 2014	633,590		$	1.68
Granted	1,146,815		3.32
Vested	(945,463	)	2.70
Forfeited	(26,444	)	1.88
Nonvested at December 31, 2014	808,498		$	2.81

The following table represents the compensation expense related to restricted stock for the years indicated below (in millions):



	Year Ended December 31,
	2014		2013		2012
Total compensation expense	$	1.6	$	—	$	—

During 2014, the Company recognized $1.6 million of stock award expense and, during 2013 and 2012, the Company recognized less than $0.1 million of stock award expense as the compensation expense was offset primarily by the effect of forfeitures in each respective year. As of December 31, 2014, there was approximately 2.0 million of unrecognized compensation expense related to unvested restricted stock outstanding to be recognized over a weighted-average period of 2.1 years.

Employee Stock Purchase Plan

In June 2011, the Company adopted an Employee Stock Purchase Plan (the “Plan”) which provides eligible employees of the Company and its subsidiaries with an opportunity to acquire shares of its common stock at a discount. The maximum aggregate number of shares of common stock that may be purchased through the Plan is 7,000,000 shares. The number of shares that may be purchased through the Plan will be subject to proportionate adjustments to reflect stock splits, stock dividends, or other changes in the Company’s capital stock.

The Plan permits eligible employees to purchase shares of common stock during two semi-annual offering periods beginning on June 15 and December 15 (the “Offering Periods”), unless adjusted by the Board or one of its designated committees. Eligible employees may purchase shares of up to 15% of their total compensation per pay period, but may purchase in any calendar year no more than the lesser of $25,000 in fair market value of common stock or 500,000 shares of common stock, as measured as of the first day of each applicable Offering Period. The price an employee pays is 85% of the fair market value of common stock. Fair market value is equal to the lesser of the closing price of a share of common stock on either the first day or the last day of the Offering Period.

For each of the years ended December 31, 2014 and 2013, the Company received $0.5 million and $0.4 million related to shares issued under this plan, respectively. For the years ended December 31, 2014 and 2013, the Company recorded compensation expense of approximately $0.4 million and $0.2 million, respectively, which is reflected in marketing, general and administrative expenses. Additionally, the Company has issued approximately 2,608,765 shares through December 31, 2014 related to the Plan.

The fair value of the employees’ stock purchase rights granted under the ESPP was estimated using the Black-Scholes option pricing model with the following assumptions for the following years:



	Year Ended December 31,
	2014		2013
Risk-free interest rate	Less than 1.00%		Less than 1.00		%
Expected term of options (months)	6		6
Volatility	100%		80 - 107%
Weighted average grant-date fair value per share	$	1.24	$	0.21

ACCUMULATED OTHER COMPREHENSIVE LOSS

12 Months Ended

Dec. 31, 2014

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

Accumulated other comprehensive loss includes all changes in equity during a period from non-owner sources. The change in accumulated other comprehensive loss for all periods presented resulted from foreign currency translation adjustments and minimum pension liability adjustments.

The components of accumulated other comprehensive loss were as follows (in thousands):



	December 31,
	2014			2013
Accumulated minimum pension liability adjustment	$	(6,950	)	$	(4,484	)
Accumulated net foreign currency translation adjustment	4,052			5,355
Total accumulated other comprehensive income (loss)	$	(2,898	)	$	871

No amounts were reclassified out of accumulated other comprehensive loss for the periods shown above.

- Definition

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

CONDENSED CONSOLIDATING FINANCIAL INFORMATION

12 Months Ended

Dec. 31, 2014

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION [Abstract]

CONDENSED CONSOLIDATING FINANCIAL INFORMATION

CONSOLIDATING FINANCIAL INFORMATION

In connection with the Company’s issuance of the 8.00% Notes issued in 2013 and the 5.0% Notes, certain of the Company’s 100% owned domestic subsidiaries (the “Guarantor Subsidiaries”), fully, unconditionally, jointly, and severally guaranteed the payment obligations under the 8.00% Notes Issued in 2013 and the 5.0% Notes. On November 7, 2013, the remaining principal amount of the 5.0% Notes was converted. The following condensed financial information sets forth, on a consolidating basis, the balance sheets, statements of operations and statements of cash flows for Globalstar, Inc. (“Parent Company”), for the Guarantor Subsidiaries and for the Parent Company’s other subsidiaries (the “Non-Guarantor Subsidiaries”).

Globalstar, Inc.

Condensed Consolidating Balance Sheet

As of December 31, 2014



	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Elimination			Consolidated
	(In Thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	3,166		$	672		$	3,283		$	—		$	7,121
Accounts receivable, net of allowance	4,470			5,265			4,955			325			15,015
Intercompany receivables	755,482			441,525			23,967			(1,220,974		)	—
Inventory	2,018			8,424			4,292			—			14,734
Advances for inventory	125			28			43			—			196
Prepaid expenses and other current assets	3,340			275			4,133			—			7,748
Total current assets	768,601			456,189			40,673			(1,220,649		)	44,814
Property and equipment	1,105,670			3,002			5,776			(888		)	$	1,113,560
Restricted cash	37,918			—			—			—			37,918
Intercompany notes receivable	13,006			—			8,285			(21,291		)	—
Investment in subsidiaries	(265,249		)	4,734			30,552			229,963			—
Deferred financing costs	63,862			—			—			—			63,862
Other assets, net	6,707			541			1,031			(13		)	8,266
Total assets	$	1,730,515		$	464,466		$	86,317		$	(1,012,878	)	$	1,268,420
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long term debt	$	6,450		$	—		$	—		$	—		$	6,450
Accounts payable	3,310			1,755			1,857			—			6,922
Accrued contract termination charge	21,308			—			—			—			21,308
Accrued expenses	6,638			7,213			8,491			—			22,342
Intercompany payables	508,503			563,183			153,067			(1,224,753		)	—
Payable to affiliates	481			—			—			—			481
Deferred revenues	3,185			15,378			3,177			—			21,740
Total current liabilities	549,875			587,529			166,592			(1,224,753		)	79,243
Long term debt	623,640			—			—			—			623,640
Employee benefit obligations	5,499			—			—			—			5,499
Intercompany notes payable	2,000			—			15,148			(17,148		)	—
Derivative liabilities	441,550			—			—			—			441,550
Long term deferred revenue	6,229			343			—			—			6,572
Deferred debt restructuring charge	20,795			—			—			—			20,795
Other non current liabilities	2,011			294			9,900			—			12,205
Total non-current liabilities	1,101,724			637			25,048			(17,148		)	1,110,261
Stockholders' equity	78,916			(123,700		)	(105,323		)	229,023			78,916
Total liabilities and ownership equity	$	1,730,515		$	464,466		$	86,317		$	(1,012,878	)	$	1,268,420

Globalstar, Inc.

Condensed Consolidating Balance Sheet

As of December 31, 2013



	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Elimination			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	12,935			676			3,797			—			17,408
Accounts receivable	5,925			5,022			4,602			174			15,723
Intercompany receivables	651,251			414,508			18,280			(1,084,039		)	—
Inventory	1,161			14,375			16,281			—			31,817
Advances for inventory	9,287			28			44			—			9,359
Prepaid expenses and other current assets	4,316			311			2,432			—			7,059
Total current assets	684,875			434,920			45,436			(1,083,865		)	81,366
Property and equipment, net	1,152,734			11,621			6,889			(1,459		)	1,169,785
Restricted cash	37,918			—			—			—			37,918
Intercompany notes receivable	13,629			—			4,285			(17,914		)	—
Investment in subsidiaries	(209,592		)	7,242			—			202,350			—
Deferred financing costs	76,436			—			—			—			76,436
Intangible and other assets, net	3,964			1,028			2,125			(14		)	7,103
Total assets	$	1,759,964		$	454,811		$	58,735		$	(900,902	)	$	1,372,608
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt	$	4,046		—			—			—			$	4,046
Accounts payable	9,906			2,041			2,680			—			14,627
Accrued contract termination charge	24,133			—			—			—			24,133
Accrued expenses	6,160			8,203			8,337			—			22,700
Intercompany payables	435,707			521,763			128,496			(1,085,966		)	—
Payables to affiliates	202			—			—			—			202
Derivative liabilities	57,048			—			—			—			57,048
Deferred revenue	1,843			13,094			2,347			—			17,284
Total current liabilities	539,045			545,101			141,860			(1,085,966		)	140,040
Long-term debt, less current portion	665,236			—			—			—			665,236
Employee benefit obligations	3,529			—			—			—			3,529
Intercompany notes payable	—			—			15,772			(15,772		)	—
Derivative liabilities	405,478			—			—			—			405,478
Deferred revenue	6,583			496			—			—			7,079
Debt restructuring fees	20,795			—			—			—			20,795
Other non-current liabilities	2,543			297			10,856			—			13,696
Total non-current liabilities	1,104,164			793			26,628			(15,772		)	1,115,813
Stockholders’ equity	116,755			(91,083		)	(109,753		)	200,836			116,755
Total liabilities and stockholders’ equity	$	1,759,964		$	454,811		$	58,735		$	(900,902	)	$	1,372,608

Globalstar, Inc.

Condensed Consolidating Statement of Operations

Year Ended December 31, 2014



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenues:
Service revenues	$	75,590		$	5,069		$	22,252		$	(33,088	)	$	69,823
Subscriber equipment sales	434			14,568			11,212			(5,973		)	$	20,241
Total revenue	76,024			19,637			33,464			(39,061		)	90,064
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	11,320			9,586			9,401			(639		)	$	29,668
Cost of subscriber equipment sales	2,220			9,492			11,861			(8,716		)	$	14,857
Cost of subscriber equipment sales - reduction in the value of inventory	7,362			6,776			7,546			—			$	21,684
Marketing, general and administrative	7,171			16,253			14,947			(4,851		)	$	33,520
Reduction in the value of long-lived assets	44			40			—			—			$	84
Depreciation, amortization, and accretion	76,656			10,176			25,270			(25,956		)	$	86,146
Total operating expenses	104,773			52,323			69,025			(40,162		)	$	185,959
Loss from operations	(28,749		)	(32,686		)	(35,561		)	1,101			(95,895		)
Other income (expense):
Loss on extinguishment of debt	(39,846		)	—			—			—			$	(39,846	)
Interest income and expense, net of amounts capitalized	(42,636		)	(34		)	(563		)	—			$	(43,233	)
Derivative gain (loss)	(286,049		)	—			—			—			$	(286,049	)
Equity in subsidiary earnings	(67,150		)	(4,734		)	—			71,884			$	—
Other	1,564			593			1,411			(530		)	$	3,038
Total other income (expense)	(434,117		)	(4,175		)	848			71,354			(366,090		)
Loss before income taxes	(462,866		)	(36,861		)	(34,713		)	72,455			(461,985		)
Income tax expense (benefit)	—			20			861			—			881
Net (loss) income	$	(462,866	)	$	(36,881	)	$	(35,574	)	$	72,455		$	(462,866	)

Globalstar, Inc.

Condensed Consolidating Statement of Operations

Year Ended December 31, 2013



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenues:
Service revenues	$	69,250		$	10,695		$	18,536		$	(33,837	)	$	64,644
Subscriber equipment sales	87			13,704			15,452			(11,176		)	18,067
Total revenue	69,337			24,399			33,988			(45,013		)	82,711
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	10,498			10,559			9,062			91			30,210
Cost of subscriber equipment sales	—			10,860			16,319			(13,556		)	13,623
Cost of subscriber equipment sales - reduction in the value of inventory	—			1,300			4,494			—			5,794
Marketing, general and administrative	5,929			15,109			13,620			(4,770		)	29,888
Depreciation, amortization, and accretion	72,456			21,286			24,103			(27,253		)	90,592
Total operating expenses	88,883			59,114			67,598			(45,488		)	170,107
Loss from operations	(19,546		)	(34,715		)	(33,610		)	475			(87,396		)
Other income (expense):
Loss on extinguishment of debt	(109,092		)	—			—			—			(109,092		)
Loss on equity issuance	(16,701		)	—			—			—			(16,701		)
Interest income and expense, net of amounts capitalized	(66,688		)	(42		)	(1,096		)	(2		)	(67,828		)
Derivative gain (loss)	(305,999		)	—			—			—			(305,999		)
Equity in subsidiary earnings	(69,790		)	(7,242		)	—			77,032			—
Other	(3,097		)	(257		)	209			183			(2,962		)
Total other income (expense)	(571,367		)	(7,541		)	(887		)	77,213			(502,582		)
Loss before income taxes	(590,913		)	(42,256		)	(34,497		)	77,688			(589,978		)
Income tax expense (benefit)	203			37			898			—			1,138
Net (loss) income	$	(591,116	)	$	(42,293	)	$	(35,395	)	$	77,688		$	(591,116	)

Globalstar, Inc.

Condensed Consolidating Statement of Operations

Year Ended December 31, 2012



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenues:
Service revenues	$	48,845		$	44,208		$	15,729		$	(51,314	)	$	57,468
Subscriber equipment sales	825			15,225			7,855			(5,055		)	18,850
Total revenue	49,670			59,433			23,584			(56,369		)	76,318
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	12,061			9,467			8,762			(219		)	30,071
Cost of subscriber equipment sales	292			11,827			7,560			(6,399		)	13,280
Cost of subscriber equipment sales - reduction in the value of inventory	—			1,274			123			—			1,397
Marketing, general and administrative	2,874			16,860			12,288			(4,526		)	27,496
Reduction in the value of long-lived assets	79			7,139			—			—			7,218
Contract termination charge	22,048			—			—			—			22,048
Depreciation, amortization, and accretion	49,132			48,869			17,308			(45,508		)	69,801
Total operating expenses	86,486			95,436			46,041			(56,652		)	171,311
Loss from operations	(36,816		)	(36,003		)	(22,457		)	283			(94,993		)
Other income (expense):
Interest income and expense, net of amounts capitalized	(19,744		)	(10		)	(1,731		)	(1		)	(21,486		)
Derivative gain (loss)	6,974			—			—			—			6,974
Equity in subsidiary earnings	(60,302		)	10,237			—			50,065			—
Other	(2,078		)	(141		)	16			(77		)	(2,280		)
Total other income (expense)	(75,150		)	10,086			(1,715		)	49,987			(16,792		)
Loss before income taxes	(111,966		)	(25,917		)	(24,172		)	50,270			(111,785		)
Income tax expense (benefit)	232			41			140			—			413
Net (loss) income	$	(112,198	)	$	(25,958	)	$	(24,312	)	$	50,270		$	(112,198	)

Globalstar, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2014



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations		Consolidated
	(In thousands)
Net cash provided by (used in) operating activities	$	2,770		$	983		$	228		$	—	$	3,981

Cash flows from investing activities:
Second-generation satellites, ground and related launch costs	(14,604		)	—			—			—		(14,604		)
Property and equipment additions	(3,272		)	(987		)	(414		)	—		(4,673		)
Investment in businesses	—			—			—			—		—
Restricted Cash	—			—			—			—		—
Net cash provided by (used in) investing activities	(17,876		)	(987		)	(414		)	—		(19,277		)

Cash flows from financing activities:
Proceeds from exercise of warrants and stock options	9,547			—			—			—		9,547
Principal payments of the Facility Agreement	(4,046		)	—			—			—		(4,046		)
Payment of deferred financing costs	(164		)	—			—			—		(164		)
Net cash provided by financing activities	5,337			—			—			—		5,337
Effect of exchange rate changes on cash and cash equivalents	—			—			(328		)	—		(328		)
Net increase (decrease) in cash and cash equivalents	(9,769		)	(4		)	(514		)	—		(10,287		)
Cash and cash equivalents at beginning of period	12,935			676			3,797			—		17,408
Cash and cash equivalents at end of period	$	3,166		$	672		$	3,283		$	—	$	7,121

Globalstar, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2013



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations		Consolidated
	(In thousands)
Net cash provided by (used in) operating activities	$	(10,789	)	$	1,524		$	2,803		$	—	$	(6,462	)

Cash flows from investing activities:
Second-generation satellites, ground and related launch costs	(43,693		)	—			—			—		(43,693		)
Property and equipment additions	—			(1,099		)	(552		)	—		(1,651		)
Investment in businesses	(634		)	—			—			—		(634		)
Restricted Cash	8,859			—			—			—		8,859
Net cash provided by (used in) investing activities	(35,468		)	(1,099		)	(552		)	—		(37,119		)

Cash flows from financing activities:
Payments to reduce principal amount of exchanged 5.75% Notes	(13,544		)	—			—			—		(13,544		)
Payments for 5.75% Notes not exchanged	(6,250		)	—			—			—		(6,250		)
Payments to lenders and other fees associated with exchange	(2,482		)	—			—			—		(2,482		)
Proceeds from equity issuance to related party	65,000			—			—			—		65,000
Proceeds from issuance of stock to Terrapin	6,000			—			—			—		6,000
Proceeds from exercise of warrants and stock options	15,414									—		15,414
Borrowings from Facility Agreement	672			—			—			—		672
Proceeds from contingent equity account	1,071			—			—			—		1,071
Payment of deferred financing costs	(16,909		)	—			—			—		(16,909		)
Net cash provided by financing activities	48,972			—			—			—		48,972
Effect of exchange rate changes on cash and cash equivalents	—			—			225			—		225
Net increase in cash and cash equivalents	2,715			425			2,476			—		5,616
Cash and cash equivalents at beginning of period	10,220			251			1,321			—		11,792
Cash and cash equivalents at end of period	$	12,935		$	676		$	3,797		$	—	$	17,408

Globalstar, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2012



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations		Consolidated
	(In thousands)
Net cash provided by (used in) operating activities	$	7,720		$	61		$	(907	)	$	—	$	6,874

Cash flows from investing activities:
Second-generation satellites, ground and related launch costs	(56,679		)	—			—			—		(56,679		)
Property and equipment additions	—			(397		)	(384		)	—		(781		)
Investment in businesses	(550		)	—			—			—		(550		)
Net cash from investing activities	(57,229		)	(397		)	(384		)	—		(58,010		)

Cash flows from financing activities:
Proceeds from exercise of warrants and stock options	244			—			—			—		244
Borrowings from Facility Agreement	7,375			—			—			—		7,375
Proceeds from Contingent Equity Agreement	45,800			—			—			—		45,800
Payment of deferred financing costs	(1,033		)	—			—			—		(1,033		)
Net cash provided by financing activities	52,386			—			—			—		52,386
Effect of exchange rate changes on cash and cash equivalents	—			—			591			—		591
Net increase (decrease) in cash and cash equivalents	2,877			(336		)	(700		)	—		1,841
Cash and cash equivalents at beginning of period	7,343			587			2,021			—		9,951
Cash and cash equivalents at end of period	$	10,220		$	251		$	1,321		$	—	$	11,792

QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

The following is a summary of consolidated quarterly financial information (amounts in thousands, except per share data):



	Quarter Ended
2014	March 31			June 30			Sept. 30		Dec. 31
Total revenue	$	20,536		$	23,994		$	23,441	$	22,093
Net income/(loss)	$	(250,541	)	$	(433,730	)	$	129,390	$	92,015
Basic income/(loss) per common share	$	(0.29	)	$	(0.48	)	$	0.13	$	0.09
Diluted income/(loss) per common share	$	(0.29	)	$	(0.48	)	$	0.11	$	0.08
Shares used in basic per share calculations	849,321			904,994			987,668		993,427
Shares used in diluted per share calculations	849,321			904,994			1,189,190		1,192,263



	Quarter Ended
2013	March 31			June 30			Sept. 30			Dec. 31
Total revenue	$	19,333		$	19,835		$	22,549		$	20,994
Net loss	$	(25,078	)	$	(126,272	)	$	(204,969	)	$	(234,797	)
Basic loss per common share	$	(0.05	)	$	(0.25	)	$	(0.30	)	$	(0.36	)
Diluted loss per common share	$	(0.05	)	$	(0.25	)	$	(0.30	)	$	(0.36	)
Shares used in basic per share calculations	472,187			496,169			673,546			779,483
Shares used in diluted per share calculations	472,187			496,169			673,546			779,483



	Quarter Ended
2012	March 31			June 30			Sept. 30			Dec. 31
Total revenue	$	16,738		$	19,981		$	20,537		$	19,062
Net loss	$	(24,525	)	$	(27,533	)	$	(41,188	)	$	(18,952	)
Basic loss per common share	$	(0.07	)	$	(0.07	)	$	(0.10	)	$	(0.05	)
Diluted loss per common share	$	(0.07	)	$	(0.07	)	$	(0.10	)	$	(0.05	)
Shares used in basic per share calculations	357,418			379,433			392,344			424,180
Shares used in diluted per share calculations	357,418			379,433			392,344			424,180

The following table reconciles basic weighted average common shares to diluted weighted average common shares outstanding:



	Three Months Ended
	September 30, 2014	December 31, 2014
Weighted average common shares outstanding:	(in thousands)
Basic shares outstanding	987,668	993,427
Incremental shares from assumed exercises of:
Stock options, restricted stock, restricted stock units and ESPP	7,340	7,557
8% Convertible Senior Notes Issued in 2013	39,625	38,192
Thermo Loan Agreement	109,469	114,083
Warrants	45,088	39,004
Diluted shares outstanding	1,189,190	1,192,263

For the three months ended September 30, 2014, and December 31, 2014, net income was adjusted for interest expense (net of capitalized amounts) related to the 8% Convertible Senior Notes Issued in 2013 and the Thermo Loan Agreement for the computation of diluted earnings per share as these notes were assumed to be converted at the start of the period. There were no anti-dilutive stock options, restricted stock or restricted stock units excluded from diluted shares outstanding for the three months ended September 30, 2014, and December 31, 2014. For all other periods shown in the tables above, diluted net loss per share of common stock was the same as basic net loss per share of common stock because the effects of potentially dilutive securities are anti-dilutive.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Dec. 31, 2014
Accounting Policies [Abstract]
Use of Estimates in Preparation of Financial Statements	Use of Estimates in Preparation of Financial Statements The preparation of Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from estimates. Certain reclassifications have been made to prior year Consolidated Financial Statements to conform to current year presentation. The Company evaluates estimates on an ongoing basis. Significant estimates include the value of derivative instruments, the allowance for doubtful accounts, the net realizable value of inventory, the useful life and value of property and equipment, the value of stock-based compensation, the reserve for product warranties, and income taxes.
Principles of Consolidation	Principles of Consolidation The Consolidated Financial Statements include the accounts of Globalstar and all its subsidiaries. All significant inter-company transactions and balances have been eliminated in the consolidation.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less.
Restricted Cash	Restricted Cash Restricted cash is comprised of funds held in escrow by the agent for the Company’s senior secured facility agreement (the “Facility Agreement”) to secure the Company’s principal and interest payment obligations under certain circumstances related to its Facility Agreement. The Company classifies restricted cash for certain debt instruments consistent with the classification of the related debt outstanding at the end of the reporting period.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents and restricted cash. Cash and cash equivalents and restricted cash consist primarily of highly liquid short-term investments deposited with financial institutions that are of high credit quality.
Accounts Receivable	Accounts Receivable Accounts receivable are uncollateralized, without interest and consist primarily of service revenue and equipment receivables. The Company performs ongoing credit evaluations of its customers and records specific allowances for bad debts based on factors such as current trends, the length of time the receivables are past due and historical collection experience. Accounts receivable are considered past due in accordance with the contractual terms of the arrangements. Accounts receivable balances that are determined likely to be uncollectible are included in the allowance for doubtful accounts. After all attempts to collect a receivable have failed, the receivable is written off against the allowance
Inventory	Inventory Inventory consists primarily of purchased products. Inventory is stated at the lower of cost or market value. Cost is computed using the first-in, first-out (FIFO) method. Inventory write downs are measured as the difference between the cost of inventory and the market value, and are recorded as a cost of subscriber equipment sales - reduction in the value of inventory in the Company’s Consolidated Financial Statements. At the point of any inventory write downs to market, a new, lower cost basis for that inventory is established, and any subsequent changes in facts and circumstances do not result in the restoration of the former cost basis or increase in that newly established cost basis. Product sales and returns from the previous 12 months and future demand forecasts are reviewed and excess and obsolete inventory is written off. A liability is recorded for firm, noncancelable, and unconditional purchase commitments with contract manufacturers and suppliers for quantities in excess of future demand forecasts consistent with the valuation of excess and obsolete inventory.
Property and Equipment	Property and Equipment The Globalstar System includes costs for the design, manufacture, test, and launch of a constellation of low earth orbit satellites (the “Space Component”), and primary and backup control centers and gateways (the “Ground Component”). Property and equipment is stated at cost, net of accumulated depreciation. Costs associated with the design, manufacture, test and launch of the Company’s Space and Ground Components are capitalized. Capitalized costs associated with the Company’s Space Component, Ground Component, and other assets are tracked by fixed asset category and are allocated to each asset as it comes into service. When a second-generation satellite was incorporated into the second-generation constellation, the Company began depreciation on the date the satellite was placed into service, which was the point that the satellite reached its orbital altitude, over its estimated depreciable life. The Company capitalizes interest costs associated with the costs of assets in progress, including primarily the construction of its Space and Ground Components. Capitalized interest is added to the cost of the underlying asset and is amortized over the depreciable life of the asset after it is placed into service. As the Company’s construction in progress decreases, specifically due to the Company placing second-generation satellites or gateways into service, the Company capitalizes less interest, resulting in greater amounts of interest expense recognized under GAAP. Depreciation is provided using the straight-line method over the estimated useful lives of the respective assets as follows: Second Generation Space Component - 15 years from the commencement of service Ground Component - Up to 15 years from commencement of service Software, Facilities & Equipment - 3 to 10 years Buildings - 18 years Leasehold Improvements - Shorter of lease term or the estimated useful lives of the improvements The Company evaluates and revises the estimated depreciable lives assigned to property and equipment based on changes in facts and circumstances. When changes are made to estimated useful lives, the remaining carrying amounts are depreciated prospectively over the remaining useful lives. For assets that are sold or retired, including satellites that are de-orbited and no longer providing services, the estimated cost and accumulated depreciation is removed from property and equipment. The Company assesses the impairment of long-lived assets when indicators of impairment are present. Recoverability of assets is measured by comparing the carrying amounts of the assets to the estimated future undiscounted cash flows, excluding financing costs. If an impairment is determined to exist, any related impairment loss is estimated based on fair values. The Company records losses from the in-orbit failure of a satellite in the period it is determined that the satellite is not recoverable.
Derivative Instruments	Derivative Instruments The Company enters into financing arrangements that are hybrid instruments that contain embedded derivative features. Derivative instruments are recognized as either assets or liabilities in the consolidated balance sheets and are measured at fair value with gains or losses recognized in earnings. The Company determines the fair value of derivative instruments based on available market data using appropriate valuation models.
Deferred Financing Costs	Deferred Financing Costs Deferred financing costs are those incurred in obtaining long-term debt. These costs are amortized as additional interest expense over the term of the corresponding debt, or the first put option date for the Company’s 8.00% Convertible Senior Notes Issued in 2013 (“8.00% Notes Issued in 2013”). As of December 31, 2014 and 2013, the Company had net deferred financing costs of $63.9 million and $76.4 million, respectively. The Company classifies deferred financing costs consistent with the classification of the related debt outstanding at the end of the reporting period.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amount of accounts receivable and accounts payable is equal to or approximates fair value. The Company believes it is not practicable to determine the fair value of the Facility Agreement. Unlike typical long-term debt, interest rates and other terms for long-term debt are not readily available and generally involve a variety of factors, including due diligence by the debt holders. As such, it is not practicable to determine the fair value of long-term debt without incurring significant additional costs. The Company was required to record at fair value, at inception, the Company’s Amended and Restated Loan Agreement with Thermo (the “Loan Agreement”) and the 8.00% Notes Issued in 2013. The Loan Agreement was amended and restated in 2013 and qualified for extinguishment accounting under applicable accounting rules. In May 2013, the Company issued 8.00% Notes Issued in 2013 and other consideration in exchange for a portion of the Company’s 5.75% Convertible Senior Notes (the “5.75% Notes”). This transaction qualified for extinguishment accounting. See Note 3: Long-Term Debt and Other Financing Arrangements for further discussion.
Gain/Loss on Extinguishment of Debt	Gain/Loss on Extinguishment of Debt Gain or loss on extinguishment of debt is generally recorded upon an extinguishment of a debt instrument or the conversion of certain of the Company’s convertible notes. Gain or loss on extinguishment of debt is calculated as the difference between the reacquisition price and net carrying amount of the debt. Differences are recorded as an extinguishment gain or loss in the Company’s consolidated statement of operations.
Revenue Recognition and Deferred Revenue	Revenue Recognition and Deferred Revenue Duplex Service Revenue. For Duplex customers and resellers, the Company recognizes revenue for monthly access fees in the period services are rendered. Access fees represent the minimum monthly charge for each line of service based on its associated rate plan. The Company also recognizes revenue for airtime minutes in excess of the monthly access fees in the period such minutes are used. Under certain annual plans where customers prepay for minutes, revenue is deferred until the minutes are used or the prepaid time period expires. Unused minutes are accumulated until they expire, usually one year after activation. In addition, the Company offers other annual plans whereby the customer is charged an annual fee to access the Company’s system. These fees are recognized on a straight-line basis over the term of the plan. In some cases, the Company charges a per minute rate whereby it recognizes the revenue when each minute is used. Credits granted to customers are expensed or charged against revenue or deferred revenue upon issuance. Certain subscriber acquisition costs, including such items as dealer commissions and internal sales commissions, are expensed at the time of the related sale, except when related to a multi-element contract as discussed below. SPOT and Simplex Service Revenue. The Company sells SPOT and Simplex services as annual plans or multi-year plans and defers and recognizes revenue ratably over the service term or as service is used, beginning when the service is activated by the customer. Royalty payments are deferred and recognized as expense over the contract term. IGO Service Revenue. The Company owns and operates its satellite constellation and earns a portion of its revenues through the sale of airtime minutes or data on a wholesale basis to IGOs. Revenue from services provided to IGOs is recognized based upon airtime minutes used by customers of the IGOs and contractual fee arrangements. Where collection is uncertain, revenue is recognized when cash payment is received. Equipment Revenue. Subscriber equipment revenue represents the sale of fixed and mobile user terminals, accessories and SPOT and Simplex products. The Company recognizes revenue upon shipment provided title and risk of loss have passed to the customer, persuasive evidence of an arrangement exists, the fee is fixed and determinable and collection is probable. Other Service Revenue. At times, the Company will sell subscriber equipment through multi-element contracts with services. When the Company sells subscriber equipment and services in bundled arrangements and determines that it has separate units of accounting, the Company will allocate the bundled contract price among the various contract deliverables based on each deliverable’s relative fair value. The Company will determine vendor specific objective evidence of fair value by assessing sales prices of subscriber equipment and services when they are sold to customers on a stand-alone basis. Initial direct costs incurred related to these contracts will be deferred to the extent they exceed the profit margin recognized at the time of sale. The Company does not record sales taxes collected from customers in revenue. The Company provides certain engineering services to assist customers in developing new applications related to its system. The revenues associated with these services are recorded when the services are rendered, and the expenses are recorded when incurred.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes compensation expense in the financial statements for both employee and non-employee share-based awards based on the grant date fair value of those awards. The Company uses the Black-Scholes option pricing model to estimate fair values of share-based awards. Option pricing models, including the Black-Scholes model, require the use of input estimates and assumptions, including expected volatility, term, and risk-free interest rate. The assumptions for expected volatility and expected term most significantly affect the estimated grant-date fair value. The Company's estimate of the forfeiture rate of its share-based awards also impacts the timing of expense recorded over the vesting period of the award. The Company's estimate for pre-vesting forfeitures is recognized over the requisite service periods of the awards on a straight-line basis, which is generally commensurate with the vesting term. See Note 13: Stock Compensation for a description of methods used to determine the Company's assumptions. If the Company determined that another method used to estimate expected volatility or expected life was more reasonable than its current methods, or if another method for calculating these input assumptions was prescribed by authoritative guidance, the estimated fair value calculated for share-based awards could change significantly. Higher volatility and longer expected lives result in increases to share-based compensation determined at the date of grant.
Foreign Currency	Foreign Currency The functional currency of the Company’s foreign consolidated subsidiaries is their local currency. Assets and liabilities of its foreign subsidiaries are translated into United States dollars based on exchange rates at the end of the reporting period. Income and expense items are translated at the average exchange rates prevailing during the reporting period. For 2014 and 2013, the foreign currency translation adjustments were losses of $1.3 million and $0.9 million, respectively. For 2012, the foreign currency translation adjustment recorded was income of $1.3 million. These amounts are reflected in the consolidated statements of comprehensive loss. Foreign currency transaction gains/losses were a $4.1 million gain, a $1.0 million loss and a $2.0 million loss for 2014, 2013, and 2012, respectively. These were classified as other income (expense) on the consolidated statement of operations. In February 2013, the Venezuelan government devalued its currency. This devaluation did not have a material impact on the Company’s operations or financial performance.
Asset Retirement Obligation	Asset Retirement Obligation Liabilities arising from legal obligations associated with the retirement of long-lived assets are measured at fair value and recorded as a liability. Upon initial recognition of a liability for retirement obligations, the Company records an asset, which is depreciated over the life of the asset to be retired. Accretion of the asset retirement obligation liability and depreciation of the related assets are included in depreciation, amortization and accretion in the accompanying consolidated statements of operations. The Company capitalizes, as part of the carrying amount, the estimated costs associated with the eventual retirement of gateways owned by the Company. As of December 31, 2014 and 2013, the Company had accrued approximately $1.2 million and $1.1 million, respectively, for asset retirement obligations. The Company believes this estimate will be sufficient to satisfy the Company’s obligation under leases to remove the gateway equipment and restore the sites to their original condition.
Warranty Expense	Warranty Expense Warranty terms extend from 90 days on equipment accessories to one year for fixed and mobile user terminals. An accrual is made when it is estimable and probable that a loss has been incurred based on historical experience. Warranty costs are based on historical trends in warranty charges as a percentage of gross product shipments. A provision for estimated future warranty costs is recorded as cost of sales when products are shipped. The resulting accrual is reviewed regularly and periodically adjusted to reflect changes in warranty cost estimates.
Research and Development Expenses	Research and Development Expenses Research and development costs were $0.5 million, $0.6 million and $0.3 million for 2014, 2013 and 2012, respectively. These costs are expensed as incurred as cost of services and primarily include the cost of new product development, chip set design, software development and engineering.
Advertising Expenses	Advertising Expenses Advertising costs were $2.6 million, $2.9 million and $1.9 million for 2014, 2013, and 2012, respectively. These costs are expensed as incurred as marketing, general and administrative expenses.
Income Taxes	Income Taxes Until January 1, 2006, the Company and its U.S. operating subsidiaries were treated as partnerships for U.S. tax purposes. Generally, taxable income or loss, deductions and credits of the partnerships were passed through to the partners. Effective January 1, 2006, the Company elected to be taxed as a C corporation for U.S. tax purposes, and the Company and its U.S. operating subsidiaries began accounting for income taxes as a corporation. The Company recognizes deferred tax assets and liabilities for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis, operating losses and tax credit carry-forwards. The Company measures deferred tax assets and liabilities using tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates in income in the period that includes the enactment date. The Company also recognizes valuation allowances to reduce deferred tax assets to the amount that is more likely than not to be realized. In assessing the likelihood of realization, management considers: (i) future reversals of existing taxable temporary differences; (ii) future taxable income exclusive of reversing temporary differences and carry-forwards; (iii) taxable income in prior carry-back year(s) if carry-back is permitted under applicable tax law; and (iv) tax planning strategies.
Comprehensive Income (Loss)	Comprehensive Income (Loss) All components of comprehensive income (loss), including the minimum pension liability adjustment and foreign currency translation adjustment, are reported in the financial statements in the period in which they are recognized. Comprehensive income (loss) is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources.
Loss Per Share	Loss Per Share The Company is required to present basic and diluted earnings per share. Basic loss per share is computed by dividing loss available to common stockholders by the weighted average number of common shares outstanding during the period. For 2014, 2013, and 2012, diluted net loss per share of common stock was the same as basic net loss per share of common stock because the effects of potentially dilutive securities are anti-dilutive. Potentially dilutive securities include outstanding stock-based awards, convertible notes, warrants and shares issuable pursuant to the Company's Employee Stock Purchase Plan. See Note 3: Long-Term Debt and Other Financing Arrangements and Note 13: Stock Compensation for further discussion of these instruments. As of December 31, 2012, 17.3 million Borrowed Shares, as defined, related to the Company’s Share Lending Agreement were outstanding. The Company did not consider the Borrowed Shares to be outstanding for the purposes of computing and reporting its earnings per share. Effective in July 2013, the Company and the Borrower, as defined, terminated the Share Lending Agreement resulting in the Borrower returning 10.2 million Borrowed Shares to Globalstar and agreeing to pay a cash settlement for the remaining 7.1 million Borrowed Shares at an average of the volume weighted stock prices over a 20-day trading period ending in August 2013.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-16, Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share Is More Akin to Debt or to Equity. The amendments in this ASU do not change the current criteria in GAAP for determining when separation of certain embedded derivative features in a hybrid financial instrument is required. An entity will continue to evaluate whether the economic characteristics and risks of the embedded derivative feature are clearly and closely related to those of the host contract, among other relevant criteria. The ASU clarifies the manner in which current GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial instrument that is issued in the form of a share. The effects of initially adopting the amendments in this ASU should be applied on a modified retrospective basis to existing hybrid financial instruments issued in the form of a share as of the beginning of the fiscal year for which the amendments are effective. Retrospective application is permitted to all relevant prior periods. The amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption, including adoption in an interim period, is permitted. The Company is currently evaluating the impact this standard will have on its Consolidated Financial Statements and related disclosures. The Company has not yet determined the effect of the standard on its ongoing reporting. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers . ASU 2014-09 outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. This ASU requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is currently evaluating the impact this standard will have on its Consolidated Financial Statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing reporting. In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. ASU 2014-15 describes how an entity’s management should assess, considering both quantitative and qualitative factors, whether there are conditions and events that raise substantial doubt about an entity’s ability to continue as a going concern within one year after the date that the financial statements are issued, which represents a change from the existing literature that requires consideration about an entity’s ability to continue as a going concern within one year after the balance sheet date. This ASU provides that if after considering management’s plans, substantial doubt about an entity’s ability to continue as a going concern is alleviated, an entity must disclose information in the footnotes to the financial statements that enables the reader to understand the events that raised substantial doubt about the entity's ability to continue as a going concern and how management’s plan alleviated the doubt. If after considering management’s plans, substantial doubt about an entity’s going concern is not alleviated, the entity must disclose in the footnotes to the financial statements that substantial doubts about the entity’s ability to continue as a going concern exists within one year of the date the financial statements are issued. Additionally, the entity must disclose the events that led to the substantial doubt about the entity's ability to continue as a going concern and management’s plans to mitigate them. The new standard applies to all entities for the first annual period ending after December 15, 2016, and for annual and interim periods thereafter. Early application is permitted. The Company has not yet determined the effect of the standard on its ongoing reporting.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Schedule of Allowance for Doubtful Accounts

The following is a summary of the activity in the allowance for doubtful accounts (in thousands):



	Year Ended December 31,
	2014			2013			2012
Balance at beginning of period	$	7,419		$	6,667		$	7,296
Provision, net of recoveries	2,281			2,321			1,097
Write-offs and other adjustments	(4,912		)	(1,569		)	(1,726		)
Balance at end of period	$	4,788		$	7,419		$	6,667

PROPERTY AND EQUIPMENT (Tables)

12 Months Ended

Dec. 31, 2014

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and equipment consists of the following (in thousands):



	December 31, 2014			December 31, 2013
Globalstar System:
Space component
Second-generation satellites in service	$	1,211,904		$	1,212,099
Prepaid long-lead items	17,040			17,040
Second-generation satellite, on-ground spare	32,481			32,365
Ground component	47,595			48,378
Construction in progress:
Space component	30			—
Ground component	141,789			116,377
Other	2,458			1,115
Total Globalstar System	1,453,297			1,427,374
Internally developed and purchased software	15,392			14,931
Equipment	12,647			12,385
Land and buildings	3,590			3,768
Leasehold improvements	1,620			1,644
Total property and equipment	1,486,546			1,460,102
Accumulated depreciation	(372,986		)	(290,317		)
Total property and equipment, net	$	1,113,560		$	1,169,785

Capitalized Interest

The following table summarizes capitalized interest for the periods indicated below (in thousands):



	Year Ended December 31,
	2014			2013			2012
Interest cost eligible to be capitalized	$	44,854		$	45,308		$	57,249
Interest cost recorded in interest income (expense), net	(36,909		)	(28,211		)	(17,133		)

Net interest capitalized	$	7,945		$	17,097		$	40,116

Depreciation Expense

The following table summarizes depreciation expense for the periods indicated below (in thousands):



	Year Ended December 31,
	2014		2013		2012
Depreciation Expense	$	84,802	$	89,828	$	67,289

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Tables)

12 Months Ended

Dec. 31, 2014

Debt Disclosure [Abstract]

Long-term Debt

The principal amount and carrying value of long-term debt consists of the following (in thousands):



	December 31, 2014				December 31, 2013
	Principal Amount		Carrying Value		Principal Amount		Carrying Value
Facility Agreement	$	582,296	$	582,296	$	586,342	$	586,342
Thermo Loan Agreement	68,154		32,971		60,383		22,854
8.00% Convertible Senior Notes Issued in 2013	22,799		14,823		46,971		26,291
8.00% Convertible Senior Unsecured Notes Issued in 2009	—		—		51,652		33,795
Total Debt	673,249		630,090		745,348		669,282
Less: Current Portion	6,450		6,450		4,046		4,046
Long-Term Debt	$	666,799	$	623,640	$	741,302	$	665,236

Summary Minimum Adjusted EBITDA Required by Debt Covenant

the Company achieve for each period the following minimum adjusted consolidated EBITDA (as defined in the Facility Agreement)(amounts in thousands):



Period	Minimum Amount
7/1/14-12/31/14	$	14,062
1/1/15-6/30/15	$	16,958
7/1/15-12/31/15	$	23,469
1/1/16-6/30/16	$	24,502
7/1/16-12/31/16	$	32,426

Schedule of Debt Agreement

The Company allocated the fair value at issuance as follows (in thousands):



Loan Agreement	$	18,958
Compound embedded derivative liability	101,114
Fair value of Loan Agreement	$	120,072

Schedule of Convertible Notes

allocated the fair value at issuance as follows (in thousands):



Senior notes	$	27,890
Compound embedded derivative liability	56,752
Fair value of 8.00% Notes Issued in 2013	$	84,642

The Company allocated the proceeds at issuance as follows (in thousands):



Fair value of compound embedded derivative	$	23,542
Fair value of Warrants	12,791
Debt	18,667
Face Value of 8.00% Notes Issued in 2009	$	55,000

allocated the proceeds at issuance as follows (in thousands):



Debt	$	11,316
Fair value of 5.0% Warrants	8,081
Beneficial Conversion Feature	17,100
Contingent Put Feature	1,503
Face Value of 5.0% Notes	$	38,000

Summary of Warrants Outstanding

As a result of the borrowings described above there were warrants outstanding to purchase shares of common stock as shown in the table below:



	Outstanding Warrants		Strike Price
	December 31,		December 31,
	2014	2013	2014		2013
Contingent Equity Agreement (1)	30,191,866	41,467,980	$	0.01	$	0.01
Thermo Loan Agreement (2)	—	4,205,608	—		0.01
5.0% Notes (3)	8,000,000	8,000,000	0.32		0.32
8.00% Notes Issued in 2009 (4)	—	39,842,813	—		0.32
	38,191,866	93,516,401


(1)	Warrants issued in connection with the Contingent Equity Agreement have a five-year exercise period from issuance. These warrants were originally issued between June 2009 and June 2012 and the exercise periods related to the remaining unexercised warrants will expire from June 2015 to June 2017.


(2)	The exercise period of the warrants issued in connection with the Thermo Loan Agreement was five years from issuance, which ended June 2014.


(3)	On April 15, 2013, the exercise price of the 5.0% Warrants was reset to $0.32 due to the reset provision in the indenture. The 5.0% Warrants are exercisable until five years after their issuance, which is June 2016.


(4)	According to the terms of the indenture, additional 8.00% Warrants would have been issued to holders if shares of common stock were issued below the then current warrant strike price. The exercise period for the 8.00% Warrants began on December 19, 2009 and ended on June 14, 2014.

Schedule of Maturities of Long-Term Debt

Annual debt maturities for each of the five years following December 31, 2014 and thereafter are as follows (in thousands):



2015	$	6,450
2016	32,835
2017	75,755
2018	100,665
2019	94,870
Thereafter	362,674
Total	$	673,249

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

+ Details

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

DERIVATIVES (Tables)

12 Months Ended

Dec. 31, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Fair Values of Derivative Instruments



	December 31, 2014			December 31, 2013
Intangible and other assets:
Interest rate cap	$	46		$	185
Total intangible and other assets	$	46		$	185

Derivative liabilities, current:
Warrants issued with 8.00% Notes Issued in 2009	—			(57,048		)

Derivative liabilities, non-current:
Compound embedded derivative with 8.00% Notes Issued in 2009	$	—		$	(66,022	)
Compound embedded derivative with 8.00% Notes Issued in 2013	(79,040		)	(109,794		)
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	(362,510		)	(229,662		)
Total derivative liabilities, non-current:	(441,550		)	(405,478		)

Total derivative liabilities, current and non-current	$	(441,550	)	$	(462,526	)

Schedule of Derivative Gains (Losses)

The following tables disclose the changes in value recorded as derivative gain (loss) on the Company’s consolidated statement of operations (in thousands):



	Year ended December 31,
	2014			2013			2012
Interest rate cap	$	(139	)	$	101		$	(171	)
Warrants issued with 8.00% Notes Issued in 2009	(67,523		)	(54,518		)	4,218
Compound embedded derivative with 8.00% Notes Issued in 2009	(16,406		)	(61,859		)	2,546
Warrants issued in conjunction with Contingent Equity Agreement	—			—			302
Contingent put feature embedded in the 5.0% Notes	—			2,978			79
Compound embedded derivative with 8.00% Notes Issued in 2013	(69,133		)	(64,153		)	—
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	(132,848		)	(128,548		)	—
Total derivative gain (loss)	$	(286,049	)	$	(305,999	)	$	6,974

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table provides a summary of the financial assets and liabilities measured at fair value on a recurring basis (in thousands):



	Fair Value Measurements at December 31, 2014:
	(Level 1)		(Level 2)		(Level 3)			Total Balance
Assets:
Interest rate cap	$	—	$	46	$	—		$	46
Total assets measured at fair value	$	—	$	46	$	—		$	46

Liabilities:
Warrants issued with 8.00% Notes Issued in 2009	$	—	$	—	$	—		$	—
Compound embedded derivative with 8.00% Notes Issued in 2009	—		—		—			—
Compound embedded derivative with 8.00% Notes Issued in 2013	—		—		(79,040		)	(79,040		)
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	—		—		(362,510		)	(362,510		)
Total liabilities measured at fair value	$	—	$	—	$	(441,550	)	$	(441,550	)



	Fair Value Measurements at December 31, 2013:
	(Level 1)		(Level 2)		(Level 3)			Total Balance
Assets:
Interest rate cap	$	—	$	185	$	—		$	185
Total assets measured at fair value	$	—	$	185	$	—		$	185

Liabilities:
Derivative Liabilities:
Warrants issued with 8.00% Notes Issued in 2009	$	—	$	—	$	(57,048	)	$	(57,048	)
Compound embedded derivative with 8.00% Notes Issued in 2009	—		—		(66,022		)	(66,022		)
Compound embedded derivative with 8.00% Notes Issued in 2013	—		—		(109,794		)	(109,794		)
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	—		—		(229,662		)	(229,662		)
Total Derivative Liabilities	—		—		(462,526		)	(462,526		)

Other Liabilities:
Liability for contingent consideration	—		—		(1,923		)	(1,923		)

Total liabilities measured at fair value	$	—	$	—	$	(464,449	)	$	(464,449	)

Reconciliation of Liabilities Measured at Fair Value on Recurring Basis

The following table presents a rollforward for all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for 2014 as follows (in thousands):



Balance at December 31, 2013	$	(464,449	)
Removal of liability for contingent consideration as no longer recorded at fair value	1,923
Derivative adjustment related to conversions and exercises	306,886
Unrealized loss, included in derivative gain (loss)	(285,910		)
Balance at December 31, 2014	$	(441,550	)

Schedule of Significant Quantitative Level 3 Inputs Utilized

The significant quantitative Level 3 inputs utilized in the valuation models as of the amendment and restatement date of the Loan Agreement are shown in the table below:



	Level 3 Inputs at July 31, 2013:
	Stock Price Volatility	Risk-Free Interest Rate		Note Conversion Price		Discount Rate		Market Price of Common Stock
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	65 - 100 %	2.6	%	$	0.75	26	%	$	0.60

The significant quantitative Level 3 inputs utilized in the valuation models as of December 31, 2014 and December 31, 2013 are shown in the tables below:



	Level 3 Inputs at December 31, 2014:
	Stock Price Volatility	Risk-Free Interest Rate		Note Conversion Price		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2013	70 - 100 %	1.2	%	$	0.73	$	2.75
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	50 - 100 %	2.1	%	$	0.73	$	2.75



	Level 3 Inputs at December 31, 2013:
	Stock Price Volatility	Risk-Free Interest Rate		Note Conversion Price		Warrant Exercise Price		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2009	65 - 100 %	1.5	%	$	1.14	N/A		$	1.75
Warrants issued with 8.00% Notes Issued in 2009	100%	0.1	%	N/A		$	0.32	$	1.75
Compound embedded derivative with 8.00% Notes Issued in 2013	65 - 100 %	1.5	%	$	0.73	N/A		$	1.75
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement	65 - 100 %	3.0	%	0.73		N/A		$	1.75

The significant quantitative Level 3 inputs utilized in the valuation models as of the issuance date of the 8.00% Notes Issued in 2013 are shown in the table below:



	Level 3 Inputs at May 20, 2013:
	Stock Price Volatility	Risk-Free Interest Rate		Note Conversion Price		Discount Rate		Market Price of Common Stock
Compound embedded derivative with 8.00% Notes Issued in 2013	65 - 100 %	0.9	%	$	0.80	27	%	$	0.40

Schedule of Nonrecurring Fair Value Measurements



	Fair Value Measurements at December 31, 2014:
	(Level 1)		(Level 2)		(Level 3)		Total Losses
Other assets:
Property and equipment, net	$	—	$	—	$	1,113,560	$	84
Total	$	—	$	—	$	1,113,560	$	84



	Fair Value Measurements at December 31, 2012:
	(Level 1)		(Level 2)		(Level 3)		Total Losses
Other assets:
Property and equipment, net	$	—	$	—	$	1,215,156	$	7,218
Total	$	—	$	—	$	1,215,156	$	7,218

The following table summarizes the amount invested in the Company pursuant to the Consent Agreement with Thermo (dollars in thousands, except amounts per share):



	Amount Invested		Issuance Price per Share		Closing Price per Share		Discount Value (4)		Total Fair Value		Shares Issued (5)
May 20, 2013 (1)	$	25,000	$	0.32	$	0.40	$	6,250	$	31,250	78,125,000
May 20, 2013 (1)	5,000		0.32		0.40		1,250		6,250		15,625,000
June 28, 2013 (1)	9,000		0.32		0.55		6,469		15,469		28,125,000
July 29, 2013 (2)	6,000		0.52		0.62		1,154		7,154		11,538,462
August 19, 2013 (2)	6,500		0.52		0.62		1,250		7,750		12,500,000
December 27, 2013 (2)	13,500		0.52		1.82		33,750		47,250		25,961,538
Total (3)	$	65,000					$	50,123	$	115,123	171,875,000


(1)	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.


(2)	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.

(3)


(4)	The discount on shares issued is recorded on the Company’s consolidated statement of operations in loss on equity issuance. This expense item represents the discount on shares issued to Thermo as well as certain other losses recorded on equity issued during 2013 related to cashless exercises of warrants issued with the 5.0% Notes.


(5)	All shares issued to Thermo in connection with these agreements were shares of the Company’s nonvoting common stock.

COMMITMENTS (Tables)

12 Months Ended

Dec. 31, 2014

COMMITMENTS [Abstract]

Schedule of Future Payments Under Purchase Commitments

The Company is obligated to make payments under these purchase commitments, excluding accrued interest, as shown below (in thousands):



Years Ending December 31,
2015	$	28,964
2016	8,033
2017	—
2018	—
2019	—
Thereafter	—
Total purchase commitments	$	36,997

Schedule of Future Minimum Payments Under Operating Leases

The following table presents the future minimum lease payments for leases having an initial or remaining noncancelable lease term in excess of one year (in thousands) as of December 31, 2014, excluding possible lease payment reimbursement from the State of Louisiana pursuant to the Cooperative Endeavor Agreement the Company entered into with the Louisiana Department of Economic Development (See Note 8: Accrued Expenses and Non-Current Liabilities):



2015	$	1,237
2016	1,152
2017	1,148
2018	1,083
2019	269
Thereafter	375
Total minimum lease payments	$	5,264

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES (Tables)

12 Months Ended

Dec. 31, 2014

Payables and Accruals [Abstract]

Schedule of Accrued Expenses

Accrued expenses consist of the following (in thousands):



	December 31,
	2014		2013
Accrued interest	$	827	$	1,200
Accrued compensation and benefits	2,597		3,927
Accrued property and other taxes	6,727		5,744
Accrued customer liabilities and deposits	2,751		2,663
Accrued professional and other service provider fees	1,925		705
Accrued liability for contingent consideration	481		1,922
Accrued commissions	686		1,316
Accrued telecommunications expenses	1,135		649
Accrued satellite and ground costs	1,531		—
Other accrued expenses	3,682		4,574
Total accrued expenses	$	22,342	$	22,700

Schedule of Changes in the Warranty Reserve Accrual

The following is a summary of the activity in the warranty reserve account, which is included in other accrued expenses above (in thousands):



	Year Ended December 31,
	2014			2013			2012
Balance at beginning of period	$	142		$	235		$	179
Provision	246			189			293
Utilization	(259		)	(282		)	(237		)
Balance at end of period	$	129		$	142		$	235

Schedule of Other Non-current Liabilities

Non-current liabilities consist of the following (in thousands):



	December 31,
	2014		2013
Long-term accrued interest	$	131	$	451
Asset retirement obligation	1,184		1,083
Deferred rent	404		456
Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana	1,391		1,575
Uncertain income tax positions	6,061		5,918
Foreign tax contingencies	3,034		4,213
Total noncurrent liabilities	$	12,205	$	13,696

RELATED PARTY TRANSACTIONS (Tables)

12 Months Ended

Dec. 31, 2014

Related Party Transactions

Thermo incurs certain expenses on behalf of the Company. The table below summarizes the total expense for the periods indicated below (in thousands):



	Year Ended December 31,
	2014		2013		2012
General and administrative expenses	$	274	$	268	$	180
Non-cash expenses	548		548		529
Loss on sale of equity issuance	—		16,373		—
Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement	—		66,088		—
Total	$	822	$	83,277	$	709

PENSIONS AND OTHER EMPLOYEE BENEFITS (Tables)

12 Months Ended

Dec. 31, 2014

Compensation and Retirement Disclosure [Abstract]

Reconciliation of Projected Benefit Obligation, Plan Assets and the Funded Status of Company's Defined Benefit Plan

Below is a reconciliation of projected benefit obligation, plan assets, and the funded status of the Company’s defined benefit plan (in thousands):



	Year Ended December 31,
	2014			2013
Change in projected benefit obligation:
Projected benefit obligation, beginning of year	$	16,685		$	18,804
Service cost	103			85
Interest cost	781			671
Actuarial (gain) loss	2,489			(1,796		)
Benefits paid	(1,126		)	(1,079		)
Projected benefit obligation, end of year	$	18,932		$	16,685
Change in fair value of plan assets:
Fair value of plan assets, beginning of year	$	13,156		$	11,583
Return on plan assets	673			1,985
Employer contributions	730			667
Benefits paid	(1,126		)	(1,079		)
Fair value of plan assets, end of year	$	13,433		$	13,156
Funded status, end of year- net liability	$	(5,499	)	$	(3,529	)

Schedule of Components of Net Periodic Benefit Cost

Components of the net periodic benefit cost of the Company’s contributory defined benefit pension plan were as follows (in thousands):



	Year Ended December 31,
	2014			2013			2012
Net periodic benefit cost:
Service cost	$	103		$	85		$	66
Interest cost	781			671			712
Expected return on plan assets	(932		)	(813		)	(739		)
Amortization of unrecognized net actuarial loss	281			518			583
Total net periodic benefit cost	$	233		$	461		$	622

Schedule of Amounts Recognized in Balance Sheet

Amounts recognized in balance sheet were as follows (in thousands):



	December 31,
	2014			2013
Amounts recognized:
Funded status recognized in other non-current liabilities	$	(5,499	)	$	(3,529	)
Net actuarial loss recognized in accumulated other comprehensive loss	6,950			4,484
Net amount recognized in retained deficit	$	1,451		$	955

Schedule of Assumptions Used to Calculate Benefit Obligation and Net Periodic Benefit Cost

The weighted-average assumptions used to determine the benefit obligation and net periodic benefit cost were as follows:



	For the Year Ended December 31,
	2014		2013		2012
Benefit obligation assumptions:
Discount rate	4.03	%	4.80	%	3.75	%
Rate of compensation increase	N/A		N/A		N/A
Net periodic benefit cost assumptions:
Discount rate	4.80	%	3.75	%	4.00	%
Expected rate of return on plan assets	7.12	%	7.12	%	7.12	%
Rate of compensation increase	N/A		N/A		N/A

Schedule of Plan Asset Allocations

The defined benefit pension plan asset allocation as of the measurement date presented as a percentage of total plan assets were as follows:



	December 31,
	2014		2013
Equity securities	56	%	57	%
Debt securities	30		29
Other investments	14		14
Total	100	%	100	%

Schedule of Fair Value of Plan Assets

The fair values of the Company’s pension plan assets by asset category were as follows (in thousands):



	December 31, 2014
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
United States equity securities	$	6,103	$	—	$	6,103	$	—
International equity securities	1,356		—		1,356		—
Fixed income securities	4,034		—		4,034		—
Other	1,940		—		1,940		—
Total	$	13,433	$	—	$	13,433	$	—



	December 31, 2013
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
United States equity securities	$	6,119	$	—	$	6,119	$	—
International equity securities	1,435		—		1,435		—
Fixed income securities	3,749		—		3,749		—
Other	1,853		—		1,853		—
Total	$	13,156	$	—	$	13,156	$	—

Schedule of Future Benefit Payments

The benefit payments to retirees over the next ten years are expected to be paid as follows (in thousands):



2015	$	970
2016	965
2017	956
2018	970
2019	993
2020 - 2024	5,163

TAXES (Tables)

12 Months Ended

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Schedule of the Components of Income Tax Expense (Benefit)

The components of income tax expense (benefit) were as follows (in thousands):



	Year Ended December 31,
	2014			2013		2012
Current:
Federal tax (benefit)	$	—		$	—	$	—
State tax	20			240		274
Foreign tax	2,430			898		139
Total	2,450			1,138		413
Deferred:
Federal and state tax (benefit)	—			—		—
Foreign tax (benefit)	(1,569		)	—		—
Total	(1,569		)	—		—
Income tax expense (benefit)	$	881		$	1,138	$	413

Schedule of U.S. and Foreign Components of Income (Loss) Before Taxes

U.S. and foreign components of income (loss) before income taxes are presented below (in thousands):



	Year Ended December 31,
	2014			2013			2012
U.S. income (loss)	$	(461,250	)	$	(585,801	)	$	(105,722	)
Foreign income (loss)	(735		)	(4,177		)	(6,063		)
Total income (loss) before income taxes	$	(461,985	)	$	(589,978	)	$	(111,785	)

Schedule of the Components of Net Deferred Income Tax Assets

The components of net deferred income tax assets were as follows (in thousands):



	December 31,
	2014			2013
Federal and foreign net operating loss and credit carry-forwards	$	554,122		$	492,839
Property and equipment and other long-term assets	111,891			53,196
Accruals and reserves	29,315			4,240
Deferred tax assets before valuation allowance	695,328			550,275
Valuation allowance	(693,759		)	(550,275		)
Net deferred income tax assets	$	1,569		$	—

Schedule of Actual Provision for Income Taxes to the Statutory U.S. Federal Income Tax Rate

The actual provision for income taxes differs from the statutory U.S. federal income tax rate as follows (in thousands):



	Year Ended December 31,
	2014			2013			2012
Provision at U.S. statutory rate of 35%	$	(161,702	)	$	(206,576	)	$	(39,125	)
State income taxes, net of federal benefit	(27,656		)	(34,923		)	(6,070		)
Change in valuation allowance	143,484			206,022			40,641
Effect of foreign income tax at various rates	243			508			759
Permanent differences	33,138			38,911			(220		)
Change in unrecognized tax benefit	(3,839		)	388			381
Recognition of pre-acquisition losses in Brazil	—			—			—
Net Change in permanent items due to provision to tax return	21,008			—			—
Other (including amounts related to prior year tax matters)	(3,795		)	(3,192		)	4,047
Total	$	881		$	1,138		$	413

Rollforward of Unrecognized Tax Benefits

A rollforward of the Company's unrecognized tax benefits is as follows (in thousands):



Gross unrecognized tax benefits at January 1, 2014	$	8,073
Gross decreases based on tax positions related to current year	(3,839		)
Gross increases based on tax positions related to prior years	—
Gross unrecognized tax benefits at December 31, 2014	$	4,234



Gross unrecognized tax benefits at January 1, 2013	$	7,750
Gross increases based on tax positions related to current year	388
Gross decreases based on tax positions related to prior years	(65		)
Gross unrecognized tax benefits at December 31, 2013	$	8,073

GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Company's Information on Revenues and Long-lived Assets by Geographic Area

The Company’s information by geographic area is as follows (in thousands):



	Year Ended December 31,
	2014		2013		2012
Revenues:
Service:
United States	$	46,519	$	44,909	$	41,139
Canada	14,584		12,436		10,505
Europe	5,536		4,085		3,132
Central and South America	2,623		2,678		2,287
Others	561		536		405
Total service revenue	69,823		64,644		57,468
Subscriber equipment:
United States	10,931		11,284		12,899
Canada	5,668		3,913		3,654
Europe	2,123		1,708		1,297
Central and South America	1,279		1,094		798
Others	240		68		202
Total subscriber equipment revenue	20,241		18,067		18,850
Total revenue	$	90,064	$	82,711	$	76,318



	December 31,
	2014		2013
Long-lived assets:
United States	$	1,108,675	$	1,164,358
Canada	357		247
Europe	413		408
Central and South America	3,309		3,595
Others	806		1,177
Total long-lived assets	$	1,113,560	$	1,169,785

STOCK COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Assumptions Used to Estimate Fair Value of Stock Options



	Year Ended December 31,
	2014		2013		2012
Risk-free interest rate	Less than 1 - 2%		Less than 1 - 2%		Less than 1 - 1%
Expected term of options (years)	5		2 - 6		1 - 5
Volatility	72%		72 - 115%		80 - 103%
Weighted average grant-date fair value per share	$	1.67	$	0.70	$	0.39

Schedule of Stock Option Activity

The following table represents the Company’s stock option activity for the year ended December 31, 2014:



	Shares		Weighted Average Exercise Price
Outstanding at January 1, 2014	8,236,855		$	0.98
Granted	1,670,100		2.80
Exercised	(1,899,725	)	0.72
Forfeited or expired	(268,325	)	1.27
Outstanding at December 31, 2014	7,738,905		1.33

Exercisable at December 31, 2014	4,827,320		$	0.94

Schedule of Aggregate Intrinsic Value of Stock Options Exercised

The following table summarizes the aggregate intrinsic value of stock options exercised during the years indicated below (in thousands):



	Year Ended December 31,
	2014		2013		2012
Intrinsic value of stock options exercised	$	5,083	$	2,263	$	78

Schedule of Nonvested Stock Option Activity

The following table represents the Company’s nonvested stock option activity for the year ended December 31, 2014:



	Shares		Weighted Average Grant Date Fair Value
Nonvested stock options at January 1, 2014	3,156,759		$	0.72
Granted	1,670,100		1.67
Vested	(1,695,479	)	0.75
Forfeited or expired	(219,795	)	0.80
Nonvested stock options at December 31, 2014	2,911,585		1.20

Schedule of Share-Based Compensation Expense

The following table presents compensation expense related to stock options for the years indicated below (in millions):



	Year Ended December 31,
	2014		2013		2012
Total compensation expense	$	1.5	$	0.5	$	0.7

The following table represents the compensation expense related to restricted stock for the years indicated below (in millions):



	Year Ended December 31,
	2014		2013		2012
Total compensation expense	$	1.6	$	—	$	—

Schedule of Weighted Average Grant Date Fair Value of Restricted Stock

The table below summarizes the weighted average grant-date fair value of restricted stock for the indicated periods:



	Year Ended December 31,
	2014		2013		2012
Weighted average grant-date fair value	$	3.32	$	1.06	$	0.71

Schedule of Nonvested Restricted Stock Activity

The following is a rollforward of the activity in restricted stock for the year ended December 31, 2014:



	Shares		Weighted Average Grant Date Fair Value
Nonvested at January 1, 2014	633,590		$	1.68
Granted	1,146,815		3.32
Vested	(945,463	)	2.70
Forfeited	(26,444	)	1.88
Nonvested at December 31, 2014	808,498		$	2.81

Schedule of Assumptions Used to Estimate Fair Value of Employees' Stock Purchase Rights

The fair value of the employees’ stock purchase rights granted under the ESPP was estimated using the Black-Scholes option pricing model with the following assumptions for the following years:



	Year Ended December 31,
	2014		2013
Risk-free interest rate	Less than 1.00%		Less than 1.00		%
Expected term of options (months)	6		6
Volatility	100%		80 - 107%
Weighted average grant-date fair value per share	$	1.24	$	0.21

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

12 Months Ended

Dec. 31, 2014

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Components of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss were as follows (in thousands):



	December 31,
	2014			2013
Accumulated minimum pension liability adjustment	$	(6,950	)	$	(4,484	)
Accumulated net foreign currency translation adjustment	4,052			5,355
Total accumulated other comprehensive income (loss)	$	(2,898	)	$	871

CONDENSED CONSOLIDATING FINANCIAL INFORMATION - (Tables)

12 Months Ended

Dec. 31, 2014

SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION [Abstract]

Supplemental Consolidating Balance Sheet

Globalstar, Inc.

Condensed Consolidating Balance Sheet

As of December 31, 2014



	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Elimination			Consolidated
	(In Thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	3,166		$	672		$	3,283		$	—		$	7,121
Accounts receivable, net of allowance	4,470			5,265			4,955			325			15,015
Intercompany receivables	755,482			441,525			23,967			(1,220,974		)	—
Inventory	2,018			8,424			4,292			—			14,734
Advances for inventory	125			28			43			—			196
Prepaid expenses and other current assets	3,340			275			4,133			—			7,748
Total current assets	768,601			456,189			40,673			(1,220,649		)	44,814
Property and equipment	1,105,670			3,002			5,776			(888		)	$	1,113,560
Restricted cash	37,918			—			—			—			37,918
Intercompany notes receivable	13,006			—			8,285			(21,291		)	—
Investment in subsidiaries	(265,249		)	4,734			30,552			229,963			—
Deferred financing costs	63,862			—			—			—			63,862
Other assets, net	6,707			541			1,031			(13		)	8,266
Total assets	$	1,730,515		$	464,466		$	86,317		$	(1,012,878	)	$	1,268,420
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long term debt	$	6,450		$	—		$	—		$	—		$	6,450
Accounts payable	3,310			1,755			1,857			—			6,922
Accrued contract termination charge	21,308			—			—			—			21,308
Accrued expenses	6,638			7,213			8,491			—			22,342
Intercompany payables	508,503			563,183			153,067			(1,224,753		)	—
Payable to affiliates	481			—			—			—			481
Deferred revenues	3,185			15,378			3,177			—			21,740
Total current liabilities	549,875			587,529			166,592			(1,224,753		)	79,243
Long term debt	623,640			—			—			—			623,640
Employee benefit obligations	5,499			—			—			—			5,499
Intercompany notes payable	2,000			—			15,148			(17,148		)	—
Derivative liabilities	441,550			—			—			—			441,550
Long term deferred revenue	6,229			343			—			—			6,572
Deferred debt restructuring charge	20,795			—			—			—			20,795
Other non current liabilities	2,011			294			9,900			—			12,205
Total non-current liabilities	1,101,724			637			25,048			(17,148		)	1,110,261
Stockholders' equity	78,916			(123,700		)	(105,323		)	229,023			78,916
Total liabilities and ownership equity	$	1,730,515		$	464,466		$	86,317		$	(1,012,878	)	$	1,268,420

Globalstar, Inc.

Condensed Consolidating Balance Sheet

As of December 31, 2013



	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Elimination			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	12,935			676			3,797			—			17,408
Accounts receivable	5,925			5,022			4,602			174			15,723
Intercompany receivables	651,251			414,508			18,280			(1,084,039		)	—
Inventory	1,161			14,375			16,281			—			31,817
Advances for inventory	9,287			28			44			—			9,359
Prepaid expenses and other current assets	4,316			311			2,432			—			7,059
Total current assets	684,875			434,920			45,436			(1,083,865		)	81,366
Property and equipment, net	1,152,734			11,621			6,889			(1,459		)	1,169,785
Restricted cash	37,918			—			—			—			37,918
Intercompany notes receivable	13,629			—			4,285			(17,914		)	—
Investment in subsidiaries	(209,592		)	7,242			—			202,350			—
Deferred financing costs	76,436			—			—			—			76,436
Intangible and other assets, net	3,964			1,028			2,125			(14		)	7,103
Total assets	$	1,759,964		$	454,811		$	58,735		$	(900,902	)	$	1,372,608
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt	$	4,046		—			—			—			$	4,046
Accounts payable	9,906			2,041			2,680			—			14,627
Accrued contract termination charge	24,133			—			—			—			24,133
Accrued expenses	6,160			8,203			8,337			—			22,700
Intercompany payables	435,707			521,763			128,496			(1,085,966		)	—
Payables to affiliates	202			—			—			—			202
Derivative liabilities	57,048			—			—			—			57,048
Deferred revenue	1,843			13,094			2,347			—			17,284
Total current liabilities	539,045			545,101			141,860			(1,085,966		)	140,040
Long-term debt, less current portion	665,236			—			—			—			665,236
Employee benefit obligations	3,529			—			—			—			3,529
Intercompany notes payable	—			—			15,772			(15,772		)	—
Derivative liabilities	405,478			—			—			—			405,478
Deferred revenue	6,583			496			—			—			7,079
Debt restructuring fees	20,795			—			—			—			20,795
Other non-current liabilities	2,543			297			10,856			—			13,696
Total non-current liabilities	1,104,164			793			26,628			(15,772		)	1,115,813
Stockholders’ equity	116,755			(91,083		)	(109,753		)	200,836			116,755
Total liabilities and stockholders’ equity	$	1,759,964		$	454,811		$	58,735		$	(900,902	)	$	1,372,608

Supplemental Consolidating Statement of Operations

Globalstar, Inc.

Condensed Consolidating Statement of Operations

Year Ended December 31, 2013



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenues:
Service revenues	$	69,250		$	10,695		$	18,536		$	(33,837	)	$	64,644
Subscriber equipment sales	87			13,704			15,452			(11,176		)	18,067
Total revenue	69,337			24,399			33,988			(45,013		)	82,711
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	10,498			10,559			9,062			91			30,210
Cost of subscriber equipment sales	—			10,860			16,319			(13,556		)	13,623
Cost of subscriber equipment sales - reduction in the value of inventory	—			1,300			4,494			—			5,794
Marketing, general and administrative	5,929			15,109			13,620			(4,770		)	29,888
Depreciation, amortization, and accretion	72,456			21,286			24,103			(27,253		)	90,592
Total operating expenses	88,883			59,114			67,598			(45,488		)	170,107
Loss from operations	(19,546		)	(34,715		)	(33,610		)	475			(87,396		)
Other income (expense):
Loss on extinguishment of debt	(109,092		)	—			—			—			(109,092		)
Loss on equity issuance	(16,701		)	—			—			—			(16,701		)
Interest income and expense, net of amounts capitalized	(66,688		)	(42		)	(1,096		)	(2		)	(67,828		)
Derivative gain (loss)	(305,999		)	—			—			—			(305,999		)
Equity in subsidiary earnings	(69,790		)	(7,242		)	—			77,032			—
Other	(3,097		)	(257		)	209			183			(2,962		)
Total other income (expense)	(571,367		)	(7,541		)	(887		)	77,213			(502,582		)
Loss before income taxes	(590,913		)	(42,256		)	(34,497		)	77,688			(589,978		)
Income tax expense (benefit)	203			37			898			—			1,138
Net (loss) income	$	(591,116	)	$	(42,293	)	$	(35,395	)	$	77,688		$	(591,116	)

Globalstar, Inc.

Condensed Consolidating Statement of Operations

Year Ended December 31, 2012



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Consolidated
	(In thousands)
Revenues:
Service revenues	$	48,845		$	44,208		$	15,729		$	(51,314	)	$	57,468
Subscriber equipment sales	825			15,225			7,855			(5,055		)	18,850
Total revenue	49,670			59,433			23,584			(56,369		)	76,318
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	12,061			9,467			8,762			(219		)	30,071
Cost of subscriber equipment sales	292			11,827			7,560			(6,399		)	13,280
Cost of subscriber equipment sales - reduction in the value of inventory	—			1,274			123			—			1,397
Marketing, general and administrative	2,874			16,860			12,288			(4,526		)	27,496
Reduction in the value of long-lived assets	79			7,139			—			—			7,218
Contract termination charge	22,048			—			—			—			22,048
Depreciation, amortization, and accretion	49,132			48,869			17,308			(45,508		)	69,801
Total operating expenses	86,486			95,436			46,041			(56,652		)	171,311
Loss from operations	(36,816		)	(36,003		)	(22,457		)	283			(94,993		)
Other income (expense):
Interest income and expense, net of amounts capitalized	(19,744		)	(10		)	(1,731		)	(1		)	(21,486		)
Derivative gain (loss)	6,974			—			—			—			6,974
Equity in subsidiary earnings	(60,302		)	10,237			—			50,065			—
Other	(2,078		)	(141		)	16			(77		)	(2,280		)
Total other income (expense)	(75,150		)	10,086			(1,715		)	49,987			(16,792		)
Loss before income taxes	(111,966		)	(25,917		)	(24,172		)	50,270			(111,785		)
Income tax expense (benefit)	232			41			140			—			413
Net (loss) income	$	(112,198	)	$	(25,958	)	$	(24,312	)	$	50,270		$	(112,198	)

Supplemental Consolidating Statement of Cash Flows

Globalstar, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2013



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations		Consolidated
	(In thousands)
Net cash provided by (used in) operating activities	$	(10,789	)	$	1,524		$	2,803		$	—	$	(6,462	)

Cash flows from investing activities:
Second-generation satellites, ground and related launch costs	(43,693		)	—			—			—		(43,693		)
Property and equipment additions	—			(1,099		)	(552		)	—		(1,651		)
Investment in businesses	(634		)	—			—			—		(634		)
Restricted Cash	8,859			—			—			—		8,859
Net cash provided by (used in) investing activities	(35,468		)	(1,099		)	(552		)	—		(37,119		)

Cash flows from financing activities:
Payments to reduce principal amount of exchanged 5.75% Notes	(13,544		)	—			—			—		(13,544		)
Payments for 5.75% Notes not exchanged	(6,250		)	—			—			—		(6,250		)
Payments to lenders and other fees associated with exchange	(2,482		)	—			—			—		(2,482		)
Proceeds from equity issuance to related party	65,000			—			—			—		65,000
Proceeds from issuance of stock to Terrapin	6,000			—			—			—		6,000
Proceeds from exercise of warrants and stock options	15,414									—		15,414
Borrowings from Facility Agreement	672			—			—			—		672
Proceeds from contingent equity account	1,071			—			—			—		1,071
Payment of deferred financing costs	(16,909		)	—			—			—		(16,909		)
Net cash provided by financing activities	48,972			—			—			—		48,972
Effect of exchange rate changes on cash and cash equivalents	—			—			225			—		225
Net increase in cash and cash equivalents	2,715			425			2,476			—		5,616
Cash and cash equivalents at beginning of period	10,220			251			1,321			—		11,792
Cash and cash equivalents at end of period	$	12,935		$	676		$	3,797		$	—	$	17,408

Globalstar, Inc.

Condensed Consolidating Statement of Cash Flows

Year Ended December 31, 2012



	Parent Company			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations		Consolidated
	(In thousands)
Net cash provided by (used in) operating activities	$	7,720		$	61		$	(907	)	$	—	$	6,874

Cash flows from investing activities:
Second-generation satellites, ground and related launch costs	(56,679		)	—			—			—		(56,679		)
Property and equipment additions	—			(397		)	(384		)	—		(781		)
Investment in businesses	(550		)	—			—			—		(550		)
Net cash from investing activities	(57,229		)	(397		)	(384		)	—		(58,010		)

Cash flows from financing activities:
Proceeds from exercise of warrants and stock options	244			—			—			—		244
Borrowings from Facility Agreement	7,375			—			—			—		7,375
Proceeds from Contingent Equity Agreement	45,800			—			—			—		45,800
Payment of deferred financing costs	(1,033		)	—			—			—		(1,033		)
Net cash provided by financing activities	52,386			—			—			—		52,386
Effect of exchange rate changes on cash and cash equivalents	—			—			591			—		591
Net increase (decrease) in cash and cash equivalents	2,877			(336		)	(700		)	—		1,841
Cash and cash equivalents at beginning of period	7,343			587			2,021			—		9,951
Cash and cash equivalents at end of period	$	10,220		$	251		$	1,321		$	—	$	11,792

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Tables)

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information Disclosure [Abstract]

Schedule of Unaudited Quarterly Financial Information

The following is a summary of consolidated quarterly financial information (amounts in thousands, except per share data):



	Quarter Ended
2014	March 31			June 30			Sept. 30		Dec. 31
Total revenue	$	20,536		$	23,994		$	23,441	$	22,093
Net income/(loss)	$	(250,541	)	$	(433,730	)	$	129,390	$	92,015
Basic income/(loss) per common share	$	(0.29	)	$	(0.48	)	$	0.13	$	0.09
Diluted income/(loss) per common share	$	(0.29	)	$	(0.48	)	$	0.11	$	0.08
Shares used in basic per share calculations	849,321			904,994			987,668		993,427
Shares used in diluted per share calculations	849,321			904,994			1,189,190		1,192,263



	Quarter Ended
2013	March 31			June 30			Sept. 30			Dec. 31
Total revenue	$	19,333		$	19,835		$	22,549		$	20,994
Net loss	$	(25,078	)	$	(126,272	)	$	(204,969	)	$	(234,797	)
Basic loss per common share	$	(0.05	)	$	(0.25	)	$	(0.30	)	$	(0.36	)
Diluted loss per common share	$	(0.05	)	$	(0.25	)	$	(0.30	)	$	(0.36	)
Shares used in basic per share calculations	472,187			496,169			673,546			779,483
Shares used in diluted per share calculations	472,187			496,169			673,546			779,483



	Quarter Ended
2012	March 31			June 30			Sept. 30			Dec. 31
Total revenue	$	16,738		$	19,981		$	20,537		$	19,062
Net loss	$	(24,525	)	$	(27,533	)	$	(41,188	)	$	(18,952	)
Basic loss per common share	$	(0.07	)	$	(0.07	)	$	(0.10	)	$	(0.05	)
Diluted loss per common share	$	(0.07	)	$	(0.07	)	$	(0.10	)	$	(0.05	)
Shares used in basic per share calculations	357,418			379,433			392,344			424,180
Shares used in diluted per share calculations	357,418			379,433			392,344			424,180

Schedule of Weighted Average Number of Shares [Table Text Block]

The following table reconciles basic weighted average common shares to diluted weighted average common shares outstanding:



	Three Months Ended
	September 30, 2014	December 31, 2014
Weighted average common shares outstanding:	(in thousands)
Basic shares outstanding	987,668	993,427
Incremental shares from assumed exercises of:
Stock options, restricted stock, restricted stock units and ESPP	7,340	7,557
8% Convertible Senior Notes Issued in 2013	39,625	38,192
Thermo Loan Agreement	109,469	114,083
Warrants	45,088	39,004
Diluted shares outstanding	1,189,190	1,192,263

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) subscriber in Thousands, shares in Thousands, $ in Thousands	1 Months Ended	12 Months Ended
	Jul. 31, 2013 shares	Dec. 31, 2014 USD ($) subscriber shares	Dec. 31, 2013 USD ($) shares	Dec. 31, 2012 USD ($) shares
Accounts Receivable
Balance at beginning of period		$ 7,419	$ 6,667	$ 7,296
Provision, net of recoveries		2,281	2,321	1,097
Write-offs and other adjustments		(4,912)	(1,569)	(1,726)
Balance at end of period		$ 4,788	7,419	6,667
Number of subscribers that were deactivated \| subscriber		26
Inventory
Cost of subscriber equipment sales - reduction in the value of inventory		$ 21,684	5,794	1,397
Deferred Financing Costs
Deferred financing costs		63,900	76,400
Foreign Currency
Foreign currency translation adjustments		1,302	856	(1,264)
Foreign currency transaction losses		4,100	1,000	2,000
Asset Retirement Obligation
Asset retirement obligation		1,200	1,100
Research and Development Expenses
Research and development expense		500	600	300
Advertising Expenses
Advertising expense		$ 2,600	$ 2,900	$ 1,900
Loss Per Share
Total Borrowed Shares excluded from computation and reporting of earnings per share \| shares			17,300	17,300
Number of shares settled with cash payment \| shares	7,100
Common Stock
Loss Per Share
Number of shares returned \| shares		10,200	10,185
Minimum
Warranty Expense
Warranty term		90 days
Maximum
Warranty Expense
Warranty term		1 year
Software, Facilities and Equipment \| Minimum
Property and Equipment
Estimated useful life		3 years
Software, Facilities and Equipment \| Maximum
Property and Equipment
Estimated useful life		10 years
Building
Property and Equipment
Estimated useful life		18 years
Global Star System \| Space component \| Second-generation satellites in service
Property and Equipment
Estimated useful life		15 years
Global Star System \| Ground component
Property and Equipment
Estimated useful life		15 years

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Additional Information (Details) - USD ($) $ in Millions		12 Months Ended
	Dec. 18, 2009	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2009
Axonn
Business Acquisition [Line Items]
Cash paid	$ 1.5
Value of stock issued	$ 5.5
Number of shares issued	6,298,058
Intangible assets recorded					$ 7.6
Amortization of acquired intangible assets		$ 0.5	$ 0.8	$ 1.2
Estimated annual amortization in 2015		0.3
Estimated annual amortization in 2016		0.1
Estimated annual amortization in 2017		0.1
Estimated annual amortization, thereafter		$ 0.1
Developed technology \| Axonn
Business Acquisition [Line Items]
Useful life of acquired intangible assets		10 years
Customer relationships \| Axonn
Business Acquisition [Line Items]
Useful life of acquired intangible assets		8 years
Trade name \| Axonn
Business Acquisition [Line Items]
Useful life of acquired intangible assets		2 years
Other Intangible Assets
Business Acquisition [Line Items]
Finite-Lived Intangible Assets, Gross		$ 3.7
Finite-Lived Intangible Assets, Accumulated Amortization		$ 0.8

PROPERTY AND EQUIPMENT (Schedule of Property and Equipment) (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 1,486,546	$ 1,460,102
Accumulated depreciation	(372,986)	(290,317)
Total property and equipment, net	1,113,560	1,169,785
Internally developed and purchased software
Property, Plant and Equipment [Line Items]
Total property and equipment	15,392	14,931
Equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	12,647	12,385
Land and buildings
Property, Plant and Equipment [Line Items]
Total property and equipment	3,590	3,768
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	1,620	1,644
Global Star System
Property, Plant and Equipment [Line Items]
Total property and equipment	1,453,297	1,427,374
Global Star System \| Ground component
Property, Plant and Equipment [Line Items]
Total property and equipment	47,595	48,378
Global Star System \| Second-generation satellites in service \| Space component
Property, Plant and Equipment [Line Items]
Total property and equipment	1,211,904	1,212,099
Global Star System \| Prepaid long-lead items \| Space component
Property, Plant and Equipment [Line Items]
Total property and equipment	17,040	17,040
Global Star System \| Second-generation satellite, on-ground spare \| Space component
Property, Plant and Equipment [Line Items]
Total property and equipment	32,481	32,365
Global Star System \| Construction in progress: \| Space component
Property, Plant and Equipment [Line Items]
Total property and equipment	30	0
Global Star System \| Construction in progress: \| Ground component
Property, Plant and Equipment [Line Items]
Total property and equipment	141,789	116,377
Global Star System \| Construction in progress: \| Other
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 2,458	$ 1,115

PROPERTY AND EQUIPMENT (Capitalized Interest and Depreciation Expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Interest Costs Incurred [Abstract]
Interest cost eligible to be capitalized	$ 44,854	$ 45,308	$ 57,249
Interest cost recorded in interest expense, net	(36,909)	(28,211)	(17,133)
Net interest capitalized	7,945	17,097	40,116
Depreciation expense	$ 84,802	$ 89,828	$ 67,289

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Long-term Debt) (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013	May 20, 2013	Dec. 31, 2010
Principal Amount
Total Debt	$ 673,249	$ 745,348
Less: Current Portion	6,450	4,046
Long-Term Debt	666,799	741,302
Carrying Value
Total Debt	630,090	669,282
Less: Current Portion	6,450	4,046
Long-Term Debt	623,640	665,236
Facility Agreement
Principal Amount
Total Debt	582,296	586,342
Carrying Value
Total Debt	582,296	586,342
Thermo Loan Agreement
Principal Amount
Total Debt	68,154	60,383
Carrying Value
Total Debt	32,971	22,854
8.00% Convertible Senior Notes Issued in 2013
Principal Amount
Total Debt	22,799	46,971	$ 54,600
Carrying Value
Total Debt	14,823	26,291	$ 27,890
8.00% Convertible Senior Unsecured Notes Issued in 2009
Principal Amount
Total Debt	0	51,652		$ 55,000
Carrying Value
Total Debt	$ 0	$ 33,795		$ 18,667

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Facility Agreement) (Details) - USD ($)		1 Months Ended		3 Months Ended		12 Months Ended
	Aug. 22, 2013	Aug. 31, 2013	Jan. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2009	Jul. 31, 2013
Debt Instrument [Line Items]
Debt restructuring fees				$ 20,795,000	$ 20,795,000	$ 20,795,000	$ 20,795,000
Proceeds from contingent equity agreement		$ 1,100,000				$ 0	1,071,000	$ 45,800,000
Terrapin Equity Line
Debt Instrument [Line Items]
Amount available to be drawn		$ 19,500,000
Facility Agreement
Debt Instrument [Line Items]
Interest above LIBOR rate									2.25%
Interest rate increase	0.50%					0.50%
Percentage of guarantee provided by French export credit agency to lending syndicate		95.00%
Minimum equity cure contribution						$ 10,000,000
Draws on line of credit		$ 700,000
Required debt service reserve, amount						37,900,000
Maximum capital expenditures covenant amount, 2015						18,800,000
Maximum capital expenditures, 2016						13,200,000
Maximum capital expenditures, thereafter						15,000,000
Minimum liquidity				4,000,000	4,000,000	$ 4,000,000	$ 4,000,000	$ 5,000,000
Maximum net debt to adjusted consolidated EBITDA						2700.00%
Minimum net debt to adjusted consolidated EBITDA, in 2022						250.00%
Restructuring fees		$ 13,900,000
Restructuring fees, percentage		40.00%
Proceeds from debt service reserve account		$ 200,000
Minimum debt service coverage ratio						100.00%
Covenant, proceeds		235,300,000
Amount available to be drawn		$ 145,000,000
Threshold for change in control	51.00%
Senior secured facility agreement maturity period									84 months
Debt service reserve account									$ 46,800,000.0
Change in debt service reserve account			$ 8,900,000						$ 8,900,000
Facility Agreement \| Thereafter
Debt Instrument [Line Items]
Interest above LIBOR rate									2.40%
Facility Agreement \| Domestic Subsidiaries
Debt Instrument [Line Items]
Percentage of equity pledged as collateral		100.00%
Facility Agreement \| Foreign Subsidiaries
Debt Instrument [Line Items]
Percentage of equity pledged as collateral		65.00%
Facility Agreement \| Minimum
Debt Instrument [Line Items]
Interest above LIBOR rate	2.75%	2.75%
Facility Agreement \| Maximum
Debt Instrument [Line Items]
Interest above LIBOR rate	5.75%	5.75%
8.00% Convertible Senior Notes Issued in 2013 \| Thermo Capital Partners LLC
Debt Instrument [Line Items]
Amount of third party credit enhancements				$ 20,000,000	$ 20,000,000
Debt service reserve account										$ 4,000,000

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Minimum EBITDA) (Details) - Facility Agreement $ in Thousands	Dec. 31, 2014 USD ($)
Line of Credit Facility [Line Items]
7/1/14-12/31/14	$ 14,062
1/1/15-6/30/15	16,958
7/1/15-12/31/15	23,469
1/1/16-6/30/16	24,502
7/1/16-12/31/16	$ 32,426

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Contingent Equity Agreement) (Details) - USD ($)		1 Months Ended	3 Months Ended	12 Months Ended
	Jun. 19, 2012	Jun. 30, 2009	Sep. 30, 2013	Dec. 31, 2014
Common Stock \| Warrants issued in conjunction with Contingent Equity Agreement
Debt Instrument [Line Items]
Warrants exercised associated with Contingent Equity Agreement				11,276,000
Thermo
Debt Instrument [Line Items]
Discount on shares			20.00%
Contingent Equity Agreement
Debt Instrument [Line Items]
Warrant exercise period				5 years
Contingent Equity Agreement \| Thermo
Debt Instrument [Line Items]
Contingent equity account		$ 60,000,000.0
Forward-looking period		90 days
Percent to be paid as availability fee		10.00%
Per share value		$ 0.01
Warrant exercise period		5 years
Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity	$ 5,900,000
Percentage of closing price of common stock		80.00%
Number of trading days		15 days
Discount on shares		20.00%
Amount drawn under agreement		$ 60,000,000
Interest earned from funds previously held in the Contingent Equity Account that have been released to the company		$ 1,100,000
Warrants exercised associated with Contingent Equity Agreement		41,467,980
Shares issued		160,916,223
Common stock, shares not yet issued		2,133,656
Percentage of ownership interest that trigger issuance of voting common stock				70.00%
Contingent Equity Agreement \| Thermo \| Maximum
Debt Instrument [Line Items]
Number of shares issuable under the warrants, calculation denominator		$ 1.37
Contingent Equity Agreement \| Thermo \| Minimum
Debt Instrument [Line Items]
Number of shares issuable under the warrants, calculation denominator		$ 0.20

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Thermo Loan Agreement) (Details) - USD ($)
$ / shares in Units, $ in Thousands

1 Months Ended

3 Months Ended

12 Months Ended

Jun. 30, 2009

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 27, 2013

^[1]

Aug. 19, 2013

^[1]

Jul. 31, 2013

Jul. 29, 2013

^[1]

Jun. 28, 2013

^[2]

May 21, 2013

^[2]

May 20, 2013

Dec. 31, 2011

Debt Instrument [Line Items]

Share Price

$ 2.75

$ 1.82

$ 0.62

$ 0.55

$ 0.40

^[2]

Loss on extinguishment of debt

$ (39,846)

$ (109,092)

$ 0

Loan Agreement

$ 669,282

630,090

669,282

Thermo

Debt Instrument [Line Items]

Maximum borrowing capacity

37,500

Loss on extinguishment of debt

$ (66,100)

$ 0

$ (66,088)

$ 0

Fair value of Loan Agreement

$ 120,100

Thermo Loan Agreement

Debt Instrument [Line Items]

Exercise price of warrants

$ 0.01

$ 0

$ 0.01

Loss on extinguishment of debt

$ (66,100)

Loan Agreement

$ 22,854

$ 32,971

$ 22,854

Fair value of Loan Agreement

$ 120,100

Thermo Loan Agreement | Thermo

Debt Instrument [Line Items]

Maximum borrowing capacity

$ 25,000

$ 37,500

Loan interest rate

12.00%

Outstanding interest

$ 30,700

Fair value, if converted, exceeding principal amount

$ 244,000

Number of common stock to be purchased with warrant

4,205,608

4,200,000

Exercise price of warrants

$ 0.01

Warrants exercise period

5 years

Percentage of ownership interest that trigger issuance of voting common stock

70.00%

Debt discount

$ 5,200

Loan Agreement

18,958

Compound embedded derivative liability

101,114

Fair value of Loan Agreement

$ 120,072

8.00% Convertible Senior Notes Issued in 2013

Debt Instrument [Line Items]

Loan interest rate

8.00%

Fair value, if converted, exceeding principal amount

$ 84,000

Loss on extinguishment of debt

(44,100)

$ 4,200

Loan Agreement

$ 26,291

$ 14,823

$ 26,291

$ 27,890

Compound embedded derivative liability

56,752

Fair value of Loan Agreement

$ 84,642

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (5.75% Convertible Senior Notes) (Details) - USD ($) $ in Thousands	Apr. 02, 2013	Dec. 31, 2014	Dec. 31, 2013	May 29, 2013	Apr. 01, 2013	Dec. 31, 2008
Debt Instrument [Line Items]
Debt, principal amount		$ 673,249	$ 745,348
5.75% Convertible Senior Unsecured Notes
Debt Instrument [Line Items]
Debt, principal amount	$ 71,800					$ 150,000
Loan interest rate	5.75%					5.75%
Percentage of debt purchase price	100.00%
Principal amount redeemed				$ 70,700	$ 70,700
Outstanding interest					$ 2,100

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Exchange Agreement) (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions			3 Months Ended		12 Months Ended
	Jul. 19, 2013	May 20, 2013	Dec. 31, 2014	Jun. 26, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jul. 31, 2013	Apr. 02, 2013	Dec. 31, 2008
Debt Instrument [Line Items]
Cash paid for interest					$ 20,216	$ 21,413	$ 27,383
Loss on extinguishment of debt					$ (39,846)	$ (109,092)	$ 0
5.75% Convertible Senior Unsecured Notes
Debt Instrument [Line Items]
Percentage of principal redeemed in exchange agreement		91.50%
Loan interest rate									5.75%	5.75%
Repayments of convertible debt		$ 13,500
Cash paid for interest		$ 500
Conversion of notes into shares of common stock		30.3
Debt conversion amount		$ 12,100
Payments to Trustee		2,100		$ 6,300
Loss on extinguishment of debt		$ (47,200)
8.00% Convertible Senior Notes Issued in 2013
Debt Instrument [Line Items]
Loan interest rate		8.00%	8.00%		8.00%	8.00%		8.00%
Conversion of notes into shares of common stock	14.3		60.3
Debt conversion amount		$ 54,600
Conversion price per share of common stock		$ 0.80	$ 0.73		$ 0.73
Participation rate		50.00%
Loss on extinguishment of debt					$ (44,100)	$ 4,200

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Consent Agreement) (Details) - USD ($)
$ in Thousands

1 Months Ended

3 Months Ended

12 Months Ended

Dec. 27, 2013

^[1]

Oct. 14, 2013

Aug. 19, 2013

^[1]

Jul. 29, 2013

^[1]

Jun. 28, 2013

^[2]

May 21, 2013

^[2]

May 20, 2013

Jun. 30, 2013

Dec. 31, 2014

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Dec. 31, 2013

Jul. 31, 2013

Apr. 02, 2013

Dec. 31, 2008

Debt Instrument [Line Items]

Amount Invested

$ 13,500

$ 6,500

$ 6,000

$ 9,000

$ 5,000

$ 25,000

^[2]

$ 9,000

$ 12,500

$ 39,000

$ 65,000

Issuance of stock, shares

25,961,538

^[3]

38,500,000

11,538,462

12,500,000

^[3]

11,538,462

^[3]

28,125,000

^[3]

15,625,000

^[3]

78,125,000

^[2],[3]

28,125,000

24,000,000

121,900,000

Nonvoting Common Stock

Debt Instrument [Line Items]

Issuance of stock, shares

171,900,000

8.00% Convertible Senior Notes Issued in 2013

Debt Instrument [Line Items]

Loan interest rate

8.00%

8.00% Convertible Senior Notes Issued in 2013 | Thermo Capital Partners LLC

Debt Instrument [Line Items]

Compensating balance, amount

$ 4,000

Amount of payment in exchange transaction

$ 25,000

Amount of third party credit enhancements

$ 20,000

8.00% Convertible Senior Notes Issued in 2013 | Thermo Capital Partners LLC | Scenario One

Debt Instrument [Line Items]

Amount of third party credit enhancements

20,000

8.00% Convertible Senior Notes Issued in 2013 | Thermo Capital Partners LLC | Scenario Two

Debt Instrument [Line Items]

Amount of third party credit enhancements

20,000

8.00% Convertible Senior Notes Issued in 2013 | Thermo Capital Partners LLC | Scenario Three

Debt Instrument [Line Items]

Amount of third party credit enhancements

20,000

8.00% Convertible Senior Notes Issued in 2013 | Thermo Capital Partners LLC | Scenario Four

Debt Instrument [Line Items]

Amount of third party credit enhancements

$ 40,000

5.75% Convertible Senior Unsecured Notes

Debt Instrument [Line Items]

Loan interest rate

5.75%

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[3]	All shares issued to Thermo in connection with these agreements were shares of the Company’s nonvoting common stock.

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Common Stock Purchase Agreement) (Details) - USD ($)
$ / shares in Units, $ in Thousands

1 Months Ended

3 Months Ended

12 Months Ended

Dec. 27, 2013

^[2]

Oct. 14, 2013

Aug. 19, 2013

^[2]

Jul. 29, 2013

^[2]

Jun. 28, 2013

^[3]

May 21, 2013

^[3]

May 20, 2013

^[3]

Jun. 30, 2013

Sep. 30, 2013

Jun. 30, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Jul. 31, 2013

Debt Disclosure [Abstract]

Issuance of stock, shares

25,961,538

^[1]

38,500,000

11,538,462

12,500,000

^[1]

11,538,462

^[1]

28,125,000

^[1]

15,625,000

^[1]

78,125,000

^[1]

28,125,000

24,000,000

121,900,000

Amount Invested

$ 13,500

$ 6,500

$ 6,000

$ 9,000

$ 5,000

$ 25,000

$ 9,000

$ 12,500

$ 39,000

$ 65,000

Shares issued, price per share (USD per share)

$ 0.52

$ 0.32

Consolidated unrestricted cash balance requirement not less than, $4.0 million

$ 4,000

Loss on sale of equity issuance

$ 14,000

$ 0

$ 16,701

$ 0

[1]	All shares issued to Thermo in connection with these agreements were shares of the Company’s nonvoting common stock.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[3]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (The Common Stock Purchase and Option Agreement) (Details) - USD ($)
$ / shares in Units, $ in Thousands

1 Months Ended

3 Months Ended

12 Months Ended

Dec. 27, 2013

^[2]

Oct. 14, 2013

Aug. 19, 2013

^[2]

Jul. 29, 2013

^[2]

Jun. 28, 2013

^[3]

May 21, 2013

^[3]

May 20, 2013

^[3]

Jun. 30, 2013

Sep. 30, 2013

Jun. 30, 2013

Dec. 31, 2014

Dec. 31, 2013

Class of Stock [Line Items]

Issuance of stock, shares

25,961,538

^[1]

38,500,000

11,538,462

12,500,000

^[1]

11,538,462

^[1]

28,125,000

^[1]

15,625,000

^[1]

78,125,000

^[1]

28,125,000

24,000,000

121,900,000

Shares issued, price per share (USD per share)

$ 0.52

$ 0.32

Amount Invested

$ 13,500

$ 6,500

$ 6,000

$ 9,000

$ 5,000

$ 25,000

$ 9,000

$ 12,500

$ 39,000

$ 65,000

Issuance of stock

$ 47,250

$ 20,000

$ 7,750

$ 7,154

$ 15,469

$ 6,250

$ 31,250

$ 114,211

Loss on sale of shares

$ (2,400)

Thermo Capital Partners LLC

Class of Stock [Line Items]

Issuance of stock

$ 82,726

Thermo Capital Partners LLC | Scenario, Plan | Option One

Class of Stock [Line Items]

Shares issued, price per share (USD per share)

$ 0.52

Issuance of stock

$ 13,500

Thermo Capital Partners LLC | Scenario, Plan | Option Two

Class of Stock [Line Items]

Issuance of stock

$ 11,500

Percentage of average closing price

85.00%

[1]	All shares issued to Thermo in connection with these agreements were shares of the Company’s nonvoting common stock.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[3]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Share Lending Agreement) (Details) - USD ($) $ in Millions	1 Months Ended
	Jul. 31, 2013	Dec. 31, 2013	Apr. 02, 2013	Dec. 31, 2009	Dec. 31, 2008
Debt Instrument [Line Items]
Shares authorized for issuance					36,100,000
Share lending agreement, share issued				4,100,000.0	32,000,000
Shares returned	10,200,000
Proceeds from cash settlement of share lending agreement	$ 4.4
Number of shares settled in cash	7,100,000
Borrowed Shares remained outstanding		17,300,000
5.75% Convertible Senior Unsecured Notes
Debt Instrument [Line Items]
Loan interest rate			5.75%		5.75%

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (8.00% Convertible Senior Notes Issued in 2013) (Details) - USD ($)
$ / shares in Units, shares in Millions

1 Months Ended

3 Months Ended

12 Months Ended

Jul. 19, 2013

May 20, 2013

Nov. 30, 2014

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 27, 2013

^[2]

Aug. 19, 2013

^[2]

Jul. 31, 2013

Jul. 29, 2013

^[2]

Jun. 28, 2013

^[1]

May 21, 2013

^[1]

Debt Instrument [Line Items]

Debt, principal amount

$ 673,249,000

$ 745,348,000

Share Price

$ 0.40

^[1]

$ 2.75

$ 1.82

$ 0.62

$ 0.55

$ 0.40

Principal converted

$ 76,532,000

49,757,000

$ 2,000,000

Loss on extinguishment of debt

39,846,000

109,092,000

$ 0

Senior notes

$ 630,090,000

630,090,000

669,282,000

8.00% Convertible Senior Notes Issued in 2013

Debt Instrument [Line Items]

Debt, principal amount

$ 54,600,000

$ 22,799,000

$ 46,971,000

Loan interest rate

8.00%

Conversion price per share of common stock

$ 0.80

$ 0.73

Fair value, if converted, exceeding principal amount

$ 84,000,000

Number of shares of common stock convertible into

1,250

Principal converted

$ 7,000,000

$ 1,000

$ 700,000

$ 32,900,000

Interest rate, payable in cash

5.75%

Interest rate, payable in additional notes

2.25%

Percentage of debt that is convertible

15.00%

Price trigger for convertibility

$ 0.50

Percentage of principal converted

12.90%

Conversion of notes into shares of common stock

14.3

60.3

Loss on extinguishment of debt

$ 44,100,000

$ (4,200,000)

Settlement period

40 days

Debt conversion, amount not yet settled

$ 200,000

Convertible debt, consecutive trading days threshold

30 days

Conversion premium percentage

25.00%

Percentage of principal issuable under covenant

5.00%

Amount of default, definition per agreement

$ 10,000,000

Percentage of debt holders required for acceleration of maturity

25.00%

Senior notes

27,890,000

$ 14,823,000

$ 26,291,000

Compound embedded derivative liability

56,752,000

Fair value of Loan Agreement

$ 84,642,000

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (5.00% Convertible Senior Notes) (Details) $ / shares in Units, $ in Thousands			3 Months Ended	12 Months Ended
	Apr. 15, 2014 USD ($) shares	Nov. 07, 2013 USD ($) shares	Jun. 30, 2014 USD ($)	Dec. 31, 2014 USD ($) $ / shares	Dec. 31, 2013 USD ($) $ / shares	Dec. 31, 2012 USD ($) $ / shares shares	Nov. 06, 2013 shares	Apr. 15, 2013 $ / shares	Dec. 31, 2010 USD ($)
Debt Instrument [Line Items]
Debt, principal amount				$ 673,249	$ 745,348
Proceeds from warrant exercise			$ 7,500
Conversion of debt into common stock				76,532	49,757	$ 2,000
Reduction in debt discount and deferred financing costs related to note conversions				28,249	27,458	0
Derivative gain (loss)				(286,049)	(305,999)	6,974
Debt				630,090	669,282
Total Debt				$ 673,249	$ 745,348
5.0% Convertible Senior Unsecured Notes
Debt Instrument [Line Items]
Debt, principal amount						$ 38,000
Number of common stock to be purchased with warrant \| shares						15,200,000
Conversion price per share of common stock \| $ / shares						$ 1.25		$ 0.50
Number of shares of common stock convertible into						800
Exercise price of warrants \| $ / shares				$ 0.32	$ 0.32			$ 0.32
Convertible notes stated interest rate				5.00%		5.00%
Debt conversion amount		$ 17,500
Notes Converted Into Common Stock Shares \| shares							7,200,000
Shares Issued Upon Conversion Of Warrants \| shares							6,700,000
Notes Converted Into Common Stock Shares Issued \| shares							41,100,000
Proceeds from warrant exercise				$ 2,000
Conversion of debt into common stock		$ 24,200
Conversion of notes into shares of common stock \| shares		51,900,000
Percentage of debt purchase price		100.00%
Reduction in debt discount and deferred financing costs related to note conversions		$ 12,900
Derivative gain (loss)		$ 800
Debt						$ 11,316
Fair value of 5.0% Warrants						8,081
Beneficial Conversion Feature						17,100
Contingent Put Feature						1,503
Total Debt						$ 38,000
8.00% Convertible Senior Unsecured Notes Issued in 2009
Debt Instrument [Line Items]
Debt, principal amount				$ 0	$ 51,652				$ 55,000
Conversion price per share of common stock \| $ / shares				$ 1.14
Exercise price of warrants \| $ / shares				$ 0	$ 0.32
Convertible notes stated interest rate				8.00%	8.00%
Debt conversion amount	$ 37,800
Conversion of notes into shares of common stock \| shares	34,500,000
Debt				$ 0	$ 33,795				18,667
Fair value of 5.0% Warrants									12,791
Contingent Put Feature									23,542
Total Debt				$ 0	$ 51,652				$ 55,000

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (8.00% Convertible Senior Notes) (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended	6 Months Ended	12 Months Ended
	Apr. 15, 2014	Nov. 07, 2013	Jun. 30, 2014	Jun. 30, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Apr. 15, 2013	Dec. 31, 2010
Debt Instrument [Line Items]
Restricted cash					$ 37,918	$ 37,918
Outstanding Warrants					38,191,866	93,516,401
Warrants exercised associated with Notes, shares			38,200,000
Proceeds from warrant exercise			$ 7,500
Loss on extinguishment of debt					$ (39,846)	$ (109,092)	$ 0
Debt					630,090	669,282
Total Debt					673,249	745,348
Facility Agreement
Debt Instrument [Line Items]
Debt					582,296	586,342
Total Debt					$ 582,296	$ 586,342
8.00% Convertible Senior Unsecured Notes Issued in 2009
Debt Instrument [Line Items]
Convertible debt, consecutive trading days threshold					30 days
Debt conversion amount	$ 37,800
Conversion of notes into shares of common stock	34,500,000
Exercise price of warrants					$ 0	$ 0.32
Conversion price per share of common stock					$ 1.14
Aggregate principal amount convertible notes maximum borrowing capacity					$ 55,000
Outstanding Warrants					0	39,842,813			15,300,000
Convertible notes stated interest rate					8.00%	8.00%
Loss on extinguishment of debt				$ 4,300
Fair value of compound embedded derivative									$ 23,542
Fair value of 5.0% Warrants									12,791
Debt					$ 0	$ 33,795			18,667
Total Debt					$ 0	$ 51,652			$ 55,000
5.0% Convertible Senior Unsecured Notes
Debt Instrument [Line Items]
Debt conversion amount		$ 17,500
Conversion of notes into shares of common stock		51,900,000
Exercise price of warrants					$ 0.32	$ 0.32		$ 0.32
Conversion price per share of common stock							$ 1.25	$ 0.50
Outstanding Warrants					8,000,000	8,000,000
Convertible notes stated interest rate					5.00%		5.00%
Proceeds from warrant exercise					$ 2,000
Percentage of debt purchase price		100.00%
Fair value of compound embedded derivative							$ 1,503
Fair value of 5.0% Warrants							8,081
Debt							11,316
Total Debt							$ 38,000

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Warrants Outstanding) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Apr. 15, 2013	Dec. 31, 2012	Dec. 31, 2010
Class of Warrant or Right [Line Items]
Outstanding Warrants	38,191,866	93,516,401
Contingent Equity Agreement
Class of Warrant or Right [Line Items]
Outstanding Warrants	30,191,866	41,467,980
Strike Price	$ 0.01	$ 0.01
Warrant exercise period	5 years
Thermo Loan Agreement
Class of Warrant or Right [Line Items]
Outstanding Warrants	0	4,205,608
Strike Price	$ 0	$ 0.01
Warrant exercise period	5 years
5.0% Convertible Senior Unsecured Notes
Class of Warrant or Right [Line Items]
Outstanding Warrants	8,000,000	8,000,000
Strike Price	$ 0.32	$ 0.32	$ 0.32
Loan interest rate	5.00%			5.00%
Warrant exercise period	5 years
8.00% Convertible Senior Unsecured Notes Issued in 2009
Class of Warrant or Right [Line Items]
Outstanding Warrants	0	39,842,813			15,300,000
Strike Price	$ 0	$ 0.32
Loan interest rate	8.00%	8.00%

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Maturities of Long-term Debt) (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013	Jul. 31, 2013	May 20, 2013
Debt Disclosure [Abstract]
2015	$ 6,450
2016	32,835
2017	75,755
2018	100,665
2019	94,870
Thereafter	362,674
Total	$ 673,249
8.00% Convertible Senior Notes Issued in 2013
Debt Instrument [Line Items]
Loan interest rate	8.00%	8.00%	8.00%	8.00%

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS (Terrapin Opportunity, L.P. Common Stock Purchase Agreement) (Details)
$ / shares in Units, $ in Thousands

1 Months Ended

3 Months Ended

12 Months Ended

Dec. 27, 2013

USD ($)

$ / shares

^[2]

Oct. 14, 2013

$ / shares

Oct. 14, 2013

$ / shares

Aug. 19, 2013

USD ($)

$ / shares

^[2]

Jul. 29, 2013

USD ($)

$ / shares

^[2]

Jun. 28, 2013

USD ($)

$ / shares

^[3]

May 21, 2013

USD ($)

$ / shares

^[3]

May 20, 2013

USD ($)

$ / shares

^[3]

Dec. 28, 2012

USD ($)

Feb. 28, 2015

USD ($)

$ / shares

Jun. 30, 2013

USD ($)

Sep. 30, 2013

USD ($)

Jun. 30, 2013

USD ($)

Dec. 31, 2014

USD ($)

draw_down_notice

Dec. 31, 2013

USD ($)

Debt Instrument [Line Items]

Maximum value of shares required to be purchased per terms of stock purchase agreement | $

$ 30,000

Stock purchase agreement term

24 months

Number Of Draw Down Notices | draw_down_notice

Draw Down Period

10 days

Minimum discount percentage per each share purchased under the stock purchase agreement

3.50%

Maximum discount percentage per each share purchased under the stock purchase agreement

8.00%

Maximum beneficial ownership percentage allowed per terms of stock purchase agreement

9.90%

Issuance of stock, shares | shares

25,961,538

^[1]

38,500,000

11,538,462

12,500,000

^[1]

11,538,462

^[1]

28,125,000

^[1]

15,625,000

^[1]

78,125,000

^[1]

28,125,000

24,000,000

121,900,000

Amount Invested | $

$ 13,500

$ 6,500

$ 6,000

$ 9,000

$ 5,000

$ 25,000

$ 9,000

$ 12,500

$ 39,000

$ 65,000

Shares issued, price per share (USD per share) | $ / shares

$ 0.52

$ 0.32

Common Stock

Debt Instrument [Line Items]

Issuance of stock, shares | shares

47,067,000

Terrapin

Debt Instrument [Line Items]

Amount Invested | $

$ 6,000

Terrapin | Subsequent Event

Debt Instrument [Line Items]

Issuance of stock, shares | shares

4,500,000

Draws on line of credit | $

$ 10,000

Shares issued, price per share (USD per share) | $ / shares

$ 2.22

Terrapin | Common Stock

Debt Instrument [Line Items]

Issuance of stock, shares | shares

6,100,000

6,131,000

[1]	All shares issued to Thermo in connection with these agreements were shares of the Company’s nonvoting common stock.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[3]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.

DERIVATIVES (Schedule of Fair Value of Derivative Instruments) (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Derivative assets:
Intangible and other assets, net	$ 46	$ 185
Derivative liabilities:
Derivative liabilities, current	0	(57,048)
Derivative liabilities, non-current	(441,550)	(405,478)
Derivative Liabilities:	(441,550)	(462,526)
Interest rate cap
Derivative assets:
Intangible and other assets, net	46	185
Warrants issued with 8.00% Notes Issued in 2009
Derivative liabilities:
Derivative liabilities, current	0	(57,048)
Compound embedded derivative with 8.00% Notes Issued in 2009
Derivative liabilities:
Derivative liabilities, non-current	0	(66,022)
Compound embedded derivative with 8.00% Notes Issued in 2013
Derivative liabilities:
Derivative liabilities, non-current	(79,040)	(109,794)
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement
Derivative liabilities:
Derivative liabilities, non-current	$ (362,510)	$ (229,662)

DERIVATIVES (Schedule of Derivative Gain (Loss)) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	$ (286,049)	$ (305,999)	$ 6,974
Interest rate cap
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(139)	101	(171)
Warrants issued with 8.00% Notes Issued in 2009
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(67,523)	(54,518)	4,218
Compound embedded derivative with 8.00% Notes Issued in 2009
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(16,406)	(61,859)	2,546
Warrants issued in conjunction with Contingent Equity Agreement
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	0	0	302
Contingent put feature embedded in the 5.0% Notes
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	0	2,978	79
Compound embedded derivative with 8.00% Notes Issued in 2013
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(69,133)	(64,153)	0
Compound embedded derivative with the Amended and Restated Thermo Loan Agreement
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	$ (132,848)	$ (128,548)	$ 0

DERIVATIVES (Additional Information) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2014 USD ($) contracts	Dec. 31, 2013 USD ($)
Derivative [Line Items]
Derivative Liability	$ 441,550	$ 462,526
Interest rate cap
Derivative [Line Items]
Number of Interest rate cap agreements \| contracts	5
Interest rate cap agreements period	10 years
Interest rate cap \| Six-month LIBOR Rate
Derivative [Line Items]
Base rate to be capped, should the Base Rate not exceed 6.50%	5.50%
Interest on outstanding amounts on the Facility Agreement	6.50%
Base rate to be lowered from LIBOR, should the base rate exceed 6.50%	1.00%
Fee for interest rate cap agreements	$ 12,400
Warrants issued in conjunction with Contingent Equity Agreement
Derivative [Line Items]
Amortization period	1 year
Contingent put feature embedded in the 5.0% Notes
Derivative [Line Items]
Derivative Liability		$ 0

FAIR VALUE MEASUREMENTS (Financial Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	$ (441,550)	$ (462,526)
Contingent put feature embedded in the 5.0% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:		0
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	46	185
Derivative Liabilities:		(462,526)
Liability for contingent consideration		(1,923)
Total liabilities measured at fair value	(441,550)	(464,449)
Fair Value, Measurements, Recurring \| Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	46	185
Fair Value, Measurements, Recurring \| Warrants issued with 8.00% Notes Issued in 2009
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	(57,048)
Fair Value, Measurements, Recurring \| Compound embedded derivative with 8.00% Notes Issued in 2009
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	(66,022)
Fair Value, Measurements, Recurring \| Compound embedded derivative with 8.00% Notes Issued in 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	(79,040)	(109,794)
Fair Value, Measurements, Recurring \| Compound embedded derivative with the Amended and Restated Thermo Loan Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	(362,510)
Fair Value, Measurements, Recurring \| Contingent put feature embedded in the 5.0% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:		(229,662)
Fair Value, Measurements, Recurring \| (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	0	0
Derivative Liabilities:		0
Liability for contingent consideration		0
Total liabilities measured at fair value	0	0
Fair Value, Measurements, Recurring \| (Level 1) \| Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	0	0
Fair Value, Measurements, Recurring \| (Level 1) \| Warrants issued with 8.00% Notes Issued in 2009
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	0
Fair Value, Measurements, Recurring \| (Level 1) \| Compound embedded derivative with 8.00% Notes Issued in 2009
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	0
Fair Value, Measurements, Recurring \| (Level 1) \| Compound embedded derivative with 8.00% Notes Issued in 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	0
Fair Value, Measurements, Recurring \| (Level 1) \| Compound embedded derivative with the Amended and Restated Thermo Loan Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0
Fair Value, Measurements, Recurring \| (Level 1) \| Contingent put feature embedded in the 5.0% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:		0
Fair Value, Measurements, Recurring \| (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	46	185
Liability for contingent consideration		0
Fair Value, Measurements, Recurring \| (Level 2) \| Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	46	185
Fair Value, Measurements, Recurring \| (Level 2) \| Warrants issued with 8.00% Notes Issued in 2009
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	0
Fair Value, Measurements, Recurring \| (Level 2) \| Compound embedded derivative with 8.00% Notes Issued in 2009
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	0
Fair Value, Measurements, Recurring \| (Level 2) \| Compound embedded derivative with 8.00% Notes Issued in 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	0
Fair Value, Measurements, Recurring \| (Level 2) \| Compound embedded derivative with the Amended and Restated Thermo Loan Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0
Fair Value, Measurements, Recurring \| (Level 2) \| Contingent put feature embedded in the 5.0% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:		0
Fair Value, Measurements, Recurring \| (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:		(462,526)
Liability for contingent consideration		(1,923)
Total liabilities measured at fair value	(441,550)	(464,449)
Fair Value, Measurements, Recurring \| (Level 3) \| Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets:	0	0
Fair Value, Measurements, Recurring \| (Level 3) \| Warrants issued with 8.00% Notes Issued in 2009
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	(57,048)
Fair Value, Measurements, Recurring \| (Level 3) \| Compound embedded derivative with 8.00% Notes Issued in 2009
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	0	(66,022)
Fair Value, Measurements, Recurring \| (Level 3) \| Compound embedded derivative with 8.00% Notes Issued in 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	(79,040)	(109,794)
Fair Value, Measurements, Recurring \| (Level 3) \| Compound embedded derivative with the Amended and Restated Thermo Loan Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:	$ (362,510)
Fair Value, Measurements, Recurring \| (Level 3) \| Contingent put feature embedded in the 5.0% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities:		$ (229,662)

FAIR VALUE MEASUREMENTS (Schedule of Significant Quantitative Level 3 Inputs Utilized) (Details) - $ / shares

12 Months Ended

Jul. 31, 2013

May 20, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 27, 2013

^[2]

Aug. 19, 2013

^[2]

Jul. 29, 2013

^[2]

Jun. 28, 2013

^[1]

May 21, 2013

^[1]

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Share Price

$ 0.40

^[1]

$ 2.75

$ 1.82

$ 0.62

$ 0.55

$ 0.40

Compound embedded derivative with 8.00% Notes Issued in 2013

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Risk-Free Interest Rate

0.90%

1.20%

1.50%

Note Conversion Price/Warrant Exercise Price

$ 0.80

$ 0.73

Discount Rate

27.00%

Share Price

$ 0.40

$ 2.75

$ 1.75

Compound embedded derivative with 8.00% Notes Issued in 2013 | Minimum

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

65.00%

70.00%

65.00%

Compound embedded derivative with 8.00% Notes Issued in 2013 | Maximum

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

100.00%

Compound embedded derivative with the Amended and Restated Thermo Loan Agreement

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Risk-Free Interest Rate

2.60%

2.10%

3.00%

Note Conversion Price/Warrant Exercise Price

$ 0.75

$ 0.73

Discount Rate

26.00%

Share Price

$ 0.60

$ 2.75

$ 1.75

Compound embedded derivative with the Amended and Restated Thermo Loan Agreement | Minimum

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

65.00%

50.00%

65.00%

Compound embedded derivative with the Amended and Restated Thermo Loan Agreement | Maximum

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

100.00%

Compound embedded derivative with 8.00% Notes Issued in 2009

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Risk-Free Interest Rate

1.50%

Note Conversion Price/Warrant Exercise Price

$ 1.14

Share Price

$ 1.75

Compound embedded derivative with 8.00% Notes Issued in 2009 | Minimum

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

65.00%

Note Conversion Price/Warrant Exercise Price

$ 1.00

Compound embedded derivative with 8.00% Notes Issued in 2009 | Maximum

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

100.00%

Warrants issued with 8.00% Notes Issued in 2009

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]

Stock Price Volatility

100.00%

Risk-Free Interest Rate

0.10%

Note Conversion Price/Warrant Exercise Price

$ 0.32

Share Price

$ 1.745

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.

FAIR VALUE MEASUREMENTS (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	12 Months Ended
	Dec. 31, 2009	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2010
Fair Value Measurements [Line Items]
Share price percentage increase		58.00%
Axonn [Member]
Fair Value Measurements [Line Items]
Contingent consideration for earnouts		$ 9.6		$ 10.8
Additional earnout payment period	5 years
Common stock, shares outstanding				26,684,807
Company outstanding common stock, percent				10.00%
Shares to be issued to exercise cash payment option for earnout payments				13,000,000
Earnout payments		$ 9.1
Issuance of voting common stock shares for settlement of earnout payments		18,835,762
Fair value of contingent consideration		$ 0.5
Compound embedded derivative with 8.00% Notes Issued in 2009
Fair Value Measurements [Line Items]
Exercise price (USD per share)			$ 1.14
Compound embedded derivative with 8.00% Notes Issued in 2009 \| Minimum
Fair Value Measurements [Line Items]
Exercise price (USD per share)		$ 1.00

FAIR VALUE MEASUREMENTS (Reconciliation of Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2014 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at December 31, 2013	$ (464,449)
Unrealized loss, included in derivative gain (loss)	(285,910)
Balance at December 31, 2014	(441,550)
Guarantees
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Earnout payments made/Adjustments related to conversions and exercises/Derecognition of derivative liability embedded in 5.0% Notes	1,923
Derivative Financial Instruments, Liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Earnout payments made/Adjustments related to conversions and exercises/Derecognition of derivative liability embedded in 5.0% Notes	$ 306,886

FAIR VALUE MEASUREMENTS (Nonrecurring Fair Value Measurements) (Details) - USD ($) $ in Thousands, shares in Millions			3 Months Ended			12 Months Ended
	Jul. 19, 2013	May 20, 2013	Dec. 31, 2014	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability			$ 441,550			$ 441,550	$ 462,526
Loss on extinguishment of debt						(39,846)	(109,092)	$ 0
Debt instrument, carrying amount			$ 673,249			673,249
8.00% Convertible Senior Notes Issued in 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of notes payable		$ 27,900
Derivative liability		56,700
Fair value of Loan Agreement		84,642
Loss on extinguishment of debt						$ (44,100)	$ 4,200
Debt conversion, shares issued	14.3		60.3
Debt conversion, value of shares issued		54,600
Thermo Loan Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of notes payable				$ 19,000
Derivative liability				101,100
Fair value of Loan Agreement				120,100
Loss on extinguishment of debt				$ (66,100)	$ (66,100)
5.75% Convertible Senior Unsecured Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of notes payable		119,000
Loss on extinguishment of debt		(47,200)
Debt instrument, carrying amount		$ 71,800
Debt conversion, shares issued		30.3
Debt conversion, value of shares issued		$ 12,100

FAIR VALUE MEASUREMENTS (Schedule of Amounts Invested) (Details) - USD ($)
$ / shares in Units, $ in Thousands

1 Months Ended

3 Months Ended

12 Months Ended

Dec. 27, 2013

^[1]

Oct. 14, 2013

Aug. 19, 2013

^[1]

Jul. 29, 2013

^[1]

Jun. 28, 2013

^[2]

May 21, 2013

^[2]

May 20, 2013

^[2]

Jun. 30, 2013

Sep. 30, 2013

Jun. 30, 2013

Dec. 31, 2014

Dec. 31, 2013

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Amount Invested

$ 13,500

$ 6,500

$ 6,000

$ 9,000

$ 5,000

$ 25,000

$ 9,000

$ 12,500

$ 39,000

$ 65,000

Shares issued, price per share (USD per share)

$ 0.52

$ 0.32

Closing Price per Share (USD per share)

$ 1.82

$ 0.62

$ 0.55

$ 0.40

$ 2.75

Discount Value

^[3]

$ 33,750

$ 1,250

$ 1,154

$ 6,469

$ 1,250

$ 6,250

Issuance of stock

$ 47,250

$ 20,000

$ 7,750

$ 7,154

$ 15,469

$ 6,250

$ 31,250

$ 114,211

Number of shares issued

25,961,538

^[4]

38,500,000

11,538,462

12,500,000

^[4]

11,538,462

^[4]

28,125,000

^[4]

15,625,000

^[4]

78,125,000

^[4]

28,125,000

24,000,000

121,900,000

Other capital contributions from Thermo

20,000

Additional Paid-In Capital

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Issuance of stock

114,206

Consent Agreement

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Amount Invested

^[5]

65,000

Discount Value

^[3],[5]

50,123

Issuance of stock

^[5]

$ 115,123

Number of shares issued

^[4],[5]

171,875,000

Consent Agreement | Additional Paid-In Capital

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of investment

53,000

Common Stock Purchase and Option Agreement | Additional Paid-In Capital

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of investment

$ 62,200

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[3]	The discount on shares issued is recorded on the Company’s consolidated statement of operations in loss on equity issuance. This expense item represents the discount on shares issued to Thermo as well as certain other losses recorded on equity issued during 2013 related to cashless exercises of warrants issued with the 5.0% Notes.
[4]	All shares issued to Thermo in connection with these agreements were shares of the Company’s nonvoting common stock.
[5]	Pursuant to the terms of the Consent Agreement, certain equity transactions which result in cash invested into Globalstar may reduced the amounts committed by Thermo. Since the execution of the Consent Agreement, the Company had received approximately $20.0 million through warrant exercises and other equity issuances in addition to amounts received through the Company’s exercise of the First Option under the Common Stock Purchase and Option Agreement (see Note 3: Long-Term Debt and Other Financing Arrangements for further discussion).

FAIR VALUE MEASUREMENTS (Schedule of Nonrecurring Fair Value Measurements) (Details) - Nonrecurring - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Total Losses
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Property and equipment, net	$ 84	$ 7,218
Assets:	84	7,218
(Level 1)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Property and equipment, net	0	0
Assets:	0	0
(Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Property and equipment, net	0	0
Assets:	0	0
(Level 3)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Property and equipment, net	1,113,560	1,215,156
Assets:	$ 1,113,560	$ 1,215,156

FAIR VALUE MEASUREMENTS (Impairment of Long-Lived Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2012
Fair Value Disclosures [Abstract]
Asset impairment charges	$ 0.1	$ 7.1

COMMITMENTS (Contractual Obligations) (Details) $ in Thousands	Dec. 31, 2014 USD ($)
COMMITMENTS [Abstract]
2015	$ 28,964
2016	8,033
2017	0
2018	0
2019	0
Thereafter	0
Total purchase commitments	$ 36,997

COMMITMENTS (Additional Information) (Details)		1 Months Ended		3 Months Ended	6 Months Ended	12 Months Ended
COMMITMENTS (Additional Information) (Details)	Jul. 01, 2014 USD ($)	Jul. 31, 2014 USD ($)	May 31, 2014 USD ($)	Jun. 30, 2014 USD ($)	Jun. 30, 2014 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2014 EUR (€)	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)
Commitments [Line Items]
Issuance of common stock to vendor for payment of invoices						$ 10,687,000		$ 9,227,000	$ 0
Advances for inventory						196,000		9,359,000
Increase (decrease) in inventories						(4,187,000)		(3,124,000)	1,018,000
Cost of subscriber equipment sales - reduction in the value of inventory						21,684,000		$ 5,794,000	$ 1,397,000
Qualcomm Incorporated
Commitments [Line Items]
Advances for inventory				$ 9,200,000	$ 9,200,000	$ 2,000,000
Increase (decrease) in inventories		$ 100,000
Cost of subscriber equipment sales - reduction in the value of inventory		7,300,000
Hughes Network Systems LLC
Commitments [Line Items]
Discount for payment in stock						7.00%	7.00%
Value of shares issued						$ 14,400,000
Loss on issuance of stock						1,000,000
Decrease in contractual obligations			$ 3,800,000.0
Shares granted, discount from market price			0.07
Issuance of common stock to vendor for payment of invoices	$ 9,900,000
Gain (loss) on change in award valuation				$ 700,000
Ericsson Inc.
Commitments [Line Items]
Accounts payable and accrued expenses						3,000,000
Deferred payments interest rate incurred					6.50%
Costs incurred under capital expenditure contracts						11,200,000
Deferred milestone payments						$ 1,000,000
Purchase commitment, remaining minimum amount committed		$ 25,400,000
Support Services \| Thales Alenia Space
Commitments [Line Items]
Satellite support services, contract term						3 years	3 years
Support services, contract amount \| €							€ 1,900,000
Support services, contract credit amount \| €							600,000.0
Support services, first annual payment contract amount \| €							€ 0

COMMITMENTS (Future Minimum Lease Obligations) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
COMMITMENTS [Abstract]
2015	$ 1,237
2016	1,152
2017	1,148
2018	1,083
2019	269
Thereafter	375
Total minimum lease payments	5,264
Rent expense	$ 1,400	$ 2,000	$ 2,000

CONTINGENCIES (Details) $ in Thousands				3 Months Ended	12 Months Ended
CONTINGENCIES (Details) $ in Thousands	Jun. 24, 2012 EUR (€)	May 10, 2012 EUR (€)	Jun. 03, 2011 satellite	Sep. 30, 2014 EUR (€)	Dec. 31, 2014 USD ($)	Dec. 31, 2014 EUR (€)	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)
Loss Contingencies [Line Items]
Number of satellites \| satellite			25
Contract termination charge \| $					$ 0		$ 0	$ 22,048
Thales Alenia Space
Loss Contingencies [Line Items]
Contract termination, damages awarded		€ 51,330,875.00
Contract termination charge		€ 53,000,000		€ 17,500,000
Gain on release of liability	€ 35,600,000
Settlement amount						€ 17,500,000

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accrued expenses:
Accrued interest	$ 827	$ 1,200
Accrued compensation and benefits	2,597	3,927
Accrued property and other taxes	6,727	5,744
Accrued customer liabilities and deposits	2,751	2,663
Accrued professional and other service provider fees	1,925	705
Accrued liability for contingent consideration	481	1,922
Accrued commissions	686	1,316
Accrued telecommunications expenses	1,135	649
Accrued satellite and ground costs	1,531	0
Other accrued expenses	3,682	4,574
Total accrued expenses	22,342	22,700
Summary of activity in the warranty reserve account:
Balance at beginning of period	142	235	$ 179
Provision	246	189	293
Utilization	(259)	(282)	(237)
Balance at end of period	129	142	$ 235
Non-current liabilities:
Long-term accrued interest	131	451
Asset retirement obligation	1,184	1,083
Deferred rent	404	456
Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana	1,391	1,575
Uncertain income tax positions	6,061	5,918
Foreign tax contingencies	3,034	4,213
Total noncurrent liabilities	$ 12,205	$ 13,696

ACCRUED EXPENSES AND NON-CURRENT LIABILITIES Headquarters Relocation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2012	Dec. 31, 2013
Restructuring Cost and Reserve [Line Items]
Relocation expenses		$ 4,500
Increase in property and equipment facility improvements and replacement equipment in connection with relocation		$ 1,300
Liabilities related to the Cooperative Endeavor Agreement with the State of Louisiana	$ 1,391		$ 1,575
Maximum \| Cooperative Endeavor Agreement
Restructuring Cost and Reserve [Line Items]
Cost of reimbursement expense	8,100
Contract Termination
Restructuring Cost and Reserve [Line Items]
Reimbursement for lease and other expense per year through 2019	$ 352

RELATED PARTY TRANSACTIONS (Additional Information) (Details) - USD ($)
$ in Thousands

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Dec. 27, 2013

^[1]

Oct. 14, 2013

Aug. 19, 2013

^[1]

Jul. 29, 2013

^[1]

Jun. 28, 2013

^[2]

May 21, 2013

^[2]

May 20, 2013

^[2]

Aug. 31, 2014

Oct. 31, 2013

Aug. 31, 2013

Jun. 30, 2013

Jun. 30, 2009

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Jul. 31, 2013

Dec. 31, 2011

Dec. 31, 2010

Payables to Thermo and other affiliates

$ 500

Amount Invested

$ 13,500

$ 6,500

$ 6,000

$ 9,000

$ 5,000

$ 25,000

$ 9,000

$ 12,500

$ 39,000

$ 65,000

Proceeds from contingent equity agreement

$ 1,100

1,071

$ 45,800

Loss on sale of equity issuance

$ 14,000

16,701

Loss on extinguishment of debt

$ (39,846)

$ (109,092)

Number of shares issued

25,961,538

^[3]

38,500,000

11,538,462

12,500,000

^[3]

11,538,462

^[3]

28,125,000

^[3]

15,625,000

^[3]

78,125,000

^[3]

28,125,000

24,000,000

121,900,000

Outstanding Warrants

93,516,401

38,191,866

93,516,401

Payables to affiliates

$ 202

$ 481

$ 202

Thermo Capital Partners LLC

Deposit to contingent equity account

60,000

Short-term loan converted into nonvoting common stock

2,300

Maximum borrowing capacity

37,500

Amount Invested

13,500

Issuance of stock for legal settlements, other issuances of stock and other transactions, shares

2,133,656

Discount on shares

20.00%

Loss on sale of equity issuance

16,373

Fair value of Loan Agreement

$ 120,100

Loss on extinguishment of debt

$ (66,100)

$ (66,088)

$ 0

Thermo Capital Partners LLC | 5.0% Convertible Senior Unsecured Notes

Notes purchased by related party

20,000

Thermo Capital Partners LLC | 8.00% Convertible Senior Unsecured Notes Issued in 2009

Notes purchased by related party

$ 11,400

Thermo Loan Agreement

Fair value of Loan Agreement

$ 120,100

Loss on extinguishment of debt

$ (66,100)

Outstanding Warrants

4,205,608

Thermo Loan Agreement | Thermo Capital Partners LLC

Maximum borrowing capacity

$ 25,000

$ 37,500

Fair value of Loan Agreement

$ 120,072

Number of common stock to be purchased with warrant

4,205,608

4,200,000

Number of shares issued

4,200,000

8.00% Convertible Senior Unsecured Notes Issued in 2009

Maximum borrowing capacity

$ 55,000

Loss on extinguishment of debt

$ 4,300

Number of shares issued

14,700,000

Outstanding Warrants

39,842,813

15,300,000

Contingent Equity Agreement

Number of common stock to be purchased with warrant

11,300,000

Number of shares issued

11,300,000

Outstanding Warrants

41,467,980

30,191,866

41,467,980

Contingent Equity Agreement | Thermo Capital Partners LLC

Discount on shares

20.00%

5.0% Convertible Senior Unsecured Notes

Number of common stock to be purchased with warrant

15,200,000

Outstanding Warrants

8,000,000

Nonvoting Common Stock

Number of shares issued

171,900,000

Number of shares of non-voting common stock converted (shares)

175,000,000

[1]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase and Option Agreement. The fair value of these investments of $62.2 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[2]	Amounts were invested pursuant to the terms of the Consent Agreement and the Common Stock Purchase Agreement. The fair value of these investments of $53.0 million is recorded in additional paid-in-capital on the Company’s consolidated balance sheet.
[3]	All shares issued to Thermo in connection with these agreements were shares of the Company’s nonvoting common stock.

RELATED PARTY TRANSACTIONS (Expense Incurred on Behalf of Company) (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Related Party Transaction [Line Items]
Non-cash expenses			$ 0	$ 16,701	$ 0
Loss on sale of equity issuance		$ 14,000	0	16,701	0
Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement			39,846	109,092	0
Thermo Capital Partners LLC
Related Party Transaction [Line Items]
General and administrative expenses			274	268	180
Non-cash expenses			548	548	529
Loss on sale of equity issuance			0	16,373	0
Loss on extinguishment of debt related to amendment and restatement of Thermo Loan Agreement	$ 66,100		0	66,088	0
Total			$ 822	$ 83,277	$ 709

PENSIONS AND OTHER EMPLOYEE BENEFITS (Defined Benefit Pension Obligation and Funded Status) (Details) - Pension Plans - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Change in projected benefit obligation:
Projected benefit obligation, beginning of year	$ 16,685	$ 18,804
Service cost	103	85	$ 66
Interest cost	781	671	712
Actuarial (gain) loss	(2,489)	1,796
Benefits paid	(1,126)	(1,079)
Projected benefit obligation, end of year	18,932	16,685	18,804
Change in fair value of plan assets:
Fair value of plan assets, beginning of year	13,156	11,583
Return on plan assets	673	1,985
Employer contributions	730	667
Benefits paid	(1,126)	(1,079)
Fair value of plan assets, end of year	13,433	13,156	$ 11,583
Funded status, end of year- net liability	$ (5,499)	$ (3,529)

PENSIONS AND OTHER EMPLOYEE BENEFITS (Net Benefit Cost) (Details) - Pension Plans - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net periodic benefit cost:
Service cost	$ 103	$ 85	$ 66
Interest cost	781	671	712
Expected return on plan assets	(932)	(813)	(739)
Amortization of unrecognized net actuarial loss	281	518	583
Total net periodic benefit cost	$ 233	$ 461	$ 622

PENSIONS AND OTHER EMPLOYEE BENEFITS (Amounts Recognized) (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Funded status recognized in other non-current liabilities	$ (5,499)	$ (3,529)
Net actuarial loss recognized in accumulated other comprehensive loss	6,950	4,484
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Funded status recognized in other non-current liabilities	(5,499)	(3,529)
Net actuarial loss recognized in accumulated other comprehensive loss	6,950	4,484
Net amount recognized in retained deficit	$ 1,451	$ 955

PENSIONS AND OTHER EMPLOYEE BENEFITS (Assumptions) (Details) - Pension Plans	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Benefit obligation assumptions:
Discount rate	4.03%	4.80%	3.75%
Net periodic benefit cost assumptions:
Discount rate	4.80%	3.75%	4.00%
Expected rate of return on plan assets	7.12%	7.12%	7.12%

PENSIONS AND OTHER EMPLOYEE BENEFITS (Schedule of Plan's Asset Allocations) (Details) - Pension Plan, Defined Benefit	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Plan Assets and Investment Policies and Strategies
Asset allocations	100.00%	100.00%
Equity securities
Plan Assets and Investment Policies and Strategies
Target allocation, minimum	50.00%
Target allocation, maximum	60.00%
Asset allocations	56.00%	57.00%
Debt securities
Plan Assets and Investment Policies and Strategies
Target allocation, minimum	25.00%
Target allocation, maximum	50.00%
Asset allocations	30.00%	29.00%
Other investments
Plan Assets and Investment Policies and Strategies
Target allocation, minimum	0.00%
Target allocation, maximum	15.00%
Asset allocations	14.00%	14.00%

PENSIONS AND OTHER EMPLOYEE BENEFITS (Schedule of Fair Value of Pension Plan Assets) (Details) - Pension Plan, Defined Benefit - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 13,433	$ 13,156	$ 11,583
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	13,433	13,156
Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
United States equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,103	6,119
United States equity securities \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
United States equity securities \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,103	6,119
United States equity securities \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
International equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,356	1,435
International equity securities \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
International equity securities \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,356	1,435
International equity securities \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Fixed income securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4,034	3,749
Fixed income securities \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Fixed income securities \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4,034	3,749
Fixed income securities \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,940	1,853
Other \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,940	1,853
Other \| Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 0	$ 0

PENSIONS AND OTHER EMPLOYEE BENEFITS (Accumulated Benefit Obligation and Benefits Payments and Contributions) (Details) - Pension Plans - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	$ 7,000	$ 4,500
Benefit payments expected to be paid during the following fiscal years:
2015	970
2016	965
2017	956
2018	970
2019	993
2020 - 2024	5,163
Employer contributions	$ 730	$ 667

PENSIONS AND OTHER EMPLOYEE BENEFITS (401(k) Plan) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
401(K) Plan
Defined Contribution Plan Disclosure [Line Items]
Contributions to employee benefits plan	$ 0.3	$ 0.2	$ 0.1

TAXES (Components of Income Tax Expense (Benefit)) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Change in deferred tax asset valuation allowance	$ (143,500)	$ 206,000
Current:
Federal tax (benefit)	0	0	$ 0
State tax	20	240	274
Foreign tax	2,430	898	139
Total	2,450	1,138	413
Deferred:
Federal and state tax (benefit)	0	0	0
Foreign tax (benefit)	(1,569)	0	0
Total	(1,569)	0	0
Income tax expense (benefit)	$ 881	$ 1,138	$ 413

TAXES (Schedule of U.S. and Foreign Components of Income (Loss) Before Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
U.S. income (loss)	$ (461,250)	$ (585,801)	$ (105,722)
Foreign income (loss)	(735)	(4,177)	(6,063)
Loss before income taxes	$ (461,985)	$ (589,978)	$ (111,785)

TAXES (Additional Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Line Items]
Change in deferred tax asset valuation allowance	$ (143.5)	$ 206.0
Undistributed earnings of the Company's foreign subsidiaries	9.7
Internal Revenue Service (IRS)
Income Tax Disclosure [Line Items]
Net operating loss carry forwards	1,300.0	1,100.0
Foreign Tax Authority
Income Tax Disclosure [Line Items]
Net operating loss carry forwards	159.2	179.1
Tax liability	$ 1.1	$ 2.2

TAXES (Schedule of Components of Net Deferred Tax Assets) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Federal and foreign net operating loss and credit carry-forwards	$ 554,122	$ 492,839
Property and equipment and other long-term assets	111,891	53,196
Accruals and reserves	29,315	4,240
Deferred tax assets before valuation allowance	695,328	550,275
Valuation allowance	(693,759)	(550,275)
Net deferred income tax assets	1,569	0
Change in deferred tax asset valuation allowance	$ (143,500)	$ 206,000

TAXES (Schedule of Actual Provision for Income Taxes to Statutory U.S. Federal Income Tax Rate) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Provision at U.S. statutory rate of 35%	$ (161,702)	$ (206,576)	$ (39,125)
State income taxes, net of federal benefit	(27,656)	(34,923)	(6,070)
Change in valuation allowance	143,484	206,022	40,641
Effect of foreign income tax at various rates	243	508	759
Permanent differences	33,138	38,911	(220)
Change in unrecognized tax benefit	(3,839)	388	381
Recognition of pre-acquisition losses in Brazil	0	0	0
Net Change in permanent items due to provision to tax return	21,008	0	0
Other (including amounts related to prior year tax matters)	(3,795)	(3,192)	4,047
Income tax expense (benefit)	$ 881	$ 1,138	$ 413
U.S. statutory rate used	35.00%	35.00%	35.00%

TAXES (Rollforward of Unrecognized Tax Benefits) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Gross unrecognized tax benefits at January 1, 2014	$ 8,073	$ 7,750
Gross decreases based on tax positions related to current year	(3,839)
Gross increases based on tax positions related to prior years	0
Gross increases based on tax positions related to current year		388
Gross increases based on tax positions related to prior years		(65)
Gross unrecognized tax benefits at December 31, 2014	4,234	8,073
Interest and penalties recorded in connection with FIN 48 adjustment	$ 1,800	$ 1,600

GEOGRAPHIC INFORMATION (Information by Geographic Area Revenues) (Details) - USD ($) $ in Thousands	3 Months Ended												12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Service revenues													$ 69,823	$ 64,644	$ 57,468
Subscriber equipment revenues													20,241	18,067	18,850
Total revenue	$ 22,093	$ 23,441	$ 23,994	$ 20,536	$ 20,994	$ 22,549	$ 19,835	$ 19,333	$ 19,062	$ 20,537	$ 19,981	$ 16,738	90,064	82,711	76,318
United States
Segment Reporting Information [Line Items]
Service revenues													46,519	44,909	41,139
Subscriber equipment revenues													10,931	11,284	12,899
Canada
Segment Reporting Information [Line Items]
Service revenues													14,584	12,436	10,505
Subscriber equipment revenues													5,668	3,913	3,654
Europe
Segment Reporting Information [Line Items]
Service revenues													5,536	4,085	3,132
Subscriber equipment revenues													2,123	1,708	1,297
Central and South America
Segment Reporting Information [Line Items]
Service revenues													2,623	2,678	2,287
Subscriber equipment revenues													1,279	1,094	798
Others
Segment Reporting Information [Line Items]
Service revenues													561	536	405
Subscriber equipment revenues													$ 240	$ 68	$ 202

GEOGRAPHIC INFORMATION (Information by Geographic Area, Long-Lived Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	$ 1,113,560	$ 1,169,785
United States
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	1,108,675	1,164,358
Canada
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	357	247
Europe
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	413	408
Central and South America
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	3,309	3,595
Others
Segment Reporting, Asset Reconciling Item [Line Items]
Property and equipment, net	$ 806	$ 1,177

STOCK COMPENSATION (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Jul. 31, 2013	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incremental compensation cost	$ 0.6	$ 0.8
2006 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares authorized for issuance			23,463,563	15,873,930
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			4 years
Expiration period			10 years
Unrecognized compensation cost related to non-vested stock options			$ 2.9
Unrecognized compensation cost, recognition period			1 year 7 months 6 days
Nonstatutory Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares modified	2,710,000
Share price triggering vesting	$ 0.80			$ 2.50
Restricted Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares modified	273,000
Share price triggering vesting	$ 0.80			$ 2.50

STOCK COMPENSATION (Fair Value Assumptions) (Details) - Employee Stock Option - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period	10 years
Risk-free interest rate, minimum	1.00%	1.00%	1.00%
Risk-free interest rate, maximum	2.00%	2.00%	1.00%
Expected term of options	5 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	72.00%
Volatility, minimum		72.00%	80.00%
Volatility, maximum		115.00%	103.00%
Weighted average grant-date fair value per share	$ 1.67	$ 0.70	$ 0.39
Expected dividend yield	$ 0.00	$ 0.00	$ 0.00
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term of options		2 years	1 year
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term of options		6 years	5 years

STOCK COMPENSATION (Summary of Stock Option Activity) (Details) - Employee Stock Option - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Shares
Outstanding at January 1, 2014	8,236,855
Granted	1,670,100
Exercised	(1,899,725)
Forfeited or expired	(268,325)
Outstanding at December 31, 2014	7,738,905	8,236,855
Exercisable at December 31, 2014	4,827,320
Weighted Average Exercise Price (USD per share)
Outstanding at January 1, 2014	$ 0.98
Granted	2.80
Exercised	0.72
Forfeited or expired	1.27
Outstanding at December 31, 2014	1.33	$ 0.98
Exercisable at December 31, 2014	$ 0.94
Shares
Nonvested stock options at January 1, 2014	3,156,759
Granted	1,670,100
Vested	(1,695,479)
Forfeited or expired	(219,795)
Nonvested stock options at December 31, 2014	2,911,585	3,156,759
Weighted Average Grant Date Fair Value (USD per share)
Nonvested stock options at January 1, 2014	$ 0.72
Granted	1.67	$ 0.70	$ 0.39
Vested	0.75
Forfeited or expired	0.80
Nonvested stock options at December 31, 2014	$ 1.20	$ 0.72

STOCK COMPENSATION STOCK COMPENSATION (Intrinsic Value) (Details) - Employee Stock Option - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from stock options exercised	$ 1,300
Intrinsic value of stock options exercised	5,083	$ 2,263	$ 78
Options, outstanding, intrinsic value	$ 11,100
Weighted average remaining contractual term	7 years
Vested and expected to vest, outstanding, aggregate intrinsic value	$ 8,600
Weighted average remaining contractual term	6 years 4 months 8 days

STOCK COMPENSATION (Stock Option Compensation Expense) (Details) - Employee Stock Option - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Expiration period	10 years
Vesting period	4 years
Total compensation expense, net of tax	$ 1.5	$ 0.5	$ 0.7

STOCK COMPENSATION (Restricted Stock) (Details) - Restricted Stock - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Shares
Nonvested at January 1, 2014	633,590
Granted	1,146,815
Vested	(945,463)
Forfeited	(26,444)
Nonvested at December 31, 2014	808,498	633,590
Weighted Average Grant Date Fair Value (USD per share)
Nonvested at January 1, 2014	$ 1.68
Granted	3.32	$ 1.06	$ 0.71
Vested	2.70
Forfeited	1.88
Nonvested at December 31, 2014	$ 2.81	$ 1.68
Allocation of compensation expense:
Total compensation expense, net of tax	$ 1.6	$ 0.1	$ 0.1
Unrecognized compensation cost related to unvested restricted shares	$ 2.0
Unrecognized compensation cost, recognition period	2 years 1 month 2 days

STOCK COMPENSATION (Employee Stock Purchase Plan) (Details) - Employee Stock Purchase Plan [Member] - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	100.00%
Total shares authorized for issuance	7,000,000
Percentage of share that can be purchased by eligible employees to their total compensation	15.00%
Maximum value of shares that can be purchased by eligible employee	$ 25,000
Maximum number of shares that can be purchased by eligible employee	500,000
Percentage of fair market value of common stock payed by employee	85.00%
Proceeds from shares issued under stock purchase plan	$ 500,000	$ 400,000
Stock-based compensation expense	$ 400,000	$ 200,000
Issuance of stock through employee stock purchase plan, shares	2,608,765
Assumptions used to value employees' stock purchase rights:
Expected term of options	6 months	6 months
Volatility, minimum		80.00%
Volatility, maximum		107.00%
Weighted average grant-date fair value per share	$ 1.24	$ 0.21

ACCUMULATED OTHER COMPREHENSIVE LOSS (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated minimum pension liability adjustment	$ (6,950)	$ (4,484)
Accumulated net foreign currency translation adjustment	4,052	5,355
Total accumulated other comprehensive income (loss)	$ (2,898)	$ 871

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

CONDENSED CONSOLIDATING FINANCIAL INFORMATION - (Supplemental Consolidating Balance Sheet) (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 7,121	$ 17,408	$ 11,792	$ 9,951
Accounts receivable	15,015	15,723
Intercompany receivables	0	0
Inventory	14,734	31,817
Advances for inventory	196	9,359
Prepaid expenses and other current assets	7,748	7,059
Total current assets	44,814	81,366
Property and equipment, net	1,113,560	1,169,785
Restricted cash	37,918	37,918
Intercompany notes receivable	0	0
Investment in subsidiaries	0	0
Deferred financing costs	63,862	76,436
Intangible and other assets, net	8,266	7,103
Total assets	1,268,420	1,372,608
Current liabilities:
Current portion of long-term debt	6,450	4,046
Accounts payable	6,922	14,627
Accrued contract termination charge	21,308	24,133
Accrued expenses	22,342	22,700
Intercompany payables	0	0
Payables to affiliates	481	202
Derivative liabilities	0	57,048
Deferred revenue	21,740	17,284
Total current liabilities	79,243	140,040
Long-term debt, less current portion	623,640	665,236
Employee benefit obligations	5,499	3,529
Intercompany notes payable	0	0
Derivative liabilities	441,550	405,478
Deferred revenue	6,572	7,079
Debt restructuring fees	20,795	20,795
Other non-current liabilities	12,205	13,696
Total non-current liabilities	1,110,261	1,115,813
Total stockholders’ equity	78,916	116,755	494,544	533,795
Total liabilities and stockholders’ equity	1,268,420	1,372,608
Reportable Legal Entities \| Parent Company
Current assets:
Cash and cash equivalents	3,166	12,935	10,220	7,343
Accounts receivable	4,470	5,925
Intercompany receivables	755,482	651,251
Inventory	2,018	1,161
Advances for inventory	125	9,287
Prepaid expenses and other current assets	3,340	4,316
Total current assets	768,601	684,875
Property and equipment, net	1,105,670	1,152,734
Restricted cash	37,918	37,918
Intercompany notes receivable	13,006	13,629
Investment in subsidiaries	(265,249)	(209,592)
Deferred financing costs	63,862	76,436
Intangible and other assets, net	6,707	3,964
Total assets	1,730,515	1,759,964
Current liabilities:
Current portion of long-term debt	6,450	4,046
Accounts payable	3,310	9,906
Accrued contract termination charge	21,308	24,133
Accrued expenses	6,638	6,160
Intercompany payables	508,503	435,707
Payables to affiliates	481	202
Derivative liabilities		57,048
Deferred revenue	3,185	1,843
Total current liabilities	549,875	539,045
Long-term debt, less current portion	623,640	665,236
Employee benefit obligations	5,499	3,529
Intercompany notes payable	2,000	0
Derivative liabilities	441,550	405,478
Deferred revenue	6,229	6,583
Debt restructuring fees	20,795	20,795
Other non-current liabilities	2,011	2,543
Total non-current liabilities	1,101,724	1,104,164
Total stockholders’ equity	78,916	116,755
Total liabilities and stockholders’ equity	1,730,515	1,759,964
Reportable Legal Entities \| Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	672	676	251	587
Accounts receivable	5,265	5,022
Intercompany receivables	441,525	414,508
Inventory	8,424	14,375
Advances for inventory	28	28
Prepaid expenses and other current assets	275	311
Total current assets	456,189	434,920
Property and equipment, net	3,002	11,621
Restricted cash	0	0
Intercompany notes receivable	0	0
Investment in subsidiaries	4,734	7,242
Deferred financing costs	0	0
Intangible and other assets, net	541	1,028
Total assets	464,466	454,811
Current liabilities:
Current portion of long-term debt	0	0
Accounts payable	1,755	2,041
Accrued contract termination charge	0	0
Accrued expenses	7,213	8,203
Intercompany payables	563,183	521,763
Payables to affiliates	0	0
Derivative liabilities		0
Deferred revenue	15,378	13,094
Total current liabilities	587,529	545,101
Long-term debt, less current portion	0	0
Employee benefit obligations	0	0
Intercompany notes payable	0	0
Derivative liabilities	0	0
Deferred revenue	343	496
Debt restructuring fees	0	0
Other non-current liabilities	294	297
Total non-current liabilities	637	793
Total stockholders’ equity	(123,700)	(91,083)
Total liabilities and stockholders’ equity	464,466	454,811
Reportable Legal Entities \| Non-Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	3,283	3,797	1,321	2,021
Accounts receivable	4,955	4,602
Intercompany receivables	23,967	18,280
Inventory	4,292	16,281
Advances for inventory	43	44
Prepaid expenses and other current assets	4,133	2,432
Total current assets	40,673	45,436
Property and equipment, net	5,776	6,889
Restricted cash	0	0
Intercompany notes receivable	8,285	4,285
Investment in subsidiaries	30,552	0
Deferred financing costs	0	0
Intangible and other assets, net	1,031	2,125
Total assets	86,317	58,735
Current liabilities:
Current portion of long-term debt	0	0
Accounts payable	1,857	2,680
Accrued contract termination charge	0	0
Accrued expenses	8,491	8,337
Intercompany payables	153,067	128,496
Payables to affiliates	0	0
Derivative liabilities		0
Deferred revenue	3,177	2,347
Total current liabilities	166,592	141,860
Long-term debt, less current portion	0	0
Employee benefit obligations	0	0
Intercompany notes payable	15,148	15,772
Derivative liabilities	0	0
Deferred revenue	0	0
Debt restructuring fees	0	0
Other non-current liabilities	9,900	10,856
Total non-current liabilities	25,048	26,628
Total stockholders’ equity	(105,323)	(109,753)
Total liabilities and stockholders’ equity	86,317	58,735
Elimination
Current assets:
Cash and cash equivalents	0	0	$ 0	$ 0
Accounts receivable	325	174
Intercompany receivables	(1,220,974)	(1,084,039)
Inventory	0	0
Advances for inventory	0	0
Prepaid expenses and other current assets	0	0
Total current assets	(1,220,649)	(1,083,865)
Property and equipment, net	(888)	(1,459)
Restricted cash	0	0
Intercompany notes receivable	(21,291)	(17,914)
Investment in subsidiaries	229,963	202,350
Deferred financing costs	0	0
Intangible and other assets, net	(13)	(14)
Total assets	(1,012,878)	(900,902)
Current liabilities:
Current portion of long-term debt	0	0
Accounts payable	0	0
Accrued contract termination charge	0	0
Accrued expenses	0	0
Intercompany payables	(1,224,753)	(1,085,966)
Payables to affiliates	0	0
Derivative liabilities		0
Deferred revenue	0	0
Total current liabilities	(1,224,753)	(1,085,966)
Long-term debt, less current portion	0	0
Employee benefit obligations	0	0
Intercompany notes payable	(17,148)	(15,772)
Derivative liabilities	0	0
Deferred revenue	0	0
Debt restructuring fees	0	0
Other non-current liabilities	0	0
Total non-current liabilities	(17,148)	(15,772)
Total stockholders’ equity	229,023	200,836
Total liabilities and stockholders’ equity	$ (1,012,878)	$ (900,902)

CONDENSED CONSOLIDATING FINANCIAL INFORMATION - (Supplemental Consolidating Statement of Operations) (Details) - USD ($) $ in Thousands	3 Months Ended												12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues:
Service revenues													$ 69,823	$ 64,644	$ 57,468
Subscriber equipment sales													20,241	18,067	18,850
Total revenue	$ 22,093	$ 23,441	$ 23,994	$ 20,536	$ 20,994	$ 22,549	$ 19,835	$ 19,333	$ 19,062	$ 20,537	$ 19,981	$ 16,738	90,064	82,711	76,318
Operating expenses:
Cost of services (exclusive of depreciation, amortization and accretion shown separately below)													29,668	30,210	30,071
Cost of subscriber equipment sales													14,857	13,623	13,280
Cost of subscriber equipment sales - reduction in the value of inventory													21,684	5,794	1,397
Marketing, general and administrative													33,520	29,888	27,496
Reduction in the value of long-lived assets													84	0	7,218
Contract termination charge													0	0	22,048
Depreciation, amortization and accretion													86,146	90,592	69,801
Total operating expenses													185,959	170,107	171,311
Loss from operations													(95,895)	(87,396)	(94,993)
Other income (expense):
Loss on extinguishment of debt													(39,846)	(109,092)	0
Loss on equity issuance							(14,000)						0	(16,701)	0
Interest income and expense, net of amounts capitalized													(43,233)	(67,828)	(21,486)
Derivative gain (loss)													(286,049)	(305,999)	6,974
Equity in subsidiary earnings													0	0	0
Other													3,038	(2,962)	(2,280)
Total other income (expense)													(366,090)	(502,582)	(16,792)
Loss before income taxes													(461,985)	(589,978)	(111,785)
Income tax expense													881	1,138	413
Net loss	$ 92,015	$ 129,390	$ (433,730)	$ (250,541)	$ (234,797)	$ (204,969)	$ (126,272)	$ (25,078)	$ (18,952)	$ (41,188)	$ (27,533)	$ (24,525)	(462,866)	(591,116)	(112,198)
Reportable Legal Entities \| Parent Company
Revenues:
Service revenues													75,590	69,250	48,845
Subscriber equipment sales													434	87	825
Total revenue													76,024	69,337	49,670
Operating expenses:
Cost of services (exclusive of depreciation, amortization and accretion shown separately below)													11,320	10,498	12,061
Cost of subscriber equipment sales													2,220	0	292
Cost of subscriber equipment sales - reduction in the value of inventory													7,362	0	0
Marketing, general and administrative													7,171	5,929	2,874
Reduction in the value of long-lived assets													44		79
Contract termination charge															22,048
Depreciation, amortization and accretion													76,656	72,456	49,132
Total operating expenses													104,773	88,883	86,486
Loss from operations													(28,749)	(19,546)	(36,816)
Other income (expense):
Loss on extinguishment of debt													(39,846)	(109,092)
Loss on equity issuance														(16,701)
Interest income and expense, net of amounts capitalized													(42,636)	(66,688)	(19,744)
Derivative gain (loss)													(286,049)	(305,999)	6,974
Equity in subsidiary earnings													(67,150)	(69,790)	(60,302)
Other													1,564	(3,097)	(2,078)
Total other income (expense)													(434,117)	(571,367)	(75,150)
Loss before income taxes													(462,866)	(590,913)	(111,966)
Income tax expense													0	203	232
Net loss													(462,866)	(591,116)	(112,198)
Reportable Legal Entities \| Guarantor Subsidiaries
Revenues:
Service revenues													5,069	10,695	44,208
Subscriber equipment sales													14,568	13,704	15,225
Total revenue													19,637	24,399	59,433
Operating expenses:
Cost of services (exclusive of depreciation, amortization and accretion shown separately below)													9,586	10,559	9,467
Cost of subscriber equipment sales													9,492	10,860	11,827
Cost of subscriber equipment sales - reduction in the value of inventory													6,776	1,300	1,274
Marketing, general and administrative													16,253	15,109	16,860
Reduction in the value of long-lived assets													40		7,139
Contract termination charge															0
Depreciation, amortization and accretion													10,176	21,286	48,869
Total operating expenses													52,323	59,114	95,436
Loss from operations													(32,686)	(34,715)	(36,003)
Other income (expense):
Loss on extinguishment of debt													0	0
Loss on equity issuance														0
Interest income and expense, net of amounts capitalized													(34)	(42)	(10)
Derivative gain (loss)													0	0	0
Equity in subsidiary earnings													(4,734)	(7,242)	10,237
Other													593	(257)	(141)
Total other income (expense)													(4,175)	(7,541)	10,086
Loss before income taxes													(36,861)	(42,256)	(25,917)
Income tax expense													20	37	41
Net loss													(36,881)	(42,293)	(25,958)
Reportable Legal Entities \| Non-Guarantor Subsidiaries
Revenues:
Service revenues													22,252	18,536	15,729
Subscriber equipment sales													11,212	15,452	7,855
Total revenue													33,464	33,988	23,584
Operating expenses:
Cost of services (exclusive of depreciation, amortization and accretion shown separately below)													9,401	9,062	8,762
Cost of subscriber equipment sales													11,861	16,319	7,560
Cost of subscriber equipment sales - reduction in the value of inventory													7,546	4,494	123
Marketing, general and administrative													14,947	13,620	12,288
Reduction in the value of long-lived assets													0		0
Contract termination charge															0
Depreciation, amortization and accretion													25,270	24,103	17,308
Total operating expenses													69,025	67,598	46,041
Loss from operations													(35,561)	(33,610)	(22,457)
Other income (expense):
Loss on extinguishment of debt													0	0
Loss on equity issuance														0
Interest income and expense, net of amounts capitalized													(563)	(1,096)	(1,731)
Derivative gain (loss)													0	0	0
Equity in subsidiary earnings													0	0	0
Other													1,411	209	16
Total other income (expense)													848	(887)	(1,715)
Loss before income taxes													(34,713)	(34,497)	(24,172)
Income tax expense													861	898	140
Net loss													(35,574)	(35,395)	(24,312)
Elimination
Revenues:
Service revenues													(33,088)	(33,837)	(51,314)
Subscriber equipment sales													(5,973)	(11,176)	(5,055)
Total revenue													(39,061)	(45,013)	(56,369)
Operating expenses:
Cost of services (exclusive of depreciation, amortization and accretion shown separately below)													(639)	91	(219)
Cost of subscriber equipment sales													(8,716)	(13,556)	(6,399)
Cost of subscriber equipment sales - reduction in the value of inventory													0	0	0
Marketing, general and administrative													(4,851)	(4,770)	(4,526)
Reduction in the value of long-lived assets													0		0
Contract termination charge															0
Depreciation, amortization and accretion													(25,956)	(27,253)	(45,508)
Total operating expenses													(40,162)	(45,488)	(56,652)
Loss from operations													1,101	475	283
Other income (expense):
Loss on extinguishment of debt													0	0
Loss on equity issuance														0
Interest income and expense, net of amounts capitalized													0	(2)	(1)
Derivative gain (loss)													0	0	0
Equity in subsidiary earnings													71,884	77,032	50,065
Other													(530)	183	(77)
Total other income (expense)													71,354	77,213	49,987
Loss before income taxes													72,455	77,688	50,270
Income tax expense													0	0	0
Net loss													$ 72,455	$ 77,688	$ 50,270

CONDENSED CONSOLIDATING FINANCIAL INFORMATION - (Supplemental Consolidating Statement of Cash Flows) (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Aug. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities		$ 3,981	$ (6,462)	$ 6,874
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		(14,604)	(43,693)	(56,679)
Property and equipment additions		(4,673)	(1,651)	(781)
Investment in businesses		0	(634)	(550)
Restricted Cash		0	8,859	0
Net cash used in investing activities		(19,277)	(37,119)	(58,010)
Cash flows from financing activities:
Payments to reduce principal amount of exchanged 5.75% Notes		0	(13,544)	0
Payments for 5.75% Notes not exchanged		0	(6,250)	0
Payments to lenders and other fees associated with exchange		0	(2,482)	0
Proceeds from equity issuance to related party		0	65,000	0
Proceeds from issuance of stock to Terrapin		0	6,000	0
Proceeds from issuance of common stock and stock options		9,547	15,414	244
Borrowings from Facility Agreement		0	672	7,375
Principal payments of the Facility Agreement		(4,046)	0	0
Proceeds from contingent equity account	$ 1,100	0	1,071	45,800
Payment of deferred financing costs		(164)	(16,909)	(1,033)
Net cash provided by financing activities		5,337	48,972	52,386
Effect of exchange rate changes on cash and cash equivalents		(328)	225	591
Net (decrease) increase in cash and cash equivalents		(10,287)	5,616	1,841
Cash and cash equivalents, beginning of period		17,408	11,792	9,951
Cash and cash equivalents, end of period		7,121	17,408	11,792
Reportable Legal Entities \| Parent Company
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities		2,770	(10,789)	7,720
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		(14,604)	(43,693)	(56,679)
Property and equipment additions		(3,272)	0	0
Investment in businesses		0	(634)	(550)
Restricted Cash		0	8,859
Net cash used in investing activities		(17,876)	(35,468)	(57,229)
Cash flows from financing activities:
Payments to reduce principal amount of exchanged 5.75% Notes			(13,544)
Payments for 5.75% Notes not exchanged			(6,250)
Payments to lenders and other fees associated with exchange			(2,482)
Proceeds from equity issuance to related party			65,000
Proceeds from issuance of stock to Terrapin			6,000
Proceeds from issuance of common stock and stock options		9,547	15,414	244
Borrowings from Facility Agreement			672	7,375
Principal payments of the Facility Agreement		(4,046)
Proceeds from contingent equity account			1,071	45,800
Payment of deferred financing costs		(164)	(16,909)	(1,033)
Net cash provided by financing activities		5,337	48,972	52,386
Effect of exchange rate changes on cash and cash equivalents		0	0	0
Net (decrease) increase in cash and cash equivalents		(9,769)	2,715	2,877
Cash and cash equivalents, beginning of period		12,935	10,220	7,343
Cash and cash equivalents, end of period		3,166	12,935	10,220
Reportable Legal Entities \| Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities		983	1,524	61
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		0	0	0
Property and equipment additions		(987)	(1,099)	(397)
Investment in businesses		0	0	0
Restricted Cash		0	0
Net cash used in investing activities		(987)	(1,099)	(397)
Cash flows from financing activities:
Payments to reduce principal amount of exchanged 5.75% Notes			0
Payments for 5.75% Notes not exchanged			0
Payments to lenders and other fees associated with exchange			0
Proceeds from equity issuance to related party			0
Proceeds from issuance of stock to Terrapin			0
Proceeds from issuance of common stock and stock options		0		0
Borrowings from Facility Agreement			0	0
Principal payments of the Facility Agreement		0
Proceeds from contingent equity account			0	0
Payment of deferred financing costs		0	0	0
Effect of exchange rate changes on cash and cash equivalents		0	0	0
Net (decrease) increase in cash and cash equivalents		(4)	425	(336)
Cash and cash equivalents, beginning of period		676	251	587
Cash and cash equivalents, end of period		672	676	251
Reportable Legal Entities \| Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities		228	2,803	(907)
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		0	0	0
Property and equipment additions		(414)	(552)	(384)
Investment in businesses		0	0	0
Restricted Cash		0	0
Net cash used in investing activities		(414)	(552)	(384)
Cash flows from financing activities:
Payments to reduce principal amount of exchanged 5.75% Notes			0
Payments for 5.75% Notes not exchanged			0
Payments to lenders and other fees associated with exchange			0
Proceeds from equity issuance to related party			0
Proceeds from issuance of stock to Terrapin			0
Proceeds from issuance of common stock and stock options		0		0
Borrowings from Facility Agreement			0	0
Principal payments of the Facility Agreement		0
Proceeds from contingent equity account			0	0
Payment of deferred financing costs		0	0	0
Effect of exchange rate changes on cash and cash equivalents		(328)	225	591
Net (decrease) increase in cash and cash equivalents		(514)	2,476	(700)
Cash and cash equivalents, beginning of period		3,797	1,321	2,021
Cash and cash equivalents, end of period		3,283	3,797	1,321
Elimination
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities		0	0	0
Cash flows from investing activities:
Second-generation satellites, ground and related launch costs		0	0	0
Property and equipment additions		0	0	0
Investment in businesses		0	0	0
Restricted Cash		0	0
Cash flows from financing activities:
Payments to reduce principal amount of exchanged 5.75% Notes			0
Payments for 5.75% Notes not exchanged			0
Payments to lenders and other fees associated with exchange			0
Proceeds from equity issuance to related party			0
Proceeds from issuance of stock to Terrapin			0
Proceeds from issuance of common stock and stock options		0	0	0
Borrowings from Facility Agreement			0	0
Principal payments of the Facility Agreement		0
Proceeds from contingent equity account			0	0
Payment of deferred financing costs		0	0	0
Effect of exchange rate changes on cash and cash equivalents		0	0	0
Cash and cash equivalents, beginning of period		0	0	0
Cash and cash equivalents, end of period		$ 0	$ 0	$ 0

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended												12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Information Disclosure [Abstract]
Total revenue	$ 22,093	$ 23,441	$ 23,994	$ 20,536	$ 20,994	$ 22,549	$ 19,835	$ 19,333	$ 19,062	$ 20,537	$ 19,981	$ 16,738	$ 90,064	$ 82,711	$ 76,318
Net loss	$ 92,015	$ 129,390	$ (433,730)	$ (250,541)	$ (234,797)	$ (204,969)	$ (126,272)	$ (25,078)	$ (18,952)	$ (41,188)	$ (27,533)	$ (24,525)	$ (462,866)	$ (591,116)	$ (112,198)
Basic loss per common share (USD per share)	$ 0.09	$ 0.13	$ (0.48)	$ (0.29)	$ (0.36)	$ (0.30)	$ (0.25)	$ (0.05)	$ (0.05)	$ (0.10)	$ (0.07)	$ (0.07)	$ (0.50)	$ (0.96)	$ (0.29)
Diluted loss per common share (USD per share)	$ 0.08	$ 0.11	$ (0.48)	$ (0.29)	$ (0.36)	$ (0.30)	$ (0.25)	$ (0.05)	$ (0.05)	$ (0.10)	$ (0.07)	$ (0.07)	$ (0.50)	$ (0.96)	$ (0.29)
Shares used in basic per share calculations	993,427	987,668	904,994	849,321	779,483	673,546	496,169	472,187	424,180	392,344	379,433	357,418	934,356	614,959	388,453
Shares used in diluted per share calculations	1,192,263	1,189,190	904,994	849,321	779,483	673,546	496,169	472,187	424,180	392,344	379,433	357,418	934,356	614,959	388,453

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

QUARTERLY FINANCIAL INFORMATION Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended												12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Basic (shares)	993,427	987,668	904,994	849,321	779,483	673,546	496,169	472,187	424,180	392,344	379,433	357,418	934,356	614,959	388,453
Stock options, restricted stock, restricted stock units and ESPP	7,557	7,340
Warrants	39,004	45,088
Diluted (shares)	1,192,263	1,189,190	904,994	849,321	779,483	673,546	496,169	472,187	424,180	392,344	379,433	357,418	934,356	614,959	388,453
Thermo Loan Agreement
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Incremental common shares attributable to dilutive effect of conversion of debt securities	114,083	109,469
Conversions of 8.00% Notes, Issued in 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Incremental common shares attributable to dilutive effect of conversion of debt securities	38,192	39,625